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ABSTRACT

TOTAL SYNTHESIS OF ()-ENIGMAZOLE A
Yanran Ai
Amos B. Smith, III

The dissertation contained herein presents a total synthesis of ()-enigmazole
A utilizing a late-stage large-fragment Petasis-Ferrier union/rearrangement protocol.
Chapter One details the isolation, structural elucidation and subsequent biological
studies of ()-enigmazole A. The previous synthetic studies of ()-enigmazole A are
also introduced. The chapter then outlines the Smith three-step Petasis-Ferrier
union/rearrangement protocol, as well as a number of the successful total syntheses
achieved over the years by the Smith group utilizing this protocol. Herein, a late-stage
large-fragment Petasis-Ferrier union/rearrangement will be utilized as the synthetic
cornerstone for the Smith total synthesis of ()-enigmazole A.
Chapter Two describes the retrosynthetic strategy toward ()-enigmazole A
and subsequent total synthesis. The late-stage large-fragment Petasis-Ferrier
union/rearrangement, which generates the entire carbon skeleton of ()-enigmazole A,
is described after the construction of the requisite eastern and western hemispheres.
The chapter then describes the subsequent macrolactonization studies and the end
game of the total synthesis. In addition to the Smith three-step Petasis-Ferrier
union/rearrangement protocol, highlights of the total synthesis includes a Negishi
cross-coupling, a dithiane-epoxide union, a Type I ARC multicomponent coupling, a
Yamaguchi macrolactonization, chemoselective oxidation/reduction strategies, as well
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as an efficient protection group strategy, the details of which are also described in
Chapter Two.
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Chapter 1. Introduction
1.1. Isolation and Biological Activity of the Enigmazoles
The enigmazoles A (1.1), and B (1.4), as well as related congeners, constitute the
first and to date only family of known phosphate-containing marine macrolides. Isolated
by Gustafson and coworkers at the National Cancer Institute in 2006 from Cinachyrella
enigmatica, a marine sponge endemic to Papua New Guinea,1 the extracts from
Cinachyrella enigmatica displayed significant cytotoxic activity in the NCI 60-cell
antitumor screen.2 Perhaps of greater interest, several of the fractions were shown to
inhibit mutant c-Kit containing cells selectively, while cells containing wild-type c-Kit
were relatively unaffected. This differentiation comprises a rare phenotype, thus far
observed only in 32 natural product extracts out of the 134,631 extracts tested at the NIH
to date.3 The mutation of c-Kit, a type-III receptor tyrosine kinase (RTK), has been
implicated in a number of cancers.4,5 With the goal of developing novel cancer
therapeutics, exploration of the most highly active chromatographic fractions of the
Cinachyrella enigmatica sponge extract led to the identification of the enigmazoles
(Figure 1.1).
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Figure 1.1. Structure of Enigmazole A, B and Related Congeners
In 2010, a full paper was published by Gustafson and coworkers presenting the
isolation, elucidation and biological activities of the enigmazole family.6 Their studies
revealed that enigmazole A (1.1) was the primary cytotoxic constituent of the
Cinachyrella enigmatica extract. In particular, enigmazole A was found to be highly
cytotoxic against IC-2 mast cells (IC50 = 0.37μg/mL), and against the 60 human tumor
cell lines with a mean activity of GI50 of 1.7 μM in the NCI 60-cell antitumor assay. This
bioactivity data illustrates the potential of enigmazole A (1.1), thus making it an
important new lead compound for the treatment of multiple cancer types. However, the
lack of a diagnostic pattern in the tumor panel specificity assay has made it difficult to
2

identify precisely the possible molecular target and/or a pathway associated with the
observed bioactivity.1,7 Although the original isolated extract fraction displayed
selectivity against c-Kit mutant cells, both enigmazole A (1.1) and the congeners (1.2 and
1.3) were equally cytotoxic against both wild-type and mutant c-Kit. Evidence however
suggests that other compounds bearing the enigmazole core, either enigmazole B (1.4) or
additional enigmazole analogues, might be responsible for the selectivity in the c-Kit
assays.1,8 Due to the limited amount of enigmazole analogues available from the natural
source, the synthesis of the enigmazoles and future chemical derivatization resulting in
analogues would hold the promise of identifying the cellular targets and pathways
involved, as well as improving both the antitumor activity and the mutation c-Kit
selectivity.
In addition to the potent biological activity, the structural complexity and
uniqueness of the enigmazoles provides the chemical community with an excellent
platform for the further development of synthetic methods and strategies. For example,
enigmazole A (1.1) is composed of an 18-member macrolide, with an embedded
methylene cis-2,6-disubstituted tetrahydropyran ring, a functionalized disubstituted
oxazole side-chain at C17, and a phosphate ester at C5. This type of functional group
array is rare in polyketide natural products. Careful examination of the structures of
enigmazole A (1.1) and B (1.4) in the Smith research group led to a synthetic plan,
whereby synthetic methods recently developed in our laboratory, including of PetasisFerrier union/rearrangement9 and Anion Relay Chemistry (ARC)10 could be applied.
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1.2. Previous Synthetic Studies of (-)-Enigmazole A
In addition to the Smith research group, the promising biological activity and
complicated architecture of enigmazole A (1.1), have attracted attention from a number of
organic groups, resulting in the first total synthesis of enigmazole A published by
Molinski and coworkers in 2010.11
One of the key reactions of the Molinski synthesis was a hetero-Diels-Alder
(HDA) reaction leading to the construction of the embedded tetrahydropyran structure
(Scheme 1.1). To this end, treatment of a mixture of aldehyde 1.7 and diene 1.8 with a
catalytic amount of BF3·OEt2 furnished the desired product 1.9 in 81% yield with a
diastereomer ratio of 4.2: 1.0: 0.25. The subsequent steps, including a Wittig olefination,
led to 1.10, which was then transformed into the requisite macrolactonization precursor
1.11, after selective hydrogenation, saponification and acetonide removal. Another key
reaction in the Molinski synthetic sequence was a chemoselective macrolactonization,
which selectively formed the macrolactone ring at C17 hydroxyl rather than at the C15
hydroxyl. Initial screening of a variety of mactolactonization conditions, however, did not
lead to desired product 1.12, but either gave the 16-member macrolide by activation of
C15 hydroxyl or complex intractable mixtures.
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Scheme 1.1. Molinski’s Synthesis of Enigmazole A: HDA Cycloaddition
To alter the conformation of the macrolactonization precursor to achieve
lactonization, intermediate 1.10 was subjected to macrolactonization after both methyl
ester hydrolysis and acetonide removal (Scheme 1.2). To Molinski’s delight, the Keck
conditions then successfully furnished the desired 18-member macrolide 1.12, albeit in
only 35% yield over the 3 step sequence. A further 6 steps were required to complete the
natural product total synthesis. In summary, Molinski and co-workers achieved the first
total synthesis of enigmazole A (1.1) in 22 steps and 0.41% yield from a known
compound.
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Scheme 1.2. Molinski’s Total Synthesis of Enigmazole A: Macrolactonizaion
Fürstner and co-workers also published a synthetic effort toward enigmazole A
in 2013.12 To increase the structural span/impact of their alkyne metathesis, they designed
a synthesis toward a model compound related to the enigmazole A core (Scheme 1.3).
Starting from alkyne 1.13, which was prepared in turn by the alkyne metathesis, DDQ
oxidation and the subsequent gold-catalyzed Meyer-Schuster rearrangement furnished
racemic cis-disubstituted tetrahydropyran 1.15. Acetyl deprotection then gave racemic
ketone 1.16, which the authors considered to be the core of enigmazole A (1.1).

Scheme 1.3. Fürstner’s Model Study Toward the Core of Enigmazole A
In the Smith research group, enigmazole A was considered an excellent candidate
both to showcase and improve the synthetic methods currently being developed. Thus,
Smith and colleagues proposed a highly convergent and stereocontrolled route utilizing a
novel late-stage large-fragment Petasis-Ferrier union/rearrangement tactic, as well as both
anion relay chemistry (ARC) and a dithiane-epoxide coupling tactic. Their synthetic plan
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shared no similarity with either the Molinski total synthesis or the Fürstner model study.

1.3. Petasis-Ferrier Union/Rearrangement – A Successful Tactic for Complex
Molecule Total Synthesis

Scheme 1.4. An Example of the Petasis-Ferrier Union/Rearrangement Protocol in a
Complex Molecule Total Synthesis
1.3.1. Development of the Petasis-Ferrier Union/Rearrangement
The pioneering work leading to the Petasis-Ferrier union/rearrangement tactic
was first published in 1962 by Ferrier and coworkers (Scheme 1.5).13 In this seminal
publication, they suggested a process involving the formation of oxocarbonium ion 1.17
in the six membered ring system, as well as a subsequent nucleophilic addition. This
synthetic tactic, named the Ferrier rearrangement, was extended in 1979 to the Ferrier
carbocyclization.14 The process involves the fragmentation of hemiacetal 1.19, promoted
by a Lewis acid, resulting in the formation of aldehyde 1.21, which undergoes a
rearrangement to β-hydroxy cyclohexanone 1.22 by an intramolecular aldol reaction.
Ferrier’s pioneering work provided a perfect starting point for the design of the PetasisFerrier union/rearrangement, including: (i) formation and fragmentation of acetal type
7

substrates; (ii) formation of oxocarbonium ions or other carbonyl intermediates as
electrophiles; and (iii) an intramolacular aldol-type nucleophilic addition to a carbonyl
intermediate.

Scheme 1.5. Ferrier Rearrangement and Carbocyclization
Twenty years later, Petasis and co-workers envisioned use of the Ferrier
rearrangement to construct the tetrahydropyran ring systems (Scheme 1.6).15 The starting
material of the Petasis cascade, enol-acetal 1.23, comprises a variant of the Ferrier
substrate (1.20 in Scheme 1.5). Triisobutylaluminum [Al(i-Bu)3] promoted the
rearrangement of enol-acetal 1.23 and an intramolecular Aldol-type addition to
oxocarbonium ion 1.24 to furnish tetrahydropyranone 1.25. However, the reaction
sequence did not yield ketone 1.25 but instead underwent a subsequent nonstereoselective
Meerwein-Pondorf-Verley reduction, to give rise to tetrahydropyranol 1.26 as final
product. Although this method held promise for the construction of a variety of
tetrahydropyran moieties, application in the synthesis of complex natural products was
hindered due to the formation of the tetrahydropyranol 1.26, often as a racemic mixture
depending on the specific substrate. Further studies were required to achieve
stereochemical control at the carbonyl center in unsymmetrical systems for efficient
8

synthesis of complex molecules.

Scheme 1.6. Petasis’ Synthesis of Tetrahydropyranol
In the late 1990s, Smith and co-workers recognized the considerable promise of
this rearrangement vis-à-vis the construction of architecturally complex natural products,
and thus designed a three step Petasis-Ferrier union/rearrangement protocol to construct
cis-2,6-disubstituted

tetrahydropyran

natural

product

fragments

in

a

highly

stereocontrolled fashion (Scheme 1.7).9 To this end, bis-silylation of a chiral non-racemic
β-hydroxy acid (1.27) with HMDS, followed by the addition of an aldehyde (1.28) and a
catalytic amount of TMSOTf, led to the union product dioxanone (1.29). Subsequent
olefination utilizing either the Tebbe16 or Petasis17 protocol, resulted in the formation of
an enol-acetal (1.30). Lewis acid-promoted rearrangement then furnished the desired cis2,6-disubstituted tetrahydropyranone (1.32) via ring opening, bond rotation and ring
closure. Further chemical modification of tetrahydropyranone (1.32) could then yield
other nonracemic pyran analogues (i.e., tetrahydropyran, tetrahydropyranol and
methylene-tetrahydropyan), which comprise important constructs in some natural product
targets.
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Scheme 1.7. The Smith 3 Step Protocol of Petasis-Ferrier Union/Rearrangement
The Smith three step protocol, which was designed and developed for application
in natural product total synthesis, has become a commonly utilized Petasis-Ferrier
union/rearrangement protocol and has proven crucial in a number of the successful total
syntheses achieved over the years by the Smith group. Examples include (+)phorboxazole A, (+)-zampanolide, (+)-dactylolide, (+)-spongistatins 1 and 2, ()kendomycin, ()-clavosolide A and ()-okilactomycin (vide infra).9
1.3.2. Application of the Petasis-Ferrier Union/Rearrangement in Natural Product
Total Synthesis
The Petasis-Ferrier union/rearrangement protocol, specifically the Smith three
step cascade, has gradually become an established tactic in the Smith group for natural
product total synthesis.
The architecturally complex marine natural product (+)-phorboxazole A (1.33)
was the first target in which the Petasis-Ferrier union/rearrangement protocol was utilized
by the Smith laboratory.18,19 Two highly functionalized 2,6-cis-tetrahydropyran fragments
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(1.34, 1.35) were constructed using this method. Importantly, the practicality of this
synthesis established the utility of this three step tactic (Scheme 1.8).
During a model study for the synthesis of tetrahydropyranone 1.35, a screen
involving a number of Lewis acids was carried out, culminating in the identification of
Me2AlCl as the most appropriate promoter. Use of Me2AlCl led to the highest yield and
importantly avoided the troublesome subsequent reduction that was incurred with the use
of the originally used reagent Al(i-Bu)3 employed by Petasis. Following the experience
gained from this model study, synthetic efforts toward tetrahydropyranone 1.35 were
undertaken.20 Unfortunately, initial attempts to carry out the rearrangement employing
enol-acetal 1.39 did not result in the formation of any of the desired product 1.35, due to
strong chelation between the aluminum and oxazole nitrogen. Therefore a secondgeneration Petasis-Ferrier rearrangement precursor enol-acetal 1.38 was constructed by
exchange of the β-hydroxy acid and aldehyde coupling partners. Gratifyingly,
rearrangement of new precursor 1.38 led to the desired product (1.35) in excellent yield
(Scheme 1.7).
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Scheme 1.8. Petasis-Ferrier Union/Rearrangement in the Total Synthesis of (+)Phorboxazole A
Encouraged by the first successful preparation of a natural product fragment
utilizing the Petasis-Ferrier union/rearrangement protocol, focus turned to the synthesis
of the cis-disubstituted tetrahydropyran fragment (1.34) of (+)-phorboxazole A (1.33)
(Scheme 1.8).21 The challenge of this synthesis was the need to control formation of two
stereocenters at C23 and C25, only one of which could be pre-installed on the union
precursor. To solve this problem, an E/Z mixture of olefin 1.43 was constructed.
Pleasingly, subjection of the mixture of isomers (1.43) to Me2AlCl led to a single
diastereomer (1.34) in excellent yield. This transformation was viewed as a divergentconvergent event.
12

During the second-generation synthetic study toward (+)-phorboxazole A (1.33),
the three step protocol underwent further development.22,23,24 In particular, by use of a
more concentrated solution of the Petasis reagent and addition of ethyl pivalate, the
reaction time of the Petasis olefination was significantly reduced, thus minimizing the
undesired [2+2] side-reaction between the enol-acetal and excess Petasis reagent. Another
undesirable reaction had also been observed during the large-scale preparation of
fragment 1.35, whereby the Lewis acidity of the Me2AlCl catalyzed the removal of the
primary PMB group. This issue could be easily overcome by the addition of Cs2CO3.
These optimizations permitted the multi-gram synthesis of cis-2,6-tetrahydropyran
moieties.
Construction of a common 2,6-cis-disubstituted tetrahydropyran fragment (1.46)
for the natural products (+)-zampanolide (1.44) and (+)-dactylolide (1.45) comprised the
Smith group’s next encounter with the Petasis-Ferrier union/rearrangement (Scheme
1.9).25,26,27 The successful union reaction between β-hydroxy acid 1.47 and α,βunsaturated aldehyde 1.48 highlighted the important role of TfOH. This acid significantly
improved the yield, particularly for larger scale preparation. Presumably, on small scale a
trace amount of water generated TfOH in situ from TMSOTf, greatly facilitating the
formation of the dioxanone. In the end, the rearrangement of enol-acetal 1.50 led to the
desired product 1.46 in 59% yield, together with 12% of the trans isomer, the formation
of which is likely due to the lack of steric hinderance, which destabilized the 1,3-diaxial
interaction in the chair-like transition state (transition states shown in Scheme 1.9).
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Scheme 1.9. Petasis-Ferrier Union/Rearrangement in the Total Synthesis of (+)Zampanolide
The Petasis-Ferrier union/rearrangement also played an important role in the
Smith total synthesis of the complex natural products spongistatin 1 and 2 (1.51 and 1.52,
respectively) (Scheme 1.10).28 The densely substituted tetrahydropyran 1.53 was
constructed via a Petasis-Ferrier union/rearrangement, followed by the diastereoselective
installation of the C(42) hydroxyl group and base epimerization of C(40) methyl group.
This successful sequence revealed the potential for the installation of additional
stereocenters on the tetrahydropyran ring after the union/rearrangement. Equally
important, the robust nature of the Petasis-Ferrier union/rearrangement reaction was
exemplified by the large-scale synthesis of intermediate 1.53 (>15 g).
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Scheme 1.10. Petasis-Ferrier Union/Rearrangement in the Total Synthesis of
Spongistatins
One of the highlights of Smith’s next total synthesis, ()-kendomycin (1.57), was
the construction of the highly sterically encumbered tetrahydropyran fragment 1.58
utilizing a Petasis-Ferrier union/rearrangement.29,30 Although the TMSOTf promoted
union of β-hydroxy acid 1.59 with the sterically encumbered aldehyde 1.60 proceeded
only in modest yield (59%), the Kurihara condensation protocol,31 involving the use of
TMSOTf and i-PrOTMS, resulted in the formation of the desired intermediate (1.61) in
the considerably improved yield of 77%. After the union/rearrangement procedure,
subsequent methylation and diastereoselective reduction furnished the fully substituted
tetrahydropyranol 1.58 (Scheme 1.11).
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Scheme 1.11. Petasis-Ferrier Union/Rearrangement in the Total Synthesis of (-)Kendomycin
Smith’s synthesis of the natural product (-)-clavosolide A (1.63) next
demonstrated that the Petasis-Ferrier union/rearrangement tactic could be utilized in the
presence of acid-labile functional groups, such as a cyclopropylcarbinyl system (Scheme
1.12).32 The union of β-hydroxy acid 1.65 and cyclopropyl aldehyde 1.66 furnished
dioxanone 1.67 in 94% yield. The addition of 2,6-di-tert-butyl-4-methylpyridine
(DtBMP) was required to prevent decomposition of the acid sensitive product. Equally
important, during the rearrangement step, the rapid addition and quenching of the Lewis
acid proved crucial for construction of the tetrahydropyranone fragment 1.64.
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Scheme 1.12. Petasis-Ferrier Union/Rearrangement in the total Synthesis of (-)Clavosolide A
Smith’s total synthesis of the natural product ()-okilactomycin (1.68) next
demonstrated that acetals could also be employed as a precursor for the Petasis-Ferrier
union/rearrangement (Scheme 1.13).33 To this end, treatment of a mixture of β-hydroxy
acid 1.70 and dimethyl acetal 1.71 under the Kurihara union conditions led to the desired
dioxanone 1.72. Olefination and rearrangement then furnished the desired product (1.69).
This sequence also demonstrated that the union/rearrangement protocol could be carried
out in the presence of a potentially labile alkyl bromide.

Scheme 1.13. Petasis-Ferrier Union/Rearrangement in the Total Synthesis of (-)Okilactomycin
17

In summary, the Smith three-step Petasis-Ferrier union/rearrangement protocol
has now been firmly established and well developed during numerous total synthetic
ventures. The protocol has demonstrated versatility, allowing the use of acid, base and
water sensitive substrates. The ability to interchange the β-hydroxy acid and aldehyde
union partners has also increased the utility of this method. Moreover, construction of
sterically encumbered fragments, including of fully substituted tetrahydropyrans, has
further illustrated the robustness of the union/rearrangement protocol. Stereocenters have
also been installed on all five positions of the tetrahydropyan ring with high
stereochemical fidelity before, during and

after the implementation of the

union/rearrangement protocol. Several additives have also been shown to improve
significantly the efficiency of the reaction. In short, this method has been demonstrated as
a powerful synthetic tool for the construction of complex natural products.
1.3.3. Late-Stage Large-Fragment Petasis Ferrier Union/Rearrangments
Although the efficiency of Petasis-Ferrier union/rearrangement protocol has now
been well established, the protocol has only been used for the construction of small and
medium size building blocks (Figure 1.2). The construction of a late stage intermediate,
such as the entire carbon skeleton of a natural product, utilizing the Petasis-Ferrier
union/rearrangement tactic employing two large fragments, has not until this thesis been
explored. The union and rearrangement of large fragments at the late stage of a total
synthesis would not only reveal the further versatility and robustness of this synthetic
method, by illustrating the tolerance of the reaction conditions to steric hinderance and
multiple functional groups, but would also demonstrate a high degree of convergence,
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which is essential to many successful synthetic plans. We therefore began a project
exploring a late-stage large-fragment Petasis-Ferrier union/rearrangement protocol in the
context of the architecturally complex natural product enigmazole A (1.1), an excellent
target to showcase the extended utility of this method.

Figure 1.2. Petasis-Ferrier Union/Rearrangement Utilized in the Total Syntheses of
Natural Products
For enigmazole A (1.1) (Scheme 1.14) we envisioned the required
macrolactonization precursor (1.70) would possess a tetrahydropyranone core embedded
in the center of a long chain. We reasoned that this intermediate could arise from a latestage Petasis-Ferrier union/rearrangement protocol. During this process, we envisioned
that excellent diastereomeric selectivity would be obtained, thus demonstrating another
advantage of employing large fragments in the union/rearrangement. Previously, during
the total synthesis of (+)-phorboxazole A18 and (+)-zampanolide,25 the Smith group
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revealed that the smaller substituents at the 2,6 positions of tetrahydropyran could
destabilize the 1,3-diaxial interaction in the chair-like rearrangement transition state, thus
leading to the undesired trans-isomer. We reasoned that two large substituents on the
tetrahydropyran ring of intermediate 1.70, derived from large fragments 1.71 and 1.72
would in contrast ensure a significant energy difference between the favored and
disfavored Petasis-Ferrier rearrangement intermediates, thus leading to satisfactory
diastereoselective control.

Scheme 1.14. Petasis-Ferrier union/rearrangement on the platform of enigmazole A
A detailed analysis of our retrosynthetic plan toward enigmazole A (1.1),
utilizing late-stage large-fragment Petasis-Ferrier rearrangment, as well as the resulting
total synthesis, will be discussed in greater detail in Chapter 2.

1.4. Anion Relay Chemistry- A Successful Tactic for Complex Molecule Total
Synthesis
In addition to the cornerstone late-stage large-fragment Petasis-Ferrier
union/rearrangement protocol, we envisioned that Anion Relay Chemistry (ARC),
another successful tactic for complex molecule total synthesis developed in the Smith
group, could be applied in the total synthesis of (-)-enigmazole A (1.1).10
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The concept of Anion Relay Chemistry (ARC) was initially introduced as
Smith’s multicomponent dithiane linchpin coupling reaction in the 1990s (Scheme
1.15).34 Treatment of dithiane linchpin 1.73 with n-BuLi or t-BuLi followed by the
addition of epoxide 1.74 leads to the lithium alkoxide 1.75. The [1,4]-Brook
rearrangement could then be triggered in a controlled manner by altering the solvent
polarity with the addition of HMPA or DMPU. Simultaneous addition of epoxide 1.76
furnishes the desired tri-component adduct 1.78 in a one-pot and stereocontrolled manner.

Scheme 1.15. Smith’s Multicomponent Dithiane Linchpin Coupling Reaction
In the following two decades, two main reaction classes of Anion Relay
Chemistry, namely Type I and Type II, have been established during ongoing studies in
the Smith group, thus enhancing the efficiency, versatility and applicability of the ARC
tactic (Scheme 1.16).35 Type I ARC involves the nucleophilic addition of an anionic
linchpin (1.79) to an electrophile (1.80), resulting in the formation of anion 1.81. The
negative charge is then transferred back to the original nucleophilic locus of the linchpin
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via a Brook rearrangement. Subsequent nucleophilic addition to a second electrophile
then furnishes the desired product 1.82. In Type II ARC the bifunctional linchpin 1.83
serves as both an electophile and a nucleophile. The anion resulting from nucleophilic
addition of the initiating nucleophile to the linchpin (1.83) can be transferred across space
to the new carbon center, stabilized by an anion stabilizing group (ASG) on the linchpin.
The addition of an electrophile then furnishes the desired product 1.85. Both Type I and
Type II ARC has proven crucial in a number of the successful total syntheses achieved to
date by the Smith group.10

Scheme 1.16. Type I and Type II Anion Relay Chemistry
Recognizing the considerable efficiency of Anion Relay Chemistry for complex
molecule synthesis in a highly stereocontrolled manner, we envisioned the use of a Type I
ARC would prove valuble for the construction of the eastern hemisphere of ()enigmazole A. The resulting synthetic study will be discussed in greater detail in Chapter
2.1 and Chapter 2.3.
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Chapter 2. Total Synthesis of ()-Enigmazole A
2.1. Retrosynthetic Analysis of ()-Enigmazole A
2.1.1. A First Generation Retrosynthetic Analysis and Synthetic Study
The first generation retrosynthetic plan for ()-enigmazole A envisioned
disconnection of the macrolide to reveal carboxylic acid 2.2 (Scheme 2.1). Carboxylic
acid 2.2 in turn would arise from olefin 2.3 via a four-step sequence. A late-stage largefragment Petasis-Ferrier union/rearrangement (Chapter 1.3) would then be utilized to
unite the eastern and western hemispheres (2.5 and 2.4).1 Construction of the eastern
hemisphere 2.5 was envisioned to be achieved by the union of aldehyde 2.7 and oxazole
2.6, while the western hemisphere 2.4 would in turn be constructed from commercially
available (-)-Roche’s ester. Our initial strategy included functionalization of the C(16-17)
double bond after formation of the tetrahydropyran core, rather than before, given that the
C(17) hydroxyl group might interfere the Petasis-Ferrier union tactic by undesired
interactions with the western hemisphere aldehyde in acidic conditions.
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Scheme 2.1. A First Generation Retrosynthetc Analysis of ()-Enigmazole A
Unfortunately, during the synthetic study based on the first retrosynthetic plan,
Smith and colleagues observed that the C(16-17) double bond was extremely stable and
very difficult to functionalize. In a model study, Dr. Mariya Kozytsaka in our research
group demonstrated that olefin 2.8 would not succumb to the desired transformation
under

various

conditions,

including

directed

hydrosilylation,

hydroboration,

iodocarbonation, as well as directed epoxidation (Scheme 2.2). We believe that this lack
of reactivity is due to the stability of the C(16-22) conjugation.

Scheme 2.2. Functionalization of C(16-17) double bond
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2.1.2. A Second Generation Retrosynthetic Analysis and Synthetic Study
We therefore launched a second generation retrosynthetic plan, whereby the
C(17) hydroxyl group would be installed before formation of the conjugated system
(Scheme 2.3). Assembly of the eastern hemisphere precursor, 1,5-dihydroxydithiane 2.13,
was envisioned to arise via the Type I Anion Relay Chemistry (ARC) protocol developed
in our group (Chapter 1.4).2

Scheme 2.3. A Second Generation Retrosynthetc Analysis of (-)-Enigmazole A
After the construction of all three fragments, Dr. Mariya Kozytsaka explored
the Type I ARC protocol (Scheme 2.4). Unfortunately, the one-pot transformation to
generate dithiane 2.13 proved unsuccessful. The major product under these conditions
was dithiane 2.17, which resulted from the addition of anionic TBS-dithiane 2.14 to
epoxide 2.15 followed by Brook rearrangement and anion protonation. The use of a
stronger base, such as t-BuLi, or treating the epoxide 2.16 with the anion of dithiane
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2.17 still did not lead to the desired product. Dr. Kozytsaka next focused on identifying
potential proton source that could quench the dithiane anion prior to the coupling with
epoxide 2.16. Interestingly, treatment of the reaction mixture of dithiane 2.17 and nBuLi with deuterated methanol gave only the deuterated oxazole 2.18, with no
deuterium-incorporation in the dithiane species. This observation suggested that Type I
ARC would be difficult to employ in the presence of an unprotected oxazole species
without further optimization.

Scheme 2.4. Anion Relay Chemistry with Oxazole Moieties
2.1.3. A Third Generation Retrosynthetic Analysis
We therefore designed a third generation retrosynthetic plan, whereby
construction of epoxide 2.24 would again be carried out using Type I ARC before
incorporation of the oxazole species (Scheme 2.5). Petasis-Ferrier union/rearrangement
would then unite the eastern hemisphere 2.22 with the western hemisphere 2.4 at a late
stage to furnish the methylene tetrahydropyran 2.21, which could be used to direct the
macrolactonization of advanced intermediate 2.20 in two to three steps. Western
29

hemisphere 2.4 in turn could be constructed from commercially available (-)-Roche’s
ester, while the eastern hemisphere 2.22 would be elaborated via a process highlighting a
dithiane-epoxide coupling protocol. Construction of the prerequisite oxazolyl dithiane
2.23 would employ a procedure including a Negishi union, while the epoxide 2.24 would
derive via a Type I ARC protocol.
Assuming

success,

the

late-stage

large-fragment

Petasis-Ferrier

union/rearrangement protocol would represent the cornerstone of the synthesis,
fashioning the entire carbon skeleton of ()-enigmazole A (2.21) in a single cascade
sequence.

Scheme 2.5. A Third Generation Retrosynthetc Analysis of (-)-Enigmazole A
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2.2. Construction of the C(17-25) Oxazolyl Dithiane (+)-2.23 via Negishi Cross
Coupling

Figure 2.1. Structure of C(17-25) Oxazoyl Dithiane (+)-2.23
We envisioned the synthesis of the C(17-25) oxazolyl dithiane (+)-2.23, a
common intermediate potentially for both the enigmazole A and enigmazole B total
syntheses, two synthetic projects undertaken by the Smith group,3 would involve a
palladium-mediated Negishi cross-coupling.4 The synthesis of one of the coupling
partners, Z-iodoalkene (+)-2.29, began with commercially available, inexpensive racemic
3-butyn-2-ol (±)-2.25 (Scheme 2.6). Although enantiopure (R)-3-butyn-2-ol (+)-2.25 was
also commercially available, the enzymatic resolution of racemic TMS-alkyne (±)-2.26
was a more economically viable altermative.5 To this end, deprotonation of racemic 2.25
with ethylmagnesium bromide, followed by the addition of TMSCl, and an acidic workup
furnished TMS-alkyne (±)-2.26.6 Using the less expensive Amano Lipase from
Pseudomonas fluorescens and hexanes, instead of Amano Lipase AK and pentane as
reported in the literature,5 we achieved the same yield and enatioselectivity in the
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enzymatic resolution. The resulting enantiopure (+)-2.27 was then treated with potassium
carbonate (K2CO3) in diethanolamine to furnish (R)-3-butyn-2-ol (+)-2.25.7 According to
literature precedent, iodo alcohol (+)-2.28 was next constructed as the single Z-isomer
via iodomethylation.8 Subsequent conversion of the alcohol to the corresponding methyl
ether (+)-2.29 was achieved with sodium hydride (NaH), methyl iodide and 15-crown-5.
Although a number of the intermediates (2.25, 2.27, 2.28 and 2.29) proved highly volatile
in this sequence, carrying out the sequence with considerable care led to high yields in all
five steps, permitting the preparation of multi-gram quantities of (+)-2.29.

Scheme 2.6. Synthesis of Z-iodoalkene (+)-2.29
The second coupling partner, oxazole 2.33, was also prepared according to
literature precedent (Scheme 2.7).8 Condensation between urea (2.30) and ethyl
bromopyruvate (2.31), followed by diazotiazation and chloride displacement generated
the desired ester 2.33. We discovered that the recrystallization of oxazole 2.33 proved
much more efficient than the flash column chromatography as described in the literature.
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Scheme 2.7. Synthesis of Oxazole 2.33
We next envisioned that a Negishi cross-coupling could be employed as the key
reaction for the formation of the C(17-25) oxazolyl dithiane (+)-2.23 (Scheme 2.8). Dr.
Anton Khartulyari and Dr. Alia Orbin in the Smith laboratory contributed significantly to
this procedure during the enigmazole B synthesis project.3 Although Molinski and coworkers synthesized the same compound, (+)-2.34, utilizing a Negishi cross-coupling in
their total synthesis of enigmazole A, we independently had designed the Negishi crosscoupling reaction with different coupling partners in 2008 before their publication.9 To
this end, lithium-halogen exchange was achieved by treatment of iodide (+)-2.29 with tBuLi; the transmetallation gave a vinylzinc species, which was then coupled with
oxazolyl chloride 2.33 in the presence of a catalytic amount of tetrakis
(triphenylphosphine) palladium to furnish oxazolyl ester (+)-2.34 in 80% yield. The
resulting ester (+)-2.34 in turn was reduced with DIBAL-H to provide aldehyde (+)-2.35.
Conversion of the aldehyde (+)-2.35 to the corresponding dithiane (+)-2.23 was then
achieved with BF3.OEt2 and 1,3-propanedithiol. We found afterwards that dithiane (+)2.23 was not stable upon storage, presumably due to the presence of residual BF3.OEt2.
Washing the reaction mixture of (+)-2.23 four to five times with 3 M aqueous NaOH
solution circumvented this problem.
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Scheme 2.8. Construction of C(17-25) Oxazolyl Dithiane (+)-2.23
In summary, after initial development most of the synthetic procedures utilized
for the synthesis of the C(17-25) oxazolyl dithiane (+)-2.23 was optimized, permitting in
good yield the large scale (> 5g) and a highly economically synthesis. In the end, more
than 15 g of (+)-2.23 was prepared, which was used in both the enigmazole A and B
projects.

2.3. Construction of the C(9-16) Epoxide (-)-2.24

Figure 2.2. Structure of C(9-16) Oxazoyl Dithiane ()-2.24
2.3.1. Construction of the C(9-16) Epoxide ()-2.24 via Type I Anion Relay Chemisty
(ARC)
Dr. Mariya Kozytsaka and I designed a route for the synthesis of the C(9-16)
epoxide (-)-2.24 utilizing Type I anion relay chemistry (ARC) (Chapter 1.4). The
34

requisite epoxides ()-2.36 and ()-2.41 were constructed via either Jacobsen kinetic
resolution10 or from enantiopure commercially available starting materials (Scheme 2.9).

Scheme 2.9. Synthesis of Requisite Epoxides for Type I ARC
The three component ARC tactic was then applied, using lithiated TBS dithiane
and the enantiopure epoxides ()-2.36 and ()-2.41 (Scheme 2.10). The desired product,
dithiane ()-2.42 was formed in high yield after careful optimization. The dithiane moiety
of ()-2.42, was in turn removed under reductive conditions to furnish alcohol ()-2.43,
and the alcohol was submitted to Raney nickel conditions to remove the PMB protecting
group to furnish diol ()-2.44 in high yield. When attempts were made to reduce directly
()-2.42 to ()-2.44, only a small amount of desired product ()-2.44 was observed,
presumably due to catalyst poisoning by dithiol. The large scale preparation of alcohol
()-2.43 (>1 g scale) also proved problematic due to the same poisoning effect. In the
end, epoxide ()-2.24 was generated in one step from diol ()-2.44 following the FraserReid protocol.11
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Scheme 2.10. Construction of the C(9-16) Epoxide (-)-2.24 via Type I ARC
In summary, epoxide ()-2.24 was constructed utilizing Type I ARC, affording
the desired intermediate as a single diastereomer in high yield (74.1% over 4 steps). The
limitation of this route, however, was the inability to carry out the reductive dithiane
removal reaction on large scale.
2.3.2. Construction of the C(9-16) Epoxide ()-2.24 via Sharpless Dihydroxylation
Another synthetic route to the C(9-16) epoxide ()-2.24 was designed beginning
with epoxide (-)-2.41 (Scheme 2.11). To this end, treatment of ()-2.41 with but-3-en-1-yl
magnesium bromide solution in the presence of a catalytic amount of copper(I) catalyst
furnished the desired product (+)-2.45. A screen of copper(I) sources led to identification
of the most efficient catalyst, copper(I) iodide, which led to the formation of (+)-2.45 in
excellent yield. Protection of the secondary alcohol with TBSOTf then furnished ()-2.46
in 92.4% yield. Subsequent Sharpless asymmetric dihydroxylation provided diol ()-2.44
in 91% yield.12 Further studies, however, revealed that the diastereoselectivity of the
dihydroxylation reaction was not higher than 2.5:1. Changing solvents, catalysts and
temperatures, unfortunately, did not affect the selectivity. Moveover, the two
diastereomers could not be separated using either normal phase silica gel flash
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chromatography or reverse phase HPLC. In the end, the requisite epoxide ()-2.24,
together with the inseparable diastereomer (about 30%), was generated in one step from
diol (-)-2.44 following Fraser-Reid protocol.11

Scheme 2.11. Construction of the C(9-16) Epoxide ()-2.24 via Copper-assistant
Grignard Reagent-Epoxide Coupling and Sharpless Dihydroxylation
In summary, the synthetic route towards the C(9-16) epoxide ()-2.24 utilizing a
copper-assisted Grignard epoxide opening, followed by Sharpless dihydroxylation,
provided the desired product in extremely high yield (78.2% over four steps) on large
scale (> 4 g). However, the major shortcoming of this route was the formation of the
inseparable, undesired diastereomer during the Sharpless dihydroxylation (d.r. = 2.5:1 to
2:1).
2.3.3. The Two Synthetic Tactics to Construct the C(9-16) Epoxide (-)-2.24
To construct C(9-16) Epoxide ()-2.24, we had designed and validated two
routes utilizing totally different synthetic methods. Both routes could be carried out
efficiently and in high yield (ARC route: 74.1% for 4 steps; dihydroxylation route: 78.2%
over 4 steps).
Besides the high yield achieved during the ARC route, the strategy permitted
formation of a diastereomerically pure compound; the only limitation however was the
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inability to carry out the reductive dithiane removal on large scale (> 1g).
The dihydroxylation route, which could be carried out quickly (3 days) and on
large scale (>4 g), provided access to the desired product in an economic fashion, albeit
as an inseparable mixture of diastereomers (2.5:1). This mixture of diastereomers could
not be separated by either silica flash chromatography or reverse phase HPLC over the
next 15 steps (!), until the formation of the macrolides. Nonetheless this was a very
valuable material that could be used to explore the subsequent 15-step sequence. In some
cases, however, there were significant difficulties with the identification and
characterization of the intermediates (Figure 2.3).

Figure 2.3. Diastereomers Derived from Sharpless Dihydroxylation
Recognizing the pros and cons for both routes, another route directed toward the
C(9-16) epoxide ()-2.24 was attempted, which combined the advantages of both the
ARC route and the dihydroxylation routes (Scheme 2.12). The C(15) stereocenter was
pre-installed from readily available, naturally abundant malic acid, which was
transformed to the Grignard reagent 2.50 in 4 steps. Unfortunately, treatment of the
epoxide (-)-2.38 with Grignard reagent 2.50 did not lead to the desired product 2.51
under various conditions. This route was thus abandoned.
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Scheme 2.12. Synthetic Study towards C(9-16) Epoxide Starting from L-malic Acid
In conclusion, considering the enormous burden of carrying mixtures of
inseparable diastereomers over 15 steps, the ARC route (Scheme 2.9) leading to the C(916) epoxide (-)-2.24 was mainly used in the total synthesis of enigmazole A albeit
requiring many iterations on small scale (< 1 g). The Sharpless dihydroxylation route
(Scheme 2.10), on the other hand, was used as a complementary method for fast reaction
development.

2.4. Construction of C(9-25) Eastern Hemisphere (+)-2.22 via DithianeEpoxide Union

Figure 2.4. Structure of C(9-25) Eastern Hemisphere (+)-2.22
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2.4.1. A First Generation Synthesis of the Eastern Hemisphere (+)-2.22
After the construction of dithiane (+)-2.23 and epoxide ()-2.24 (Scheme 2.8 and
2.10), we turned to the elaboration of the eastern hemisphere starting with a dithianeepoxide union tactic. This eight step, first generation procedure was designed by Dr.
Mariya Kozytsaka and I (Scheme 2.13). Deprotonation of dithiane (+)-2.23 with n-BuLi
generated the nucleophile, which after the addition of epoxide ()-2.24 in a mixture of
Et2O and HMPA furnished the desired product dithiane (+)-2.52 in fair yield (40-60%),
with recovery of the excess epoxide ()-2.24. The mercury(II)-mediated hydrolysis of
the dithiane then successfully removed the dithiane moiety of (+)-2.52 to furnish βhydroxyketone (+)-2.53,13 which was next exposed to the Narasaka-Prasad reduction
conditions to produce diol (+)-2.54 as a single diastereomer.14 The diol (+)-2.54 was then
protected with p-methoxybenzaldehyde dimethyl acetate in the presence of a catalytic
amount of CSA to provide PMP acetal (+)-2.55 in 80% yield.
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Scheme 2.13. The First Generation Synthesis of Eastern Hemisphere (+)-2.22
Previous studies carried out during the Smith total synthesis of phorboxazole A
had revealed that the oxazole moiety could form a strong complex with boron and
aluminum Lewis acids.15 We therefore hypothesized that the DIBAL-H reagent could
reduce chemoselectively the benzylacetal functional group of (-)-2.55 to open the acetal
C-O bond proximal to the oxazole. Treatment of (+)-2.55 with a DIBAL-H solution at 78 °C furnished the desired product (+)-2.56 in excellent yield (92%) with near perfect
selectivity. To the best of our knowledge there is no precedent of a similar transformation
aside from the work of Smith, whereby the neighboring nitrogen atom chemoselectively
directs the reduction of a benzyl acetal.
HF-pyridine was then used to remove chemoselectively the primary TBS group
over the secondary TBS group of alcohol (+)-2.56 to furnish diol (+)-2.57 in 80% yield.
The subsequent chemoselective oxidation proved problematic. Due to the stability of the
C(17-22) conjugated system, which had been observed in our earlier endeavor with the
first retrosynthetic analysis (Scheme 2.2), the hydroxyl group at C17 proved very prone
to undergo oxidation. Thus the chemoselective oxidation of the primary alcohol over the
C17 alcohol using TEMPO, albeit viable, in some cases provided irreproducible (1060%) yields. Notwithstanding this problem, we were able to remove the remaining
secondary TBS group with hydrochloric acid in ethanol, thus furnishing the desired
eastern hemisphere (+)-2.22 in 85% yield for the final step.
In summary, eastern hemisphere (+)-2.22 was constructed, albeit with our first
generation procedure employing the dithiane-epoxide protocol proceeded in only 1.1% to
6.4% yield for the eight steps. Thus reactions with fair to low yield, or with
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irreproducible problems, including of dithiane-epoxide coupling and TEMPO oxidation,
required revision and/or optimization.
2.4.2. Dithiane-Epoxide Union Studies
Although we had demonstrated that the dithiane anion was difficult to generate
in the presence of an oxazole moiety in our earlier synthetic endeavors (e.g., dithiane 2.17
in Scheme 2.4), Dr. Alia Orbin revealed that dithiane (+)-2.23 was an exception in her
studies directed toward the total synthesis of enigmazole B, the structure of which
possesses the same conjugated oxazole side chain as enigmazole A.3 In particular,
treatment of dithiane (+)-2.23 with n-BuLi provided the dithiane anion which could be
readily attacked with a variety of alkyl iodides to furnish dithiane 2.58 in 40%-70% yield
(Scheme 2.14). The more ready deprotonation of the dithiane (+)-2.23 could be due to a
stabilizing effect of the anion via the C(17-22) conjugated system.

Scheme 2.14. Nuclephilic Addition Utilizing Dithiane (+)-2.23
We therefore utilized the dithiane (+)-2.23 in our first generation synthesis of the
eastern hemisphere (+)-2.22. However, the yield of the dithiane-epoxide coupling was not
satisfactory (40-60%). Analysis of the reaction by-products revealed the formation of
diastereomer 2.59 and dithiane 2.60. Formation of such products, strongly suggests the
generation of the dianion, whereby deprotonation had occurred at both C17 and C23
(Table 2.1)
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Table 2.1. the Dithiane-Epoxide Coupling
Observing the unusually high reactivity of dithiane (+)-2.23, again presumably
due to the C(17-22) conjugated system, brought into question the necessity for the polar
solvent HMPA, and suggested that perhaps greater success could be achieved by altering
the number of equivalents of n-BuLi and epoxide ()-2.24. As a result, a screen, using
different conditions was performed to achieve higher yield (Table 2.1).
During the screen, although HMPA is commonly used in dithiane-epoxide union
reactions to increase the reactivity, we found that the presence of HMPA only led to more
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by-products in the case of dithiane (+)-2.23, while similar side reactions were also
observed when more than 1.5 equivalents of n-BuLi was used. On the other hand, the use
of less than 1.15 equivalent of n-BuLi induced the formation of an inseparable mixture
due to incomplete reaction. Pleasingly, we subsequently discovered that the best
conditions (entry 9, Table 2.1) led to the desired product in 77% yield. Although under
these conditions some complex intractable by-products with high polarity were found,
by-products 2.59 and 2.60 were not observed. Thus, the conditions of entry 9 in Table 2.1
were employed to advance material to (+)-2.52.
2.4.3. Chemoselective Oxidation and Reduction Studies
In addition to the dithiane-epoxide union, optimization of the chemoselective
TEMPO oxidation (Scheme 2.15) also proved to be very important. Again, due to the
C(17-22) conjugated system, differentiation between the C9 primary hydroxyl and the
C17 oxazolyl hydroxyl under oxidative conditions was difficult. Moreover, the similar
retention on TLC of the starting material (+)-2.57 and the desired product (+)-2.61 further
complicated optimization. As a result, the reaction results were inconsistent because of
either over-oxidation, which led either to by-product 2.62, or to incomplete reaction.

Scheme 2.15. Chemoselective TEMPO Oxidation
Initially, a stepwise procedure was implemented, utilizing a TEMPO/BAIB
(bisacetoxyiodobenzene) oxidation to furnish aldehyde 2.63, followed by a Pinnick
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oxidation to the corresponding acid (Scheme 2.16).16,17 Formation of aldehyde 2.63 could
be easily observed on TLC, which led to a more consistent yield. However, the efficiency
of this procedure remained unsatisfactory, due both to the inclusion of an additional step
and the formation of the unstable aldehyde 2.63. Thus further revision was still necessary.

Scheme 2.16. Stepwise TEMPO Oxidation
The most straightforward solution for this differentiation problem was to mask
the C17 hydroxyl group. However, the inclusion of further protection/deprotection steps
would lead to inefficiency. Given that the C19 hydroxyl group was just released during
the PMP ring opening reaction, two steps before the problematic chemoselective
oxidation, we realized that this problem could be solved by alteration of the reaction
sequence. The oxidation was thus carried out prior to the PMP ring opening reaction
(Scheme 2.17). After chemoselective removal of the primary TBS group of (-)-2.55, the
resulting alcohol (-)-2.64 was submitted to the TEMPO oxidation. Now there was no
selectivity problem for the oxidation; thus carboxylic acid (+)-2.65 was obtained in
excellent yield (95%). Focus was then turned to the chemoselective PMP ring opening
reaction.

Scheme 2.17. Oxidation Prior to the PMP Ring Opening
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In our first generation synthesis, we disclosed the chemoselective PMP ring
opening reaction, whereby treatment of (+)-2.55 with a DIBAL-H solution furnished the
desired product (+)-2.56 (Scheme 2.13). This selective reaction would become more
challenging after the formation of the carboxylic acid because DIBAL-H can also
potentially reduce the carboxylic acid moiety. Pleasingly however, treatment of (+)-2.65
with a DIBAL-H solution in hexanes at -78 °C furnished the desired product (+)-2.61 in
surprisingly high yield (93%). This result represented completion of our optimization of
the route to (+)-2.61 by altering the sequence of the oxidation and reduction steps
(Scheme 2.16). In the end, deprotection of TBS group of (+)-2.61 led to the eastern
hemisphere (+)-2.22.
The intermidiates involved in this chemoselective reduction is outlined in Scheme
2.18. The first equivalent of DIBAL-H would react with the carboxylic acid proton, while
the second would complex with the oxazole nitrogen to form a reactive five-member ring
intermediate together with the neighboring acetal oxygen. Due to the potential chelation
between the nitrogen or oxygen in the five member ring, we reason that the reduction is
directed selectively toward the neighboring C-O bond of the acetal. Presumably the low
temperature of the reaction prevents further reduction of the carboxylic acid. Aqueous
work-up in turn then leads to the desired product (+)-2.61. This reaction sequence
revealed the strong potential of DIBAL-H as a chemoselective reagent.
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Scheme 2.18. Intermediated in the Chemoselective Reduction
2.4.4. A Second Generation Synthesis of the Eastern Hemisphere (+)-2.22
The optimizations carried out for the dithiane-epoxide union, as well as the
chemoselective oxidation and reduction, provided the framework for a second generation
synthesis of eastern hemisphere (+)-2.22 (Scheme 2.21). Utilizing the conditions found in
the screen revealed in Chapter 2.4.2, the union of dithiane (+)-2.23 with epoxide (-)-2.24
furnished the desired product (+)-2.52 in 77% yield (Scheme 2.19). Compared with the
traditional mercury(II)-mediated hydrolysis that was utilized in our first generation
synthesis, a new environmentally friendly protocol disclosed in 2013, employing
hydrogen peroxide catalyzed by Fe(acac)3 and sodium iodide, was applied to remove the
dithiane moiety leading to the ketone (+)-2.53 in higher yield (75 vs. 63%).18 Subsequent
exposure of ketone (+)-2.53 to the Narasaka-Prasad reduction then provided diol (+)-2.54
as a single diastereomer in excellent yield (95%).14
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Scheme 2.19. The Second Generation Synthesis of Eastern Hemisphere (+)-2.22:
Dithaine-Epoxide Union, Dithiane Removal and Narasaka-Prasad Reduction
Protection of diol (+)-2.54 with p-methoxybenzaldehyde dimethyl acetate in the
presence of CSA next provided the desired PMP acetal ()-2.55 in 80% yield (Scheme
2.20). Despite the good yield, about 10% of alcohol ()-2.64, which was the desired
product for the next step, was also observed. This result presented the possibility of
achieving the two steps in one-pot. To this end, treatment of the mixture resulting from
the PMP protection with an additional 10% of CSA, followed by stirring a further 5 hours
in the same solvent, led to the desired product (+)-2.64 however in only 23% together
with multiple by-products. Similar results were obtained utilizing the HF-pyridine
complex. Pleasingly however, upon exposure of the mixture resulting from the PMP
protection reaction to TBAF/HOAc without changing the solvent, the desired product
()-2.64 was obtained now in very good yield (ca. 88%, entry 3 in Scheme 2.19).
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Scheme 2.20. One-pot Chemoselective TBS Group Removal
With a significantly improved route to alcohol ()-2.64, oxidation employing
TEMPO/NaClO/NaClO2 resulted in the formation of carboxylic acid (+)-2.65 in excellent
yield (Scheme 2.21). The subsequent chemoselective DIBAL-H reduction, which was
discussed in detail in Chaper 2.4.3 for opening the acetonide, now furnished the desired
alcohol (+)-2.61 in 93% yield with excellent selectivity. Finally, TBAF/AcOH cleanly
removed the secondary TBS group on (+)-2.61 to furnish eastern hemisphere (+)-2.22 in
88% yield. Compared with the HCl/EtOH conditions employed previously, the neutral
conditions avoided the undesired deprotection of the PMB group, thus leading to a more
reproducible reaction.
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Scheme 2.21. The Second Generation Synthesis of Eastern Hemisphere (+)-2.22
In summary, the second-generation synthesis of eastern hemisphere (+)-2.22
furnished the desired product in 37.4% yield over the 7 steps. This procedure was one
step shorter and proceeded in consistent yield, which was now 6 to 34 times higher than
our first generation synthesis. Highlights of the second-generation synthesis include the
carefully optimized dithiane-epoxide union, an efficient one-pot protection/deprotection
reaction sequence, as well as an unprecedented tris-chemoselective DIBAL-H reduction
reaction. Most importantly, the second generation synthesis provided (+)-2.22 on gram
scale.
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2.5. Construction of C(1-7, 26-27) Western Hemisphere (-)-2.4

Figure 2.5. Structure of theWestern Hemisphere (-)-2.4
With the eastern hemisphere (+)-2.22 now in hand, we turned to construction of
the western hemisphere ()-2.4, the synthesis of which at the outset appeared relatively
straightforward (Scheme 2.22). Beginning with the commercially available (-)-R-Roche’s
acid, TBDPS protection of hydroxyl group, followed by DIBAL-H reduction of the ester
and iodination led to the desired iodide ()-2.66 in 89% over 3 steps. Exposure of ()2.66 to the two-step Myers alkylation protocol employing pseudoephedrine as the chiral
auxiliary provided alcohol ()-2.68 as a single diastereomer in excellent yield (99% over
two steps).19 Subsequent Parikh-Doering oxidation and Brown allylation then furnished
olefin ()-2.69 in excellent yield (91% over two steps), again as a single diastereomer.20,21
Having generated the requisite three stereogenic centers required for the western
hemisphere ()-2.4, the hydroxyl group in olefin ()-2.69 was protected with TIPSOTf to
furnish the requisite TIPS silyl ether ()-2.70 in 91% yield. Finally, ozonolysis provided
the western hemisphere ()-2.4 in good yield (e.g., 77%).
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Scheme 2.22. Construction of the Western Hemisphere ()-2.4
Although satisfied in general with the high yields and diastereoselectivity
achieved in the construction of (-)-2.4, three problems remained. First, the final product
aldehyde (-)-2.4 was not stable for long periods of time, and secondly, the decomposition
often occurred during large scale purification after the ozonolysis. The third problem
from a preparative scale viewpoint was the presence of the pinene residue, produced
during the Brown allylation, which was difficult to separate from either ()-2.69, ()-2.70
or ()-2.4. Pleasingly, a minor optimization solved two of the problems. Instead of the
final ozonolysis, treatment of olefin ()-2.70 with the dihydroxylation conditions of
OsO4/NMO led to the corresponding stable diol, which was easily separated from the
pinene residue. Transformation of the diol to the final product ()-2.4 could then be
carried out utilizing the inorganic reagent NaIO4 to cleave the resultant diol in a fast and
clean manner, permitting the fresh preparation of the aldehyde ()-2.24 immediately
before the key union reaction of the eastern and western hemispheres [(+)-2.22 and ()52

2.4, respectively].
In summary, a viable construction of C(1-7, 26-27) western hemisphere ()-2.4,
designed by Dr. Anoton Khartulyari and I, had been achieved. The reaction sequence
could be carried out in excellent yield (54.7% over 10 steps), and importantly permitted
large scale access to the western hemisphere with perfect diastereomer selectivity.

2.6. Construction of the Entire Carbon Skeleton of (-)-Enigmazole A (+)-2.21
via a Late-Stage Large-Fragment Petasis-Ferrier Union/Rearrangement
Protocol

Figure 2.6. Late-Stage Large-Fragment Petasis-Ferrier Union/Rearrangement Protocol
2.6.1. The First Union of the Eastern and Western Hemispheres, (+)-2.22 and ()-2.4
After the syntheses of ample quantities of the eastern hemisphere β-hydroxy acid
(+)-2.22 and the western hemisphere aldehyde ()-2.4, the unprecedented late-stage
large-fragment Petasis-Ferrier union/rearrangement directed toward the formation of the
entire carbon skeleton of engimazole A was attempted.
Two potential challenges were envisioned for the first step of the Smith three
step Petasis-Ferrier union/rearrangement protocol: (i) the potential problem of
overcoming the steric effects due to the large fragments; and (ii) the difficulty associated
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with the formation of the tris-silylated β-hydroxy acid. To solve these challenges, both
the use of the HMDS/TMSOTf protocol and the Kurihara protocol22 were investigated
(Table 2.2). By exposure of (+)-2.22 to a mixture of HMDS/THF, tris-silylated β-hydroxy
acid was formed as comfirmed by 1H NMR. After thorough removal of the HMDS/THF
by high vacuum, treatment of the tris-silylated β-hydroxy acid with ()-2.4 in the
presence of TMSOTf at -78°C provided the desired union product ()-2.70, albeit in very
low yield (<5%). Fortunately, when employing HMDS/TMSOTf, most of the starting
materials, namely the aldehyde ()-2.4 and a mixture of silylated (+)-2.22 (mono-, bis-,
or tris-) could be recovered. However in the case of Kurahara protocol, although similar
amounts (< 5%) of the union product ()-2.70 were produced, the starting materials could
not be recovered. Multiple unstable by-products were observed by NMR studies, all of
which revealed the lack of the C17 TMS ether. This result suggested that Kurahara
protocol would be incapable of installing the TMS protecting group at low temperature.
Further optimization of the Kurahara protocol using different temperatures and reaction
times did not lead to a favorable result. We therefore focused our optimization studies on
the HMDS/TMSOTf protocol.
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Table 2.2. Large-Fragmental Petasis-Ferrier Union Reaction
At the beginning of our optimization study (Table 2.3), we reasoned that the low
conversion was due to the mild conditions. As a result, we increased the temperature.
Unfortunately, although the conversion increased at the higher temperature, no starting
material was recovered; moreover the yield of desired product ()-2.70 remained
unsatisfactory (5-20%). Multiple by-products, including the cis-isomer of ()-2.70, were
observed. These results suggested that low temperatures were essential to avoid sidereactions and to obtain high diastereoselectivity. We then recalled that in the Smith total
synthesis of (+)-zampanolide,23 the addition of catalytic amount of TfOH significantly
improved the yield, especially on larger scale. The presumption in that case was that on
small scale, trace amounts of water generated TfOH in situ from TMSOTf, greatly
facilitating the formation of the dioxanone. We therefore added a catalytic amount of
TfOH to our reaction mixture at low temperature. Unfortunately, the yield of desired
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product ()-2.70 was still unsatisfactory (5%-25%); moreover no starting material could
be recovered. The NMR analysis of multiple major by-products suggested that although
the dioxanone moiety had been generated, an undesired loss of the TMS group or both
the TMS and PMB groups had also occurred. The derived alcohol or diol then underwent
further reactions with aldehyde ()-2.4 to form multiple complex by-products. This result
suggested that addition of TfOH was necessary but that the substrates in hand were
sensitive under the acidic conditions. A similar situation arose in the Smith synthesis of
spongistatin,24 whereby the addition of the sterically hindered base DtBMP (2,6-di-tertbutyl-4-methylpyridine) to buffer the catalytic amount of TfOH led to the dioxanone.
This protocol was applied to our synthesis, but did not lead to a satisfactory result.
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Table 2.3. Optimization of Large-Fragmental Petasis-Ferrier Union Reaction
Finally, we turned to generate TfOH in situ with TMSOTf. The addition of
catalytic amount of water again resulted in a similar outcome. Surprisingly however, slow
introduction of moisture via simple exposure of the -78 °C reaction mixture to room
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temperature air via the insertion of a needle (1.2 mm diameter) for 5 to 10 minutes
proved successful, and remarkably led to the desired product ()-2.70 in excellent yield
(95%) as a single diastereomer, with no by-products observed!
In summary, after introducing moisture through an innovative and simple
method, the Petasis-Ferrier union of western hemisphere ()-2.4 and eastern hemisphere
(+)-2.22 had been achieved in excellent yield (95%). The important role of TfOH in the
Petasis union had been demonstrated yet again. The near perfect cis-selectivity (NMR) on
the tetrahydropyran ring provided strong evidence that larger fragments led to better cisselectivities. This experiment also demonstrated that acid-sensitive substrates could be
utilized in this acid-facilitated Petasis-Ferrier union reaction in the absence of a base
buffer.
2.6.2. Microwave-Augmentation of the Petasis Olefination: the Second Step of the
Smith 3-Step Petasis-Ferrier Union/Rearrangement.
Turning next to the olefination, the second step of the Smith 3-step of PetasisFerrier union/rearrangement protocol; both Petasis olefination25 and Tebbe olefination26
were initially explored (Table 2.4). Commercially available Tebbe’s reagent and freshly
prepared Petasis reagent following the literature procedure27 had been employed in our
laboratory.

Similar

to

other

Smith’s

syntheses

utilizing

Petasis-Ferrier

union/rearrangement as the synthetic cornerstone, the Petasis reagent led to enol acetal
()-2.71 in better yield compared to that obtained with Tebbe’s reagent. We thus focused
on the optimization of the Petasis olefination.
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Table 2.4. Olefination of Dioxanone ()-2.70
Although the Petasis olefination led to a much better yield compared with Tebbe
olefination, the 40-50% yield obtained was not considered satisfactory at this stage of a
total synthesis. A major by-product, which was not easy to separate from the desired
reaction, was observed. We thus turned to the Smith second-generation synthetic study
leading to (+)-phorboxazole A, wherein higher concentrations of the Petasis reagent, as
well as the addition of ethyl pivalate, significantly decreased the reaction time of Petasis
olefination and minimized the unwanted known [2+2] side reaction between the product
enol-acetal and excess Petasis reagent.28 We therefore applied this tactic to our synthesis
(Table 2.5). The experiments demonstrated that although the more concentrated Petasis
reagent could lead both to a shorter reaction time (10 h) and to a slightly higher yield
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(55%), further optimization was still necessary. We next turned our attention to the
possibility of utilizing microwave heating, which has become a widely accepted energy
source for organic synthesis. To our delight, exposure of the reaction mixture to
microwave heating conditions furnished the desired enol acetal ()-2.71 in very good
yield (87%). Moreover, the microwave heating significantly decreased the reaction time
and led to the clean formation of ()-2.71. Compared to conventional heating, microwave
heating has a number of special characteristics, including rapid and volumetric heating, as
well as selective heating of polar substrates.29 Studies have also revealed that more than
10 °C above the normal boiling point can be achieved in the case of polar solvents
without leading to boiling when utilizing microwave heating.30 All or only one of these
thermal effects upon microwave heating could be responsible for the improvement of our
Petasis olefination, while the shorter reaction times could disfavor formation of side
products. (See the experimental section for exact details.)
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Table 2.5. Optimization of Petasis Olefination
In summary, by employing microwave heating, we were able to achieve the
Petasis olefination, the second step of the Smith 3-step protocol, to furnish the enol acetal
()-2.71 in very good yield (87%). Thus microwave augmentation of the Petasis
olefination has the potential to be utilized in future natural product synthesis.
2.6.3. Petasis-Ferrier Rearrangement to the Methylene Tetrahydropyran Core of
()-Enigmazole A
Turning to the final step of the Smith three step protocol of Petasis-Ferrier
union/rearrangement, Me2AlCl is generally employed as the promoter for the catalytic
rearrangement (Table 2.6). Unfortunately, during initial attempts the desired
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rearrangement product ()-2.72 was not observed under a variety of conditions (Table
2.6). The molecular weight of the major undesired product 2.73, when utilizing 1 to 2
equivalent of Me2AlCl, was 15 amu units higher by MS than the substrate (-)-2.71, with
the structure remaining unclear. On TLC the rf of the undesired product 2.73 was similar
to that of the substrate ()-2.71, which also made the reaction difficult to monitor.

Table 2.6. Initial Attempts of Petasis-Ferrier rearrangement
When additional equivalents of Me2AlCl (3.0 equiv to 6.0 equiv) were applied,
another major undesired product 2.74 was observed, the NMR of which clearly
demonstrated an α,β-unsaturated ketone structure. We reasoned that the formation of 2.74
was due to catalyst promoted intramolecular retro-Michael addition, after the
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construction of the desired tetrahydropyranone structure (Scheme 2.23). This observation
suggested that utilizing a large excess of the Lewis acid might permit the formation of the
desired product ()-2.72, but unfortunately these conditions also led to further undesired
over-reactions assisted by the excess Lewis acid. We therefore started to optimize the
reaction by shortening the reaction time, decreasing the reaction temperature, and the
screening of base additives.

Scheme 2.23. Formation of α,β-unsaturated ketone
Fortunately, by shortening the reaction time to 2 seconds at 0 °C, a 40% yield of
the desired product ()-2.72 could be isolated after careful separation by PTLC (Table
2.7). This was an exciting observation but the required 2-second reaction time led to
extremely inconsistent results. Pleasingly, the reaction could be controlled by simply
decreasing the reaction temperature to -78 °C. Within a reaction time range between 20
seconds and 35 seconds at -78 °C, the desired product ()-2.72 could be isolated in 50%
to 85% yield. To increase further the consistency of the reaction, additives such as
Cs2CO3, utilized in the synthesis of spongistatin,31 and molecular sieves, utilized in the
synthesis of clavosolide32 were investigated. Unfortunately, neither led to a promising
result.
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Table 2.7. Optimizations of Petasis-Ferrier rearrangement
During the optimization studies, we also discovered that the yield of the
rearrangement reaction significantly varied depending on the applied quenching
conditions. Quenching with organic bases such as trimethylamine, diisopropylethylamine
or 2,6-lutidine only led to low yield. In contrast, quenching with aqueous solutions of
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NaHCO3 or NaOH at -78 °C led to a 50% to 85% isolated yields. However again the
reaction results remained inconsistent. We therefore developed an unconventional
quenching and further olefination tactic by using a methylene ylide solution to generate
directly the methylene tetrahydropyran structure in a one-pot fashion. Surprisingly,
treatment of the rearrangement mixture with a solution of freshly prepared methylene
ylide in THF at -78 °C led to the desired product ()-2.21 in 70% to 85% yield with good
consistency (Scheme 2.24). We therefore had successfully achieved the entire carbon
skeleton of enigmazole A utilizing a more efficient late-stage large-fragmente PetasisFerrier union/rearrangement.

Scheme 2.24. Direct Formation of Methylene Tetrahydropyran
2.6.4.

Summary

of

the

Late-Stage

Large-Fragment

Petasis-Ferrier

Union/Rearrangment
In summary, as outlined in Scheme 2.25 we have achieved an unprecedented
late-stage large-fragment Petasis-Ferrier union/rearrangement to furnish the entire carbon
skeleton of enigmazole A in high yield (70% over 3 steps) with excellent
diastereoselectivity (>20:1). Contributions of this synthetic sequence included: (i)
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construction of the entire carbon skeleton, including all stereocenters of the natural
product; (ii) demonstration that our presumption that larger fragments in the PetasisFerrier union/rearrangement would proceed to furnish better cis-selectivities; (iii)
development of the versatility of the Petasis-Ferrier union/rearrangement through
significant optimizations, including slow introduction of moisture to the union mixture,
microwave-augmentation of the olefination protocol, an unconventional ylide quenching
method; and (iv) the demonstration that substrates containing free hydroxyl groups could
be employed in the union/rearrangement reactions without protection.

Scheme 2.25. Late-Stage Large-fragment Petasis-Ferrier Union/Rearrangement
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2.7. Construction of the Advanced Enigmazole Macrolide (+)-2.48

Figure 2.7. Structure of Macrolide (+)-2.48
2.7.1. Construction of the Macrolactonization Precursor (+)-2.20 via Chemoselective
Oxidation
Attention turned next to the synthesis of macrolactonization precursor, whereby
we planned to remove the primary TBDPS and secondary TMS ether together in one step.
Unfortunately, neither fluoride nor acidic conditions (TBAF, HF/pyridine or CSA) led to
the desired product in a good yield. We therefore attempted to utilize basic conditions.
During the Smith total synthesis of phorboxazole A, potassium hydroxide (KOH) and 18crown-6 had been used to remove selectively a primary TBDPS ether in the presence of
secondary TBS and TIPS ethers.15 Pleasingly, by utilizing similar conditions in our
system, the desired diol (+)-2.75 was available in 75-80% yield, together with 15% to
20% of the transsilylation by-product 2.76 (Scheme 2.26).
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Scheme 2.26. Deprotection of TBDPS and TMS group
The

subsequent

chemoselective

oxidation

to

furnish

the

requisite

macrolactonization precursor acid (+)-2.20 however proved problematic. In particular,
the similar retention time on TLC of the starting material (+)-2.75 and the desired acid
(+)-2.20 complicated reaction monitoring. As a result, a stepwise procedure was
implemented, utilizing a TEMPO/BAIB oxidation to furnish aldehyde (+)-2.76 in 76.9%
yield, followed by a Pinnick oxidation to provide the desired acid (+)-2.20 in 85.4%
yield.16, 17 With a TLC sample of desired acid (+)-2.20 in hand, direct oxidation from (+)2.75 to (+)-2.48 using TEMPO/NaClO/NaClO2 could now be carried out. Pleasingly,
such conditions yielded the macrolactonization precursor (+)-2.20 in 67.3% yield,
together with 20% of an over-oxidized by-product 2.77 (Scheme 2.27).
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Scheme 2.27. Synthesis of Macrolactonization Precursor (+)-2.20
2.7.2. Macrolactonization: Construction of (+)-2.48
Turning to the macrolactonization, the Keck conditions, as utilized in the
Molinski total synthesis of enigmazole A, led to the desired (+)-2.48 in modest yield
(40%-50%).9, 33 Unfortunately, macrolide (+)-2.48 proved very difficult to purify due to
the large amount of urea residue derived from the macrolactonization reagent DCC.
Another macrolactonization reagent, EDCI.HCl, which would have permitted for simpler
purification, was also tested but only provided the desired product in low yield (10%)
(Scheme 2.28).
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Scheme 2.28. Construction of Macrolide via Keck macrolactonization
Pleasingly

however

the

Yamaguchi

conditions,

commonly

used

for

macrolactonizations, furnished the desired (+)-2.48 in 88.5% yield without any
purification problems (Scheme 2.29).34

Scheme 2.29. Construction of Macrolide via Yamaguchi macrolactonization
In summary, macrolide (+)-2.48 was successfully constructed from the Petasis-Ferrier
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union/rearrangement product ()-2.21 via chemoselective silyl ether removal,
chemoselective oxidation and macrolactonization.

2.8. Construction of Enigmazole A: Endgame of the Total Synthesis

Figure 2.8. Endgame of the Total Synthesis
2.8.1. Removal of the TIPS Protecting Group
Turning to the endgame of the total synthesis after the construction of macrolide
(+)-2.48, the TIPS group at C5 would require removal before phosphorylation. This
deprotection reaction seemed relatively straightforward at the outset of our retrosynthetic
analysis given the TIPS group would be the only silyl ether protecting group remaining
on our advanced intermediate, and thus there would be no differentiation issues.
However, upon screening a variety of different conditions, including most of the common
silyl ether removal methods such as acid, base or fluoride ion, a promising result was not
obtained (Table 2.8). Mild conditions were incapable of removing the protecting group,
while harsher conditions, led to either complex intractable mixtures or a single undesired
product having the same molecular weight as the desired product (+)-2.78. Subsequent
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NMR analysis of the undesired product suggested a δ-lactone structure (2.79), which we
envisioned arising via an intramolecular transesterification after formation of desired
alcohol (+)-2.78. Additional evidence for a δ-lactone was the observation of an IR
absorption at 1738 cm-1.

Table 2.8. Initial Attempts of TIPS Deprotection
A similar transesterification had been observed in the dephosphorylation of (-)enigmazole A during Gustafson’s structure elucidation study. More specifically, δ-lactone
2.81 was observed together with the desired dephosphorylation product 2.80 upon
treatment with weak acid. Despite the undesired side reaction, the absolute configurations
of C4 and C5 of enigmazole A could be assigned via the NMR studies of δ-lactone 2.81
(Scheme 2.30).35
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Scheme 2.30. Dephosphorylation of Enigmazole A, Formation of the δ-lactone
To compare the TIPS deprotection by-product ()-2.79 with the natural productderived δ-lactone ()-2.81, PMB deprotection studies were carried out (Scheme 2.31).
Initially, treatment of 2.79 with DDQ did not furnish the desired product ()-2.81, but the
PMP acetal 2.82. An acetonide removal from 2.82, employing TFA/H2O, smoothly led to
the desired δ-lactone ()-2.81. Subsequent studies also demonstrated that direct exposure
of PMB ether ()-2.79 with the same TFA/H2O conditions successfully removed the
PMB protecting group to furnish δ-lactone ()-2.81. To our delight, the deprotection
product ()-2.81 displayed NMR spectral properties in excellent agreement with those
recorded in the structural elucidation paper [i.e., 1H and

13

C NMR (500 and 125 MHz,

respectively), HRMS parent ion identification, and chiroptic properties].35 This result not
only confirms the structure of the transesterification by-product (-)-2.79, but also proves
the precise configurations of all eight stereogenic centers of our advanced intermediates.
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Scheme 2.31. PMB Deprotection of δ-lactone 2.79
Despite the promising evidence relating the stereogenic centers, the
transesterification side-reaction remained problematic. Presumably in our case, formation
of the six membered ring lactone and the associated conformational stability were the
driving force for formation of the undesired product (+)-2.79 (Table 2.8). Importantly, the
transesterification reaction proceeded extremely fast, thus making access to alcohol (+)2.78 very challenging.
Turning to the literature, Carreira et al. had encountered a similar problem in
their synthesis of (+)-zaragozic acid (Scheme 2.32).36 Indeed, in their attempt to remove
the TBS group from advanced intermediate 2.83, a variety of commonly employed
deprotection conditions were screened. The desired alcohol 2.85 however could not be
isolated, given that it instantaneously underwent an intramolecular reaction with an acetyl
group to yield 2.84. After extensive screening, Carreira et al. found that the desired
primary alcohol 2.85 could only be obtained by employing HF-pyridine, buffered with
large excess of pyridine. We therefore applied this method to our substrate (+)-2.48.
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Scheme 2.32. TBS Deprotection in the Synthesis of (+)-Zaragozic Acid
Upon treatment of (+)-2.48 with HF-pyridine complex buffered with large
excess of pyridine, the desired macrolide (+)-2.78 could be isolated. Although the
undesired by-product 2.79 was still observed, a screen of different ratios of HF and
pyridine, as well as reaction temperatures and times led to the best conditions, furnishing
alcohol (+)-2.78 in 70% yield (Scheme 2.33).

Scheme 2.33. Deprotection of TIPS Protecting Group
In summary, advanced intermediate (+)-2.78 was constructed via a carefully
optimized TIPS removal protocol to avoid an undesired transesterification. Importantly,
the further transformation of the transesterification by-product (+)-2.79 provided strong
evidence of the precise stereogenicity of all eight centers of our advanced synthetic
intermediates.
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2.8.2. Phosphate Installation and Removal of the PMB Protecting Group
Focus next turned to the formation of the phosphate ester. One of the most
commonly utilized methods for the formation of phosphate esters is the conversion of a
P-N bond of phosphorus(III) reagent to a P-O bond by the substrate alcohol in the
presence of a catalytic amount of 1H-tetrazole, followed by oxidation of the
phosphorus(III) compound to the phosphorus(IV) compound with peroxides.37 We
attempted to employ this method to our synthesis. Due to the possible acid-lability of the
natural product enigmazole A, a base-cleavage phosphate protecting group 9fluorenylmethyl (Fm) was employed,40 which had proven efficient in the Molinski total
synthesis of enigmazole A,9 as well as the Boger total synthesis of cytostatin.38 The
requisite phosphate reagent, difluorenyl phosphoramidite, was freshly prepared according
to a conventional procedure via phosphoramidous chloride.40,41
However, initial attempts at the phosphorylation proved problematic (Scheme
2.34). Fewer equivalents (< 10 equiv) of phosphate reagent only led to incomplete
reaction, whereas employing more equivalents of phosphate reagent led to reaction
mixtures very difficult to purify due to the large amount of phosphate residue.

Scheme 2.34. Initial Attempts of Phosphorylation
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Given the limited amount of advanced intermediate (+)-2.78, a model study
employing the western hemisphere intermediate ()-2.69 was carried out to screen
phosphorylation conditions, as well as to practice purification methods to remove
phosphate residue (Scheme 2.35). The model study demonstrated that a large excess of
iPr2NP(OFm)2 (>15 equiv) proved necessary to achieve complete conversion. A screen of
different equivalents of the phosphate reagent led to a best conditions (20 equiv of
iPr2NP(OFm)2, 93% isolated yield of 2.87)

Scheme 2.35. Model Study of Phosphorylation
Employing the best conditions found in the model study, phosphoric ester (+)-2.86
could be constructed in good NMR yield (Scheme 2.35). However, a small amount of
phosphate residue could not be removed from the desired product 2.86 by normal phase
silica gel flash chromatography. We envisioned that those impurities could be removed
after the subsequnt PMB deprotection of (+)-2.86. Thus the mixture was moved to the
next step.
The PMB protecting group of the phosphoric ester was envisioned to be
removed utilizing the commonly applied oxidative reagent DDQ. Although literature
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precedents suggested conjugated systems, including of 1,3-dienes, 1,4-dienes and trienes,
could not withstand the DDQ oxidative conditions,41,42 our earlier studies of PMB
deprotection of δ-lactone 2.79 demonstrated the robustness of the C(18-22) conjugated
system upon DDQ oxidative conditions (Scheme 2.31). Pleasingly, treatment of PMB
ether 2.86 with DDQ led not only to the desired alcohol (-)-2.67, but also permitted
during purificaiton removal of phosphate impurities derived from the phosphate
installation step (Scheme 2.36).

Scheme 2.36. Phosphorylation and PMB Removal, Construction of ()-2.87
In summary, alcohol ()-2.87, the last intermediate in the total synthesis of
enigmazole A, had been successfully constructed via phosphate installation followed by a
PMB removal reaction; the yield was 61% over two steps.
2.8.3. Removal of Fm Group: Total Synthesis of ()-Enigmazole A (2.1)
Turning to the final step of the total synthesis of ()-enigmazole A (2.1), K2CO3
was used to remove the Fm protecting group on the phosphoric acid (Scheme 2.37)
following the procedure outlined in the Molinski publication.9 Monitoring the reaction by
LC-MS revealed complete conversion after 3 hours. NMR experiments of the reaction
product were carried out after removal of Fm residue through extraction.
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Scheme 2.37. Deprotection of Fm Group, Construction of Dipotassium Phosphate of
Enigmazole A
Disappointingly, although our deprotection product 2.88 displayed a very similar
1

H NMR spectrum to enigmazole A recorded in the isolation paper, two disagreements

(e.g., 0.11 ppm) for H2 and H5 were observed (Table 2.9). Given that the correctness of
all eight stereogenic centers of our advanced intermediates had been demonstrated in the
experiments related to δ-lactone 2.79 (Scheme 2.31 in Chapter 2.8.1), we initially
reasoned these spectral disagreements, particularly of the protons near to the phosphoric
acid and carbonyl functional groups including of H2 and H5, arose due to the presence of
different counter-ions on the phosphate group based on the suggestion in the Molinski’s
publication.9 Thus ion-exchange experiments were carried out.

79

Table 2.9. Comparison of 1H NMR Spectra of Potassium Salt of Enigmazole A 2.88 with
Natural Enigmazole A
Ion-exchange chromatography as well as further purification studies were
carried out employing similar procedures as those recorded in the Molinski total synthesis
publication. By employing reverse phase HPLC, using an aqueous solution buffered with
NaClO4 furnished the desired enigmazole A ()-2.1 probably as a sodium salt. Despite
the limited quality of our NMR sample due to the large amount of H2O co-crystallized
with NaClO4, our synthetic enigmazole A ()-2.1 displayed 1H NMR spectral properties
in excellent agreement with those recorded in the elucidation paper (Table 2.10).
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Table 2.10. Initial Comparisons of 1H NMR Spectra of Synthetic Enigmazole A with
Natural Enigmazole A
Although the 1H NMR spectra of our totally synthetic enigmazole A matched
that of natural product, the real format of the isolated enigmazole A remained an issue.
Despite utilizing exactly the same method employed in the final purification, Gustafson
and Molinski came to a different conclusion related to the counter-ions of ()-enigmazole
A in their publications. Gustafson et al. reported ()-enigmazole A as a free phosphoric
acid,35 whereas Molinski et al. concluded that the synthetic natural product as a sodium
salt.9 Neither group however provided further evidence to justify their solution structural
assignments.
To obtain full characterization data of our final product, as well as to solve the
question related the real format of the isolated natural product, further experiments were
carried out. To avoid the involvement of unnecessary potassium ion and subsequent
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troublesome ion-exchange experiment, Na2CO3 was employed in the Fm deprotection
reaction instead of K2CO3 (Scheme 2.38). Monitoring the reaction by C18 TLC revealed
complete conversion after 24 hours, with the Fm residue removed via extraction with
pentane. NMR experiments of the reaction product after solvent removal were carried
out. To our surprise, the 1H NMR spectrum of the sodium salt 2.89 is exactly the same as
that of the potassium salt 2.88, thus proving that the different counter ions (Na+ or K+) are
not the main reason for the spectral disagreements for H2 and H5. We then reasoned these
disagreements were due to the different levels of proton dissociation of the phosphoric
acid.

Scheme 2.38. Deprotection of Fm Group and Construction of Disodium Phosphate of
Enigmazole A
To prove this hypothesis, proton exchange experiments were carried out in a 5 mmdiameter glass NMR tube (Scheme 2.39). Treatment of a solution of disodium phosphate
2.89 in CD3OD with 10 μL of TFA-d furnished the free phosphoric acid. The 1H NMR
spectrum of 2.90 changed significantly for the H2 and H5 signals compared with those of
the sodium salt 2.89. However the spectrum was still not in full agreement with the
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enigmazole A spectrum recorded in the original elucidation paper. We next treated
phosphoric acid 2.90 with 20 mg of solid NaHCO3 to furnish monosodium phosphate
2.91. To our surprise, the 1H NMR spectrum of 2.91 was now in excellent agreement with
enigmazole A recorded in the isolation paper.

Scheme 2.39. Phosphoric Acid Dissociation Experiments
Based on these NMR experiments, we conclude that the natural product ()enigmazole A was isolated as a monophosphate. The 1H NMR spectra of the different
levels of phosphoric acid dissociation however presented no neglectable disagreements,
whereas the different counter ions (Na+ or K+) does not make an observable difference in
the NMR spectra (Table 2.11). The product of Fm removal reaction utilizing K2CO3 is a
dipotassium phosphate rather than the monopotassium phosphate recorded in Molinski’s
publication.9 The disagreements of NMR spectra after the subsequent HPLC ionexchange experiment are not due to the cation exchange, but due to the change of the
proton association on the phosphate.
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Table 2.11. Comparisons of 1H NMR Spectra of Different Acid Dissociation Levels of
Engimazole A
To synthesize all three phosphate formats of enigmazole A, we next employed
acetic acid-d4 (CD3COOD) to quench the reaction mixture during the Fm deprotection
reaction utilizing Na2CO3 (Scheme 2.40). After removal of the Fm residue by extraction
with pentane, the reaction mixture was concentrated to give enigmazole A
monophosphate (2.1) together with sodium acetate-d3. The product was then purified and
converted to phosphoric acid format 2.90 by employing reverse phase HPLC
(CH3CN/H2O, 0.1% TFA). After obtaining 1H and
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13

C NMR spectra of the free acid

format 2.90, the synthetic enigmazole A was converted to the monophosphate format
through the addition of saturated NaHCO3 Methanol-d4 solution. The resulting synthetic
monophosphate ()-enigmazole A 2.1 displayed NMR spectral properties in excellent
agreement with those recorded in the elucidation paper [i.e., 1H, 13C, 31P NMR (500, 125,
200 MHz, respectively), HRMS parent ion identification, and chiroptic properties]. The
NMR spectra comparisons are summarized in Figure 2.9, Figure 2.10. Table 2.12 and
Table 2.13. Subsequent Treatment of monophosphate 2.1 with dilute NaOH Methanol-d4
solution then furnished the diphosphate format 2.91.

Scheme 2.40. Synthesis of all Three Phosphates Formats of Enigmazole A (2.1)
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Figure 2.9. Comparisons of 1H NMR Spectra of Synthetic Enigmazole A with Natural
Enigmazole A (Upper: Natural Enigmazole A, Lower: Synthetic Monophosphate)

Figure 2.10. Comparisons of 13C NMR Spectra of Synthetic Enigmazole A with Natural
Enigmazole A (Upper: Literature Enigmazole A, Lower: Synthetic Monophosphate)
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Table 2.12. Comparisons of 1H NMR Spectra of Synthetic Enigmazole A with Natural
Enigmazole A
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Table 2.13. Comparisons of 13C NMR Spectra of Synthetic Enigmazole A with Natural
Enigmazole A
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Finally, we synthesized all three possible phosphate forms of enigmazole A. The
comparisons of 1H NMR are summarized in Figure 2.11 and the detail full characters of
all the three formats are attached in experimental information (Chapter 3). Moreover,
enigmazole A could exist as a mixture of two different phosphate formats in some certain
pH level. Interestingly, the 1H NMR spectra in that case does not demonstrate a mixture
of two different compounds, but one single compound with average signals between the
two formats, presumably due to the rapid proton exchange (e.g. Figure 2.12). We
therefore conclude that the NMR specta of enigmazole A vary with the different pH
levels.

Figure 2.11. Comparisons of 1H NMR Spectra of Three Phosphate Formats of
Enigmazole A (Upper: Diphosphate, Middle: Monophosphate, Lower: Phosphoric Acid)
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Figure 2.11. 1H NMR Spectra of the Mixture of Monophosphate and Diphosphate
(Upper: Diphosphate, Middle: Mixture of Monophosphate and Diphosphate, Lower:
Monophosphate)

2.9. Summary of the Total Synthesis Enigmazole A
In summary, we have completed the total synthesis of enigmazole A ()-2.1 in 22
steps and 2.45% overall yield from the commercially available (+)-2.25 exploiting a
highly convergent retrosynthetic analysis (Scheme 2.41). The cornerstone of the synthesis
is an unprecedented late-stage large-fragment Petasis-Ferrier union/rearrangement, which
generated the entire carbon skeleton of ()-enigmazole A in a single cascade sequence,
further developing the versatility and robustness of the Smith three step Petasis-Ferrier
union/rearrangement protocol. Other key reactions of the synthesis include a Negishi
cross-coupling, a dithiane-epoxide union, a Type I multicomponent ARC coupling and a
Yamaguchi macrolactonization. Chemoselective oxidation/reduction strategies and onepot reactions were frequently used in the synthetic sequence, thus enhancing the
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efficiency. Moreover, the total synthesis had been achieved in a highly stereocontrolled
manner with no undesired diastereomer observed in the process of construction of all
eight stereogenic centers. Finally, all the three formats of the natural products have been
synthesized.

Scheme 2.41. Summary of the Total Synthesis of Enigmazole A
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Post Script: Potential Synthesis Access to the Congeners of (-)Enigmazole A
Although enigmazole A comprises the principle cytotoxic constituent of the
Cinachyrella enigmatica extract, a number of related congeners including enigmazole B,
15-MeO-enigmazole A, 13-OH-15-MeO-enigmazole A, cis-enigmazole B and 14-15dehydro-enigmazole B were also identified (Figure P.S.).1,2 While the original
Cinachyrella enigmatica extract fraction displayed selectivity against c-Kit mutant cells,
enigmazole A (3.1) upon isolation proved equally cytotoxic to both wild-type and mutant
c-Kit. This observation suggests the possiblity that the other congeners, either enigmazole
B (3.4) or the related enigmazole analogues, might be responsible for the selectivity
observed in the c-Kit assays.1,3 Due to the importance of the selectivity issue, in
conjunction with the limited amounts of the enigmazole congeners available from the
natural source, the synthesis of seminal congeners could prove important in improving
both the antitumor activity and the c-Kit mutation selectivity. With these considerations
in mind, recognizing the considerable advantages of our now complete synthesis of
enigmazole A, utilizing a late-stage large-fragment Petasis-Ferrier union/rearrangement,
in conjunction with anion relay chemistry (ARC) to access diverse advanced synthesis,
we have the potential to access 15-MeO-enigmazole A, 13-OH-15-MeO-enigmazole A,
enigmazole B and cis-enigmazole B (Figure P.S.). Such studies are planned in the Smith
group.

95

Figure P.S. Structure of Enigmazole A, B and Related Congeners
Reference:
1.Oku, N.; Gustafson, K. R.; Fuller, R. W.; Wilson, J. A. Book of abstracts of
“ Symposium on the chemistry of natural products”, Kyoto, Japan, September 15th,
2006, pp 73-77
2. Oku, N.; Takada, K.; Fuller, R. W.; Wilson, J.A.; Peach, M. L.; Pannell, L. K.;
MaMahon, J. B.; Gustafson, K. R. J. Am. Chem. Soc. 2010, 132, 10278
3. Takada, K. Presented at the 47th Annual Meeting of the American Society of
Pharmacognosy, Arlington, VA, 2006
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Chapter 3. Experimental Information
3.1. Material and Methods
Reactions were carried out in oven-dried glassware unless otherwise specified.
Anhydrous THF, DCM, diethyl ether and toluene were obtained from the Pure SolveTM
PS-400. Triethylamine, diisopropylamine, diisopropylethylamine, HMPA and DMPU
were freshly distilled from calcium hydride under an nitrogen atmosphere, All chemicals
were purchased from Sigma Aldrich, Acros or TCI America. Reactions were magnetically
stirred unless stated otherwise and monitored by SiO2 thin layer chromatography (TLC).
Silica gel chromatography was performed utilizing ACS grade solvents and silica gel
from Silicycle.
Infrared spectra were obtained using a Jasco FT/IR-480 plus spectrometer. Optical
rotations were obtained using a Jasco polarimeter or Jasco P2000 polarimeter. 1H
magnetic resonance spectra and 13C magnetic resonance spectra were obtained on either a
Bruker AMX 500 MHz or a Bruker Avance III 500 MHz spectrometer. Chemical shifts
are reported relative to chloroform (δ 7.26), benzene (δ 7.16) or methanol (δ 3.30) for 1H
NMR spectra and chloroform (δ 77.23), benzene (δ 128.39) or methanol (δ 49.00) for 13C
NMR spectra. High resolution mass spectra were measured at the University of
Pennsylvania.
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3.2. Detailed Experimental Procedures Relevant to Chapter 2

Z-iodoalkene (+)-2.29 To a stirred suspension of NaH (23.1 g, 578 mmol, 60% in
mineral oil, 5.0 equiv) in 250 mL of Et2O at 0 °C under a nitrogen atmosphere, a solution
of iodide (+)-2.28 (24.5 g, 115.5 mmol, 1.0 equiv.) in 100 mL Et2O was added slowly.
After complete addition, the temperature was increased to room temperature and the
reaction mixture was allowed to stir for 20 min before it was recooled to 0 °C. Methyl
iodide was added dropwise, followed by very slow addition (over 40 min) of 15-crown-5
(30.5 g, 138.7 mmol, 1.2 equiv.) at 0 °C. The resulted mixture was stirred overnight at
room temperature and quenched at 0 °C by very careful addition of saturated aqueous
NH4Cl (100 mL over 1 hour) The organic layer was removed and the aqueous layer was
extracted with diethyl ether (50 mL) twice. The combined organic layers were washed
with brine (50 mL), dried over MgSO4, filtered and concentrated, the resulting oil was
purified by reduced pressure distillation (80 °C at 5 mm Hg) to give Z-iodoalkene (+)2.29 (23.4 g, 104 mmol, 90.0%) as a colorless liquid; []20
D = +9.45 (c 2.16, CHCl3); IR
(film) 2979, 2927, 2900, 2819, 1654, 1443, 1370, 1338, 1281, 1206, 1145, 1115, 1098,
1031, 968, 866, 774, 655 cm-1; 1H NMR (500 MHz, CDCl3-d) δ = 6.03 (d, J = 1.0 Hz,
1H), 4.27 (q, J = 6.5 Hz, 1H), 3.23 (s, 3H), 1.80 (d, J = 1.0 Hz, 3H), 1.20 (d, J = 6.5 Hz,
3H); 13C NMR (125 MHz, CDCl3) δ = 147.5, 80.9, 75.7, 56.5, 18.6, 18.0; high resolution
mass spectrum (CI) m/z 225.9852 [(M)+ calcd for C6H11IO]
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Oxazolyl Chloride 2.33: To a solution of tert-butyl nitrite (90%, 7.62 mL, 57.7 mmol,
1.5 equiv) and copper(II) chloride (7.67 g, 57.7 mmol, 1.5 equiv) in acetonitrile (200 mL)
at 60 °C was added portionwise aminooxazole 2.32 (6.0 g, 38.4 mmol, 1.0 equiv) over
15 min. The resulted mixture was then heated at 80 °C for 2 hours (warning: toxic gas
formation). The reaction mixture was then cooled to room temperature and quenched by
the addition of large amount of hydrochloric acid (200 mL 1M in water). The mixture
was diluted with dichloromethane (500 mL). The organic layer was removed and the
aqueous layer was extracted with dichloromethane (50 mL) twice. The combined organic
layers were washed with saturated aqueous NH4Cl and brine, dried over MgSO4, filtered
and concentrated. The crude product was then purified by recrystallization (ethyl acetate:
hexanes 10:90, 0 °C) to furnish oxazolyl chloride 2.33 (4.83 g, 27.6 mmol, 72.0%) as a
white solid. IR (film) 3148, 2995, 1728, 1538, 1375, 1333, 1278, 1141, 1097, 977, 945,
858, 773, 675 cm-1; 1H NMR (500 MHz, CDCl3-d) δ = 8.16 (s, 1H), 4.35 (q, J = 7.0 Hz,
2H), 1.34 (t, J = 7.0 Hz, 3H);

13

C NMR (125 MHz, CDCl3) δ = 160.1, 148.4, 145.5,

135.3, 61.8, 14.3; high resolution mass spectrum (ES+) m/z 176.0116 [(M+H)+ calcd for
C6H7ClNO3]

Oxazolyl Easter (+)-2.34: To a solution of Z-iodoalkene (+)-2.29 (19.0 g, 84.1 mmol, 1.0
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equiv) in Et2O (70 mL) under a nitrogen atmosphere at -78 °C was added dropwise tBuLi (99 mL, 1M in pentane, 168.0 mmol, 2.0 equiv) over 30 min. The resulting
heterogeneous mixture was stirred for 1 hour at the same temperature, then ZnCl2
solution (100 mL, freshly prepared from solid flame-dried ZnCl2, 1 M in THF, 100.0
mmol, 1.19 equiv) was added dropwise and the reaction mixture was allowed to warm to
room temperature over a 30 min period. At this point pentane and diethyl ether were
removed from the reaction under reduced pressure and nitrogen atmosphere. A solution of
oxazolyl chloride 2.33 (14.9 g, 84.1 mmol, 1.0 equiv) and Pd(PPh3)4 (2.0 g, 1.73 mmol,
0.02 equiv) was separately prepared in THF (80 mL) and was added dropwise. The
resulting mixture was vigorously stired at reflux for 2 hours, then cooled to room
temperature and quenched by the addition of a saturated aqueous NH4Cl solution (50
mL). The mixture was diluted with diethyl ether. The organic layer was removed, and the
aqueous layer was extracted with diethyl ether (30 mL) twice. The combined organic
layers were washed with brine (20 mL), dried over MgSO4, filtered, and concentrated, the
resulting oil was purified by column chromatography (SiO2, ethyl acetate: hexanes 10:90,
15:85, 20:80) to furnish oxazolyl easter (+)-2.34 (16.1 g, 67.3 mmol, 80.0%) as a
colorless oil: []20D = +43.94 (c 0.47, CHCl3); IR (film) 2980, 1743, 1722, 1654, 1576,
1448, 1370, 1316, 1178, 1113, 1025, 839, 770 cm-1; 1H NMR (500 MHz, CDCl3) δ =
8.11 (s, 1H), 6.26 (s, 1H), 5.14 (q, J = 6.5 Hz), 4.39 (q, J = 7.1 Hz, 2H), 3.23 (s, 3H), 1.93
(d, J =1.0 Hz, 3H), 1.38 (t, J = 7.1 Hz, 3H), 1.32 (d, J = 6.5 Hz, 3H);

13

C NMR (125

MHz, CDCl3) δ = 161.4, 161.0, 153.2, 142.8, 134.2, 112.7, 74.8, 61.2, 56.5, 19.4, 17.9,
14.4; high resolution mass spectrum (ES+) m/z 262.1051 [(M+Na)+ calcd for
C12H17NO4Na]
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Oxazolyl Aldehyde (+)-2.35: A solution of ester (+)-2.34 (9.00 g, 37.6 mmol, 1 equiv) in
200 mL CH2Cl2 was treated with DIBAL-H (1 M in hexanes, 75.2 mL, 75.2 mmol, 2.0
equiv) at -78 °C under nitrogen atmosphere, followed by stirring at that temperature for
30 min. The resulted mixture was quenched with MeOH (20 mL) at -78 °C before it was
warmed to room temperature. Saturated aqueous Rochelle’s salt solution (80 mL) was
then added and the mixture was stirred vigorously for 1 h. The resulting mixture was
diluted with 100 mL diethyl ether. The organic layer was removed, and the aqueous layer
was extracted with diethyl ether (50 mL) twice. The combined organic layers were
washed with brine (20 mL), dried over MgSO4, filtered, and concentrated, the resulting
oil was purified by column chromatography (SiO2, ethyl acetate: hexanes 10:90, 15:85,
20:80) to furnish aldehyde (+)-2.35 (6.35 g, 32.7 mmol, 87.0%) as a white amorphous
solid; []20D = +25.15 (c 1.0, CHCl3); IR (film) 2978, 2924, 1699, 1651, 1562, 1114 cm-1;
1

H NMR (500 MHz, CDCl3) δ = 9.95 (s, 1H), 8.18 (s, 1H), 6.23 (s, 1H), 5.24 (q, J = 6.5

Hz), 3.24 (s, 3H), 1.94 (d, J =1.5 Hz), 1.33 (d, J = 6.5 Hz); 13C NMR (125 MHz, CDCl3)
δ = 184.8, 161.5, 154.8, 143.0, 141.7, 112.2, 75.0, 56.8, 19.4, 18.1; high resolution mass
spectrum (ES+) m/z 196.0971 [(M+H)+ calcd for C10H14NO3]
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Oxazolyl Dithiane (+)-2.23: A solution of aldehyde (+)-2.35 (2.30 g, 11.7 mmol, 1.0
equiv) in 60 mL CH2Cl2 was treated with 1,3-propanedithiol (1.75 mL 17.51 mmol, 1.5
equiv.) and BF3.OEt2 (0.55 mL, 4.08 mmol, 0.35 equiv) respectively at 0°C under a
nitrogen atmosphere, followed by stirring at that temperature for 2 h. The resulting
mixture was quenched by the addition of a 2 M NaOH aqueous solution (20 mL), and
diluted with 30 mL diethyl ether. The organic layer was removed, and the aqueous layer
was extracted with diethyl ether (30 mL) twice. The combined organic layers were
washed with the 2 M NaOH aqueous (15 mL) three times, saturated aqueous NaHCO3
(20 mL), and brine (20 mL), dried over MgSO4, filtered and concentrated, and the
resulting oil was purified by column chromatography (SiO2, ethyl acetate: hexanes 10:90,
15:85, 20:80) to furnish dithiane (+)-2.23 (3.21 g, 11.2 mmol, 96.1%) as an amorphous
white solid; []20D = +43.68 (c 4.75, CHCl3); IR (film) 2977, 2931, 2900, 2819, 1654,
1542, 1446, 1422, 1368, 1273, 1204, 1149, 1112, 1095, 971.0, 875, 760 cm-1; 1H NMR
(500 MHz, CDCl3) δ = 7.60 (s, 1H), 6.21 (t, J = 1.5 Hz, 1H), 5.16 (q, J = 6.5 Hz), 5.13 (s,
1H), 3.23 (s, 3H), 3.06 – 2.95 (m, 4H), 2.17 (m, 1H), 2.01 (m, 1H), 1.89 (d, J = 1.5 Hz,
3H) 1.31 (d, J = 6.5 Hz, 3H);

13

C NMR (125 MHz, CDCl3) δ = 160.2, 151.1, 140.6,

134.4, 113.2, 74.7, 56.4, 41.3, 30.3, 25.3, 19.2, 17.6; high resolution mass spectrum
(ES+) m/z 286.0940 [(M+H)+ calcd for C13H20NO2S2]
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Dithiane ()-2.42: A solution of tert-butyl(1,3-dithian-2-yl)dimethylsilane (4.12 g, 17.6
mmol, 1.2 equiv) in diethyl ether (30 mL) was treated dropwise with n-BuLi (7.70 mL,
19.3 mmol, 2.5 M in hexanes, 1.3 equiv) at 0 °C under a nitrogen atmosphere. The
mixture was kept at 0 °C for 15 min, warmed to ambient temperature and then stirred for
18 min before it was cooled to -78 °C. Epoxide ()-2.41 (4.00 g, 19.8 mmol, 1.35 equiv.)
in 40 mL of diethyl ether was added to the reaction mixture dropwise via a syringe
followed by warming to -30 °C and stirring at that temperature for 2 hours. The reaction
mixture was cooled back to -78 °C, and the epoxide ()-2.36 (2.85 g, 14.7 mmol, 1.0
equiv.) in 25 mL of diethyl ether and 5 mL of DMPU was added dropwise via a syringe.
The reaction mixture was kept at -78 °C for 30 min and then slowly warmed to ambient
temperature overnight without removing the bath. The resulting mixture was quenched
with the addition of saturated aqueous NH4Cl (20 mL) and diluted with diethyl ether (30
mL). The organic layer was removed, and the aqueous layer extracted with diethyl ether
(15 mL) twice. The combined organic layers were washed with brine, dried over MgSO4,
filtered and concentrated, and the resulting oil was purified by column chromatography
(SiO2, ethyl acetate: hexanes 10: 90, 15: 85, 20: 80) to furnish dithiane ()-2.42 (8.30 g,
13.2 mmol, 89.8%) as a light yellow oil. []20
D = -3.80 (c 4.0, CHCl3); IR (film) 3466,
2954, 2928, 2856, 1613, 1514, 1471, 1250, 1097, 1038, 836, 775, 664 cm-1; 1H NMR
(500 MHz, CDCl3) δ = 7.27 (d, J = 8.5 Hz, 2H), 6.87 (d, J = 8.5 Hz, 2H), 4.50 (s, 2H),
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4.28 – 4.20 (m, 2H), 3.80 (s, 3H), 3.75 – 3.67 (m, 2H), 3.43 (dd, J = 4.5 Hz, 9.0 Hz, 1H),
3.39 (dd, J = 6.5 Hz, 9.0 Hz, 1H), 3.15 (s, 1H), 2.97 – 2.91 (m, 1H), 2.89 – 2.75 (m, 3H),
2.31 (m, 2H), 2.10 (m, 2H), 1.98 (m, 2H), 1.92 (m, 1H), 1.76 (m, 1H), 0.91 (s, 9H), 0.89
(s, 9H), 0.12 (s, 3H), 0.11 (s, 3H), 0.07 (s, 6H); 13C NMR (125 MHz, CDCl3) δ = 159.4,
130.4, 129.5, 112.9, 74.4, 73.0, 68.0, 67.6, 59.8, 55.4, 51.6, 47.1, 43.1, 42.2, 26.7, 26.3,
26.2, 26.1, 24.9, 18.3, 18.2, -3.6, -4.0, -5.1, -5.14; high resolution Mass-spectrum (ES+)
m/z 653.3168 [(M+Na)+ calcd for C31H58O5S2Si2Na]

Alcohol ()-2.43: Commercially available Raney nickel (19.0 g with water, Grade: Raney
Ⓡ 2800 nickel from Aldrich) as a slurry in water was weighed out into the 200 mL
round-bottomed flask and washed with anhydrous ethanol (20 mL) three times under a
nitrogen atmosphere. Dithane ()-2.42 (1.59 mmol, 1.0 equiv) in 35 mL ethanol was
added via syringe to the slurry mixture before hydrogen gas was bubbled through for 20
min. The mixture was heated to 80 °C and kept at that temperature for 2.5 hours with
stirring under a hydrogen atmosphere before it was brought to room temperature. Then
the liquid phase was carefully transferred using a pipet to separate the desired product
from residual flammable Raney nickel and washed with ethanol (15 mL) 4 times. The
combined liquid was concentrated and purified by column chromatography (SiO2, ethyl
acetate: hexanes 10: 90, 15: 85, 20: 80) to furnish alcohol ()-2.43 (0.79 g, 1.50 mmol,
94.5 %) as a colorless oil. []20
D = -4.1 (c 5.0, CHCl3); IR: 3466, 2953, 2929, 2857, 1613,
1514, 1463, 1388, 1361, 1302, 1251, 1093, 1039, 836, 775, 664 cm-1; 1H NMR (500
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MHz, CDCl3) δ = 7.25 (d, J = 8.5 Hz, 2H), 6.88 (d, J = 8.5 Hz, 2H), 4.48 (s, 2H), 3.80 (s,
3H), 3.80 – 3.75 (m, 2H), 3.64 (m, 2H), 3.47 (dd, J = 9.8 Hz, 2.8 Hz, 1H), 3.28 (t, J = 8.8
Hz, 1H), 2.31 (brs, 1H), 1.63 (q, J = 6.5 Hz, 2H) 1.55 – 1.30 (m, 6H), 0.88 (s, 9H), 0.87
(s, 9H), 0.04 (s, 9H), 0.03(s, 3H); IR (film) 3466, 2954, 2929, 2857, 1613, 1514, 1463,
1388, 1360, 1302, 1251, 1094, 1039, 836, 775, 664 cm-1; 13C NMR (125 MHz, CDCl3) δ
= 159.4, 130.2, 129.4, 113.9, 74.4, 73.0, 70.3, 69.2, 60.0, 55.2, 40.1, 37.5, 33.4, 26.1,
26.0, 21.2, 18.3, 18.2, -4.3, -4.5, -5.2; high resolution mass-spectrum (ES+) m/z 549.3394
[(M+Na)+ calcd for C28H54O5Si2Na]

Diol ()-2.44 (Synthesis via Raney nickel reduction, route 1): Commercially available
Raney nickel (9.0 g with water, Grade: RaneyⓇ 2800 nickel from Aldrich) as a slurry in
water was weighed out into the 100 mL round-bottomed flask and washed with
anhydrous ethanol (10 mL) three times under a nitrogen atmosphere. Alcohol ()-2.43
(0.50 g, 0.95 mmol, 1.0 equiv) in 25 mL ethanol was added via syringe to the slurry
mixture before hydrogen gas was bubbled through over 20 min. The mixture was heated
to 80 °C and kept at that temperature for 15 hours with stirring under a hydrogen
atmosphere before it was allowed to attain room temperature. The liquid phase was
transferred carefully using a pipet to separate it from residual flammable Raney nickel
and washed with ethanol (8 mL) 4 times. The combined liquid was concentrated and
purified by column chromatography (SiO2, ethyl acetate: hexanes, 20: 80, 30:70, 40:60)
to furnish diol ()-2.44 (337 mg, 0.830 mmol, 87.3 %) as a colorless oil.
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[]20D = -7.54 (c 5.0, CHCl3); IR (film) 3379, 2953, 2929, 2857, 1472, 1361, 1255, 1094,
938, 836, 774, 664 cm-1; 1H NMR (500 MHz, CDCl3) δ = 3.81 (m, 1H), 3.71 (m, 1H),
3.70 – 3.63 (m, 3H), 3.43 (dd, J = 8.0 Hz, 11.0 Hz, 1H), 1.95 – 1.75 (brs, 2H), 1.65 (ddd,
J = 2.3 Hz, 6.5 Hz, 11Hz, 2H), 1.58 – 1.42 (m, 5H), 1.42 – 1.35 (m, 1H), 0.89 (s, 9H),
0.88 (s, 9H), 0.04 (s, 6H), 0.04(s, 6H);

13

C NMR (125 MHz, CDCl3-d) δ = 72.4, 69.3,

66.9, 60.2, 40.2, 37.5, 33.5, 26.2 (3C), 26.1 (3C), 21.3, 18.5, 18.3, -4.2, -4.4, -5.1; high
resolution mass-spectrum (ES+) m/z 429.2844 [(M+Na)+ calcd for C20H46O4Si2Na ]
Diol ()-2.41 (Synthesis via Sharpless dihydroxylation, route 2): To a solution of
olefin ()-2.46 (4.70 g, 12.62 mmol, 1.0 equiv) in 80 mL t-BuOH and 80 mL water, a
mixture of (DHQ)2PHAL (500 mg, 0.642 mmol, 5 mol %), K2CO4 (5.23 g, 37.86 mmol,
3.0 equiv), K3Fe(CN)6 (12.50 g, 37.86 mmol, 3.0 equiv) and potassium osmate(VI)
dehydrate (100 mg, 0.271 mmol, 2 mol %) was added at 0 °C. The reaction mixture was
stirred for 10 hours at 0 °C before it was diluted with ethyl acetate (200 mL). The organic
layer was removed, and the aqueous layer was extracted with ethyl acetate (50 mL) twice.
The combined organic layers were washed with brine (10 mL), dried over MgSO4,
filtered and concentrated, and the resulting oil was purified by column chromatography
(SiO2, ethyl acetate: hexanes 20:90, 30:70) to furnish diol ()-2.41 with its diastereomer
(4.66 g, 11.5 mmol, 91.0%) as a colorless oil.

Epoxide ()-2.24: To a solution of diol ()-2.44 (1.57 g, 3.87 mmol, 1.0 equiv.) in 40 mL
THF 223 mg of NaH (95 weight-%, 8.83 mmol, 2.28 equiv) was added at 0 °C in
nitrogen atmosphere, followed by stirring at room temperature for 20 min. The reaction
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mixture was then cooled to 0 °C and solid TrisIm (1.54 g, 4.62 mmol, 1.2 equiv) was
added in one portion. The resulting mixture was stirred for 1 h before it was quenched
with the addition of 10 mL saturated aqueous NH4Cl and diluted with diethyl ether. The
organic layer was removed, and the aqueous layer was extracted with diethyl ether (15
mL) twice. The combined organic layers were washed with the saturated aqueous
NaHCO3 (10 mL) and brine (10 mL) subsequently, dried over MgSO4, filtered and
concentrate. The resulting oil was purified by column chromatography (SiO2, ethyl
acetate: hexanes 5:95, 10:90) to furnish epoxide ()-2.24 (1.50 g, 3.86 mmol,
quantitative) as a colorless oil. []20D = -10.33 (c 4.4, CHCl3); IR (film) 2954, 2929, 2857,
1472, 1388, 1361, 1255, 1095, 1006, 938, 836, 774, 664 cm-1; 1H NMR (500 MHz,
CDCl3) δ = 3.83 (m, 1H), 3.71 (td, J = 6 Hz, 3.5 Hz, 2H), 2.90 (m, 1H), 2.75 (t, J = 4.5
Hz, 1H), 2.46 (dd, J = 5.2 Hz, 2.8 Hz, 1H), 1.65 (ddd, J = 2.3 Hz, 6.5 Hz, 11Hz, 2H),
1.58 – 1.42 (m, 6H), 0.89 (s, 9H), 0.88 (s, 9H), 0.05 (s, 3H), 0.04 (s, 9H);

13

C NMR (125

MHz, CDCl3) δ = 69.1, 59.9, 52.3, 47.0, 40.1, 37.3, 32.8, 26.1, 26.0, 21.7, 18.4, 18.2, 4.3, -4.4, -5.2; high resolution mass-spectrum (ES+) m/z 411.2729 [(M+Na)+ calcd for
C20H44O3Si2Na ]

Alcohol (+)-2.45: To a solution of epoxide ()-2.38 (1.80 g, 8.90 mmol, 1.0 equiv) and
copper(I) iodide (0.70 g, 3.67 mmol, 0.41 equiv) in 30 mL Et2O at -78 °C under a
nitrogen atmosphere, a solution of but-3-en-1-ylmagnesium bromide (1 M in Et2O, 26.7
mL, 26.7 mmol, 3.0 equiv) was added dropwise. After complete addition, the temperature
was increased to room temperature, and the reaction mixture was continued to stir for 4
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hours before it was recooled to 0 °C. The resulting mixture was quenched at 0 °C by
addition of saturated aqueous NH4Cl (20 mL). The organic layer was removed and the
aqueous layer was extracted with diethyl ether (30 mL) twice. The combined organic
layers were washed with brine (10 mL), dried over MgSO4, filtered and concentrated, and
the resulting oil was purified by column chromatography (SiO2, ethyl acetate: hexanes
10:90, 15:85, 20:80) to furnish alcohol (+)-2.45 (2.14 g, 8.28 mmol, 93.0%) as a colorless
oil. []20
D = +14.40 (c 1.40, CHCl3); IR (film) 3443, 3077 2928, 2858, 1641, 1472, 1463,
1256, 1090, 1005, 910, 837, 777 cm-1; 1H NMR (500 MHz, CDCl3) δ = 5.77 (m, 1H),
4.97 (d, J = 17.0 Hz, 1H), 4.91 (d, J = 10.0 Hz, 1H), 3.86 (m, 1H), 3.78 (m, 2H), 3.44 (s,
1H), 2.04 (m, 2H), 1.61 (m, 2H), 1.48 – 1.60 (m, 2H), 1.39 – 1.48 (m, 2H), 0.87 (s, 9H),
0.05 (s, 6H); 13C NMR (125 MHz, CDCl3) δ = 139.0, 114.6, 72.1, 63.0, 38.5, 37.1, 33.9,
26.0, 25.0, 18.3, -5.39, -5.41; high resolution mass spectrum (ES) m/z 259.2088 [(M+H)+
calcd for C14H31O2Si]

Olefin ()-2.46: To a solution of alcohol (+)-2.45 (3.70 g, 14.3 mmol, 1.0 equiv) in 80
mL dichloromethane at 0 °C under a nitrogen atmosphere, 2,6-lutidine (3.5 mL, 30.1
mmol, 2.1 equiv) was added followed by TBSOTf (4.0 g, 15.15 mmol, 1.06 equiv). The
reaction mixture was stirred for 2 hours at 0 °C before it was quenched by addition of
saturated aqueous NaHCO3 (20 mL). The organic layer was removed, and the aqueous
layer was extracted with dichloromethane (20 mL) twice. The combined organic layers
were washed with brine (10 mL), dried over MgSO4, filtered and concentrated, and the
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resulting oil was purified by column chromatography (SiO2, ethyl acetate: hexanes 2:98,
5:95, 10:90) to furnish olefin ()-2.46 (4.93 g, 13.2 mmol, 92.4%) as a colorless oil.
[]20D = -9.45 (c 3.00, CHCl3); IR (film) 2956, 2928, 2858, 1472, 1256, 1094, 839, 833,
775 cm-1; 1H NMR (500 MHz, CDCl3) δ = 5.80 (m, 1H), 5.00 (d, J = 17.0 Hz, 1H), 4.94
(d, J = 10.5 Hz, 1H), 3.81 (brs, 1H), 3.66 (m, 2H), 2.04 (d, J = 6.5 Hz, 2H), 1.65 (q, J =
6.0 Hz, 2H), 1.48 – 1.52 (m, 4H), 0.89 (s, 18H), 0.04 (s, 12H);

13

C NMR (125 MHz,

CDCl3) δ = 139.1, 114.6, 69.4, 60.2, 40.3, 37.1, 34.1, 26.18, 26.15, 24.7, 18.5, 18.3 -4.2, 4.4, -5.1; high resolution mass spectrum (ES) m/z 373.2955 [(M+H)+ calcd for
C20H45O2Si2]

Dithiane (+)-2.52 (the second generation synthesis): To a solution of dithiane (+)-2.23
(3.30 g, 11.6 mmol, 1.0 equiv.) in 40 mL of Et2O at -78 °C under a nitrogen atmosphere,
a solution of n-BuLi (2.30 M in hexanes, 5.79 mL, 13.3 mmol, 1.15 equiv) was allowed
to add in 5 minutes. After complete addition, the reaction mixture was stirred for 20
minutes at -78 °C. Epoxide (-)-2.24 (4.50 g, 11.57 mmol, 1.0 equiv.) in 20 mL of E2O
was added to reaction mixture dropwise at the same temperature over 5 minutes. The
resulting mixture was gradually allowed to come to 0 °C over 2 hours before it was
quenched by addition of saturated aqueous NH4Cl (20 mL). The organic layer was
removed, and the aqueous layer was extracted with Et2O (30 mL) twice. The combined
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organic layers were washed with brine (10 mL), dried over MgSO4, filtered, and
concentrated, and the resulting oil was purified by column chromatography (SiO2, ethyl
acetate: hexanes 15:85, 20:80, 30:70) to furnish dithiane (+)-2.52 (6.01 g, 8.92 mmol,
77.0%) as a colorless oil. []20
D = +16.00 (c 1.68, CHCl3); IR (film) 2928, 2856, 1468,
1255, 1096, 836, 774 cm-1; 1H NMR (500 MHz, CDCl3) δ = 7.71 (s, 1H), 6.21 (s, 1H),
5.11 (q, J = 6.5 Hz, 1H), 3.89 (brs, 1H), 3.78 (m, 1H), 3.64, (dd, J = 10.5 Hz, 6.5 Hz,
2H), 3.49 (s, 1H), 3.23 (s, 3H), 2.78 – 2.92 (m, 4H), 2.22 – 2.35, (m, 2H), 2.01 (m, 2H),
1.90 (s, 3H), 1.45 (m, 2H), 1.47 – 1.52 (m, 6H), 1.31 (d, J = 6.5 Hz, 3H), 0.88 (s, 9H),
0.87 (s, 9H), 0.03 (s, 12H); 13C NMR (125 MHz, CDCl3) δ = 160.9, 152.1, 143.9, 136.5,
113.3, 75.1, 69.4, 68.5, 60.2, 56.8, 49.5, 40.2, 37.9, 37.7, 27.8, 27.6, 26.2, 26.1, 25.0,
21.4, 19.4, 18.5, 18.3, 17.9, -4.2, -4.4, -5.09, -5.10; high resolution mass spectrum (ES)
m/z 674.3765 [(M+H)+ calcd for C33H64NO5S2Si2]

Ketone (+)-2.53 (synthesis via mercury(II)-mediated hydrolysis, the first generation
synthesis): To a solution of dithiane (+)-2.52 (900 mg, 1.33 mmol, 1.0 equiv) and CaCO3
(280 mg, 2.80 mmol, 2.10 equiv) in 20 mL of THF/H2O (3:1) at 0 °C under air
atmosphere, HgClO4.6H2O (1120 mg, 2.80 mmol, 2.1 equiv.) was added as a solid in one
portion. The reaction mixture was stirred for 30 minutes at 0 °C before it was diluted by
dichloromethane (30 mL). After filtering through a plug of Celite (5 g), the resulting
mixture was washed with saturated aqueous Na2S2O3 (20 mL). The organic layer was
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removed, and the aqueous layer was extracted with dichloromethane (30 mL), The
combined organic layers were washed with brine (10 mL), dried over MgSO4, filtered,
and concentrated, and the resulting oil was purified by column chromatography (SiO2,
ethyl acetate: hexanes 15:85, 20:80, 30:70) to furnish dithiane (+)-2.52 (489 mg, 0.837
mmol, 62.9%) as a colorless oil.
Ketone (+)-2.53 (synthesis utilizing hydrogen peroxide catalyzed by Fe(acac)3 and
sodium iodide, the second generation synthesis): To a solution of dithiane (+)-2.52
(2.55 g, 3.77 mmol, 1.0 equiv) in ethyl acetate (40 mL) and water (40 mL), Fe(acac)3
(271 mg, 0.757 mmol, 0.2 equiv), sodium iodide (848 mg, 5.66 mmol, 1.5 equiv) and 30%
hydrogen peroxide (1.3 mL aqueous solution, 11.31 mmol, 3.0 equiv) were added
sequentially at 0 °C under an aerobic atmosphere. The reaction mixture was stirred for 30
minutes at the same temperature before it was quenched by the addition of saturated
aqueous Na2S2O3. The organic layer was separated, and the aqueous phase was extracted
with ethyl acetate (20 ml) three times. The combined organic layers were washed with
brine (10 mL), dried over MgSO4, filtered and concentrated, and the resulting oil was
purified by column chromatography (SiO2, ethyl acetate: hexanes 15:85, 20:80, 30:70) to
furnish dithiane (+)-2.52 (1.65 g, 2.83 mmol, 75.0%) as a colorless oil.
[]20D = +24.60 (c 1.40, CHCl3); IR (film) 3465, 2928, 2856, 1686, 1562, 1463, 1386,
1255, 1096, 968, 836, 774, 664 cm-1; 1H NMR (500 MHz, CDCl3) δ = 8.15 (d, J = 1.5
Hz, 1H), 6.24 (s, 1H), 5.19 (q, J = 6.5 Hz, 1H), 4.19 (brs, 1H), 3.83 (brs, 1H), 3.67 (brs,
2H), 3.25 (s, 3H), 3.13 (d, J = 17.5 Hz, 2H), 3.01 (d, J = 17.5 Hz, 9.0 Hz, 1H), 1.95 (s,
3H), 1.66 (q, J = 6.0 Hz, 2H), 1.35 – 1.68 (m, 6H), 1.34 (dd, J = 6.5 Hz, 1.0 Hz, 3H),
0.891 (s, 9H), 0.887 (s, 9H), 0.05 (s, 12H);
111
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C NMR (125 MHz, CDCl3) δ = 196.1,

160.7, 154.2, 141.4, 141.2, 112.4, 75.1, 69.4, 67.9, 60.2, 56.8, 46.9, 40.2, 37.5, 37.2, 26.2,
26.1, 21.3, 19.4, 18.5, 18.3, 18.1, -4.2, -4.4, -5.1; high resolution mass spectrum (ES) m/z
584.3802 [(M+H)+ calcd for C30H58NO6Si2]

Diol (+)-2.54 (the second generation synthesis): To a solution of ketone (+)-2.52 (1.70
g, 2.91 mmol, 1.0 equiv) in 30 mL of THF/MeOH (4:1), a solution of Et2BOMe (1M in
THF, 6.11 mL, 6.11 mmol, 2.1 equiv) was added dropwise at -78 °C under a nitrogen
atmosphere. After the reaction mixture was stirred for 15 minutes at the same
temperature, NaBH4 (250 mg, 6.58 mmol, 2.25 equiv.) was added in one portion. The
resulting mixture was stirred for 2 hours before it was diluted by MeOH (20 mL). The
temperature was then allowed to increase to 0 °C followed by the addition of saturated
aqueous Rochelle’s salt solution (30 mL). The resulting miture was stirred at room
temperature for 30 minutes before it was diluted by ethyl acetate (50 mL). The organic
layer was separated, and the aqueous phase was extracted with ethyl acetate (20 mL)
three times. The combined organic layers were washed with 2 M NaOH aqueous solution
(20 mL * 3), saturated aqueous NH4Cl (20 mL), and brine (20 mL), then dried over
MgSO4, filtered and concentrated. The resulting oil was purified by column
chromatography (SiO2, ethyl acetate: hexanes 20:80, 30:70, 50:50) to furnish diol (+)2.54 (1.62 g, 2.76 mmol, 95.0%) as a colorless oil. []20
D = +12.75 (c 1.00, CHCl3); IR
(film) 3388, 2929, 2857, 1655, 1472, 1363, 1255, 1095, 836, 775 cm-1; 1H NMR (500
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MHz, CDCl3) δ = 7.48 (s, , 1H), 6.18 (s, 1H), 5.13 (q, J = 6.5 Hz, 1H), 4.93 (d, J = 7.0
Hz, 1H), 3.95 (brs, 1H), 3.81 (brs, 2H), 3.66 (brs, 2H), 3.21 (s, 3H), 3.13 (brs, 1H), 1.98
(d, J = 14.5 Hz, 1H), 1.88 (s, 3H), 1.86 (m, 1H), 1.64 (q, J = 6.0 Hz, 2H), 1.32 – 1.58 (m,
6H), 1.29 (dd, J = 6.5 Hz, 3H), 0.874 (s, 9H), 0.868 (s, 9H), 0.03 (s, 12H); 13C NMR (125
MHz, CDCl3) δ = 160.7, 151.1, 144.7, 133.1, 113.5, 75.0, 72.4, 69.4, 68.5, 60.2, 56.7,
43.0, 40.2, 38.5, 37.5, 26.2, 26.1, 21.0, 19.5, 18.5, 18.3, 17.9, -4.2, -4.4, -5.1; high
resolution mass spectrum (ES) m/z 586.3953 [(M+H)+ calcd for C30H60NO6Si2]

PMP-acetal ()-2.55 (the first generation synthesis): To a solution of diol (+)-2.54 (610
mg, 1.04 mmol, 1.0 equiv) in 20 mL of dichloromethane, CSA (20 mg, 0.086 mmol,
0.083 equiv) was added as one portion followed by addition of p-methoxybezaldehyde
dimethyl acetate (304 mg, 1.67 mmol, 1.60 equiv.) at 0 °C under an air atmosphere. The
resulting mixture was stirred for 20 minutes at the same temperature before it was
quenched by saturated aqueous NaHCO3 (10 mL). The organic layer was separated, and
the aqueous phase was extracted with dichloromethane (10 mL) twice. The combined
organic layers were washed with brine (10 mL), dried over MgSO4, filtered and
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concentrated, and the resulting oil was purified by column chromatography (SiO2, ethyl
acetate: hexanes 5:95, 10:90, 20:80) to furnish PMP acetal ()-2.55 (585 mg, 0.83 mmol,
80.0%) as a colorless oil. []20D = -1.62 (c 0.77, CHCl3); IR (film) 2929, 2856, 1616,
1518, 1463, 1362, 1251, 1097, 1037, 835, 774 cm-1; 1H NMR (500 MHz, CDCl3) δ =
7.54 (s, 1H), 7.46 (d, J = 7.8 Hz, 2H), 6.88 (d, J = 7.8 Hz, 2H), 6.21 (s, 1H), 5.65 (s, 1H),
5.17 (q, J = 6.5 Hz, 1H), 4.92 (d, J = 11.0 Hz, 1H), 3.93 (brs, 1H), 3.81 (brs, 1H), 3.80 (s,
3H), 3.66 (d, J = 3.5 Hz, 2H), 3.23 (s, 3H), 2.00 (d, J = 12.5 Hz, 1H), 1.89 (s, 3H), 1.73
(m, 2H), 1.65 (q, J = 6.0 Hz, 2H), 1.39 – 1.61 (m, 5H), 1.31 (d, J = 6.5 Hz, 3H), 0.89 (s,
18H), 0.04 (s, 12H); 13C NMR (125 MHz, CDCl3) δ = 160.5, 160.1, 150.7, 142.5, 134.0,
131.4, 127.7, 113.8, 113.7, 101.1, 75.0, 73.1, 69.4, 60.2, 56.7, 55.5, 40.3, 37.6, 36.6, 36.3,
26.2, 26.1, 20.9, 19.5, 18.5, 18.3, 17.8, -4.2, -4.3, -5.1; high resolution mass spectrum
(ES) m/z 704.4380 [(M+H)+ calcd for C38H66NO7Si2]

PMP-acetal ()-2.64 (one pot reaction from diol (+)-2.54, the second generation
synthesis): To a solution of diol (+)-2.54 (790 mg, 1.35 mmol, 1.0 equiv) in 20 mL of
dichloromethane, CSA (30 mg, 0.13 mmol, 0.096 equiv) was added in one portion
followed by addition of p-methoxybenzaldehyde dimethyl acetate (345 mg, 1.89 mmol,
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1.4 equiv) at 0 °C under an air atmosphere, . The resulting mixture was stirred for 20
minutes at the same temperature before subsequent addition of TBAF (1.0 M in THF,
10.80 mL, 10.80 mmol, 8.0 equiv) and acetic acid (473 mg, 6.75 mmol, 5.0 equiv). The
resulting mixture was allowed to increase to room temperature and was allowed to stir for
16 hours before it was quenched with brine. The organic layer was separated, and the
aqueous phase was extracted with ethyl acetate (20 mL) twice. The combined organic
layers were dried over MgSO4, filtered and concentrated, and the resulting oil was
purified by column chromatography (SiO2, ethyl acetate: hexanes 5:95, 10:90, 20:80) to
furnish PMP acetal ()-2.64 (700 mg, 1.19 mmol, 88.0%) as a colorless oil. []20
D = -3.39
(c 1.60, CHCl3); IR (film) 3435, 2929, 2856, 1615, 1518, 1463, 1368, 1336, 1250, 1171,
1112, 1035, 835, 775 cm-1; 1H NMR (500 MHz, CDCl3) δ = 7.54 (s, 1H), 7.45 (d, J = 7.8
Hz, 2H), 6.88 (d, J = 7.8 Hz, 2H), 6.20 (s, 1H), 5.64 (s, 1H), 5.17 (q, J = 6.5 Hz, 1H),
4.92 (d, J = 11.0 Hz, 1H), 3.93 (brs, 2H), 3.81 (brs, 1H), 3.80 (s, 3H), 3.72 (brs, 1H), 3.22
(d, J = 1.0 Hz, 3H), 2.34 (brs, 1H), 2.00 (d, J = 12.8 Hz, 1H), 1.89 (s, 3H), 1.81 (m, 1H),
1.75 (m, 1H), 1.68 (m, 2H), 1.58 (m, 4H), 1.42 (m, 1H), 1.30 (d, J = 6.5 Hz, 3H), 0.89 (s,
9H), 0.09 (s, 3H), 0.07 (s, 3H);

13

C NMR (125 MHz, CDCl3) δ = 160.5, 160.1, 150.6,

142.4, 133.9, 131.2, 127.6, 113.7, 113.6, 101.1, 76.8, 74.8, 72.9, 71.6, 60.3, 56.6, 55.4,
38.0, 36.9, 36.5, 36.1, 26.0, 21.0, 19.4, 18.1, 17.7, -4.3, -4.5; high resolution mass
spectrum (ES) m/z 590.3506 [(M+H)+ calcd for C32H52NO7Si]
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Alcohol (+)-2.56 (the first generation synthesis): To a solution of PMP acetal ()-2.55
(250 mg, 0.355 mmol, 1.0 equiv) in 10 mL of dichloromethane, a DIBAL-H solution (1
M in hexanes, 1.24 mL, 1.24 mmol, 3.5 equiv) was added dropwise at -78 °C under a
nitrogen atmosphere. The resulting mixture was stirred for 100 minutes at the same
temperature before it was quenched with MeOH at -78 °C. The temperature was then
allowed to increase to 0 °C, at which point a saturated aqueous Rochelle’s salt solution
(10 mL) was added. The resulting mixture was stirred at room temperature for 30 minutes
before it was diluted by ethyl acetate (20 mL). The organic layer was separated, and the
aqueous phase was extracted with ethyl acetate (10 mL) twice. The combined organic
layers were washed with brine (5 mL), dried over MgSO4, filtered and concentrated, and
the resulting oil was purified by column chromatography (SiO2, ethyl acetate: hexanes
10:90, 30:70) to furnish acid (+)-2.56 (230 mg, 0.327 mmol, 92.0%) as a colorless oil.
[]20D = +27.72 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ = 7.44 (d, J = 1.0 Hz, 1H),
7.27 (d, J = 8.6 Hz, 2H), 6.88 (d, J = 8.6 Hz, 2H), 6.19 (s, 1H), 5.16 (q, J = 6.5 Hz, 1H),
4.84 (d, J =9.5 Hz, , 1H), 4.61 (d, J = 11.0 Hz, 1H), 4.39 (s, 1H), 3.85-3.74 (m, 2H), 3.82
(s, 3H), 3.67 (m, 2H), 3.22 (s, 3H), 2.07 (dt, J = 11.0 Hz, 3.5 Hz, 1H), 1.93-1.89 (m, 1H),
1.89 (s, 3H), 1.65 (m, 4H), 1.51-1.37 (m, 4H), 1.30 (d, J = 6.5 Hz, 3H), 0.90 (s, 9H), 0.89
(s, 9H) 0.054 (s, 3H), 0.047 (s, 3H);
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C NMR (125 MHz, CDCl3) δ = 160.5, 159.6,

150.3, 144.9, 133.3, 130.2, 129.8, 114.2, 113.7, 79.5, 74.9, 70.6, 69.3, 68.3, 60.1, 56.6,
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55.4, 41.1, 40.2, 37.9, 33.9, 26.11, 26.07, 20.3, 19.4, 18.4, 18.3 17.7, -4.2, -4.4, -5.1; high
resolution mass spectrum (ES) m/z 706.4501 [(M+H)+ calcd for C38H68NO7Si2]

Acid (+)-2.65 (the second generation synthesis): To a solution of PMP acetal (-)-2.64
(184 mg, 0.312 mmol, 1.0 equiv) in 2.5 mL of t-BuOH and 0.25 mL of pH 7 buffer
solution, TEMPO solution (0.025 M in CH3CN, 5 mL, 0.125 mmol, 0.4 equiv) was added
at room temperature under an air atmosphere. The resulting mixture was stirred for 20
minutes at the same temperature before the subsequent addition of NaClO2 (1 M in water,
0.624 mL, 0.624 mmol, 2.0 equiv) and NaClO (0.025 M in water, 12.5 mL, 0.312 mmol,
1.0 equiv) solution. The reaction was stirred at room temperature for 3 hours before it
was quenched by saturated aqueous Na2SO3 (10 mL), After dilution with ethyl acetate (20
mL), the organic layer was separated, and the aqueous phase was extracted with ethyl
acetate (20 mL) twice. The combined organic layers were washed with brine (10 mL),
dried over MgSO4, filtered and concentrated, and the resulting oil was purified by column
chromatography (SiO2, ethyl acetate: hexanes 5:95, 10:90, 20:80, 30:70) to furnish acid
(+)-2.65 (184 mg, 0.296 mmol, 95.0%) as a colorless oil. []20
D = +4.84 (c 1.00, CHCl3);
IR (film) 2930, 1711, 1518, 1250, 1114, 834, 776 cm-1; 1H NMR (500 MHz, CDCl3) δ =
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7.55 (s, 1H), 7.45 (d, J = 8.8 Hz, 2H), 6.88 (d, J = 8.8 Hz, 2H), 6.23 (s, 1H), 5.64 (s, 1H),
5.15 (q, J = 6.5 Hz, 1H), 4.93 (d, J = 10.5 Hz, 1H), 4.14 (t, J = 5.4 Hz, 1H), 3.93 (brs,
1H), 3.80 (s, 3H), 3.23 (s, 3H), 2.50 (d, J = 6.1 Hz, 2H), 2.00 (d, J = 12.8 Hz, 1H), 1.89
(d, J = 1.5 Hz, 3H), 1.72 (m, 1H), 1.70 (m, 1H) , 1.59 (m, 4H), 1.45 (brs, 1H), 1.30 (d, J
= 6.7 Hz, 3H), 0.87 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H); 13C NMR (125 MHz, CDCl3) δ =
176.4, 160.5, 160.0, 150.8, 142.3, 134.0, 131.2, 127.6, 113.7, 113.6, 101.1, 76.7, 75.0,
72.8, 69.4, 56.6, 55.4, 42.1, 37.4, 36.4, 36.0, 25.9, 20.8, 19.4, 18.1, 17.7, -4.4, -4.7; high
resolution mass spectrum (ES) m/z 626.3118 [(M+Na)+ calcd for C32H49NO8SiNa]

Diol (+)-2.57 (the first generation synthesis): To a solution of alcohol (+)-2.56 (227 mg,
0.322 mmol, 1.0 equiv) in 5 mL of THF in a 50 mL plastic container, 4.7 mL of the
mixture of HF-pyridine complex/pyridine/THF (1:1.5:2.5) was added dropwise at 0 °C.
The reaction mixture was allowed to stir at the same temperature for 45 minutes before it
was slowly quenched by saturated aqueous NaHCO3. After dilution with ethyl acetate
(20 mL), the organic layer was separated, and the aqueous phase was extracted with ethyl
acetate (20 mL) twice. The combined organic layers were washed with brine (5 mL),
dried over MgSO4, filtered and concentrated. The resulting oil was purified by column
chromatography (SiO2, ethyl acetate: hexanes 20:80, 30:70, 40:60) to furnish diol (+)2.57 (152 mg, 0.258 mmol, 80.0%) as a colorless oil. []20
D = +21.11 (c 1.33, CHCl3); IR
118

(film) 3407, 2929, 2856, 1613, 1514, 1250, 1095, 1036, 856, 775 cm-1; 1H NMR (500
MHz, CDCl3) δ = 7.44 (s, 1H), 7.26 (d, J = 8.5 Hz, 2H), 6.87 (d, J = 8.6 Hz, 2H), 6.19 (s,
1H), 5.16 (q, J = 6.5 Hz, 1H), 4.83 (dd, J =8.9 Hz, 2.9 Hz, 1H), 4.58 (d, J = 11.0 Hz, 1H),
4.40 (d, J = 11.0 Hz, 1H), 4.02-3.92 (m, 2H), 3.79 (s, 3H), 3.78 (m, 2H), 3.72 (m, 1H),
3.21 (s, 3H), 2.07 (dt, J = 11.0 Hz, 3.5 Hz, 1H), 1.92 (m, 1H), 1.88 (s, 3H), 1.77 (m, 1H),
1.55 (m, 2H), 1.63 (m, 3H), 1.38 (m, 2H), 1.29 (d, J = 6.5 Hz, 3H), 0.89 (s, 9H), 0.09 (s,
3H), 0.07 (s, 3H);
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C NMR (125 MHz, CDCl3) δ = 160.5, 159.6, 150.4, 144.8, 133.3,

130.2, 129.7, 114.2, 113.7, 79.0, 74.9, 71.5, 70.6, 67.9, 60.2, 56.6, 55.4, 41.0, 38.1, 37.3,
33.8, 26.0, 20.5, 19.4, 18.1, 17.7, -4.2, -4.5; high resolution mass spectrum (ES) m/z
592.3612 [(M+H)+ calcd for C32H54NO8Si]

Acid (+)-2.61 (synthesis via chemoselective oxidation, the first generation synthesis)
To a solution of diol (+)-2.57 (58 mg, 0.098 mmol, 1.0 equiv) in 0.775 mL of t-BuOH
and 0.5 mL of pH 7 buffer solution, a TEMPO solution (0.025 M in CH3CN, 1.18 mL,
0.029 mmol, 0.3 equiv) was added at room temperature. The resulting mixture was stirred
for 20 minutes at the same temperature before the subsequent addition of NaClO2 (1 M in
water, 0.196 mL, 0.196 mmol, 2.0 equiv) and NaClO (0.025 M in water, 4.0 mL, 0.1
mmol, 1.0 equiv). The reaction was stirred at room temperature for 3 hours before it was
quenched with saturated aqueous Na2SO3 solution (5 mL). After dilution with ethyl
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acetate (10 mL), the organic layer was separated, and the aqueous phase was extracted
with ethyl acetate (10 mL) twice. The combined organic layers were washed with brine (5
mL), dried over MgSO4, filtered and concentrated, and the resulting oil was purified by
column chromatography (SiO2, ethyl acetate: hexanes 20:80, 30:70, 50:50, 80:20) to
furnish acid (+)-2.61 (36 mg, 0.059 mmol, 60.0%) as a colorless oil
Acid (+)-2.61 (synthesis via chemoselective reduction, the second generation
synthesis): To a solution of PMP acetal (+)-2.55 (1.25 g, 2.07 mmol, 1.0 equiv) in 50 mL
of dichloromethane, a DIBAL-H solution (1 M in hexanes, 9.93 mL, 9.93 mmol, 4.8
equiv) was added dropwise at -78 °C under nitrogen atmosphere. The resulting mixture
was stirred for 100 minutes at the same temperature before it was quenched with MeOH
at -78 °C. The temperature was then allowed to increase to 0 °C followed by the addition
of saturated aqueous Rochelle’s salt (30 mL). The resulting mixture was stirred at room
temperature for 30 minutes before it was diluted by ethyl acetate (50 mL). The organic
layer was separated, and the aqueous phase was extracted with ethyl acetate (30 mL) six
times. The combined organic layers were washed with brine (10 mL), dried over MgSO4,
filtered and concentrated. The resulting oil was purified by column chromatography
(SiO2, ethyl acetate: hexanes 20:80, 30:70, 50:50, 80:20) to furnish acid (+)-2.61 (1.17 g,
1.93 mmol, 93.0%) as a colorless oil. []20
D = +32.42 (c 1.00, CHCl3); IR (film) 2930,
1712, 1514, 1245, 1096, 836 cm-1; 1H NMR (500 MHz, CDCl3) δ = 7.43 (s, 1H), 7.26 (d,
J = 8.6 Hz, 2H), 6.87 (d, J = 8.6 Hz, 2H), 6.19 (s, 1H), 5.11 (q, J = 6.5 Hz, 1H), 4.83 (dd,
J =9.5 Hz, 2.9 Hz, 1H), 4.57 (d, J = 11.0 Hz, 1H), 4.39 (d, J = 11.0 Hz, 1H), 4.12 (m,
1H), 3.79 (s, 3H), 3.75 (m, 1H), 3.21 (s, 3H), 2.28 (d, J = 6.1 Hz, 2H), 2.05 (dt, J = 11.0
Hz, 3.5 Hz, 1H), 1.95 (m, 1H), 1.88 (s, 3H), 1.73 (m, 2H), 1.67 (m, 2H) , 1.42 (m, 2H),
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1.29 (d, J = 6.5 Hz, 3H), 0.86 (s, 9H), 0.07 (s, 3H), 0.06 (s, 3H);

13

C NMR (125 MHz,

CDCl3) δ = 175.9, 160.7, 159.6, 150.8, 144.6, 133.5, 130.2, 129.8, 114.2, 113.6, 78.8,
75.0, 70.7, 69.4, 67.6, 56.6, 55.5, 42.2, 40.8, 37.7, 33.6, 26.0, 20.3, 19.5, 18.2, 17.8, -4.3,
-4.6; high resolution mass spectrum (ES) m/z 606.3466 [(M+H)+ calcd for C32H52NO8Si]

β-Hydroxy Acid (+)-2.22 (synthesis utilizing HCl/EtOH, the first generation
synthesis): To a solution of (+)-2.61 (55 mg, 0.091 mmol, 1.0 equiv) in 1.5 mL of EtOH,
0.6 mL of HCl solution (0.54 M in EtOH, prepared by addition of 0.2 mL of
trichloroacetyl chloride to 5 mL of ethanol) was added at room temperature. The reaction
mixture was stirred for 3 hours before it was quenched by the addition of pyridine (0.05
mL). The resulting mixture was then concentrated under reduced pressure followed by
azeotropic evaporation with toluene (5 mL) to remove excess pyridine. The resulting oil
was purified by column chromatography (SiO2, ethyl acetate: hexanes 50:50, 80:20 then
ethyl acetate: acetic acid 99:1) to furnish β-hydroxy acid (+)-2.22 (38 mg, 0.0774 mmol,
85.0%) as a colorless oil.
β-Hydroxyl Acid (+)-2.22 (synthesis utilizing TBAF/HOAc, the second generation
synthesis): To a solution of (+)-2.61 (800 mg, 1.32 mmol, 1.0 equiv) in 30 mL of THF,
TBAF (1.0 M in THF, 9.24 mL, 9.24 mmol, 7.0 equiv) was added dropwise followed by
acetic acid (400 mg, 6.60 mmol, 5.0 equiv) at room temperature. The resulting mixture
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was stirred for 8 hours before it was quenched with brine. The organic layer was
separated, and the aqueous phase was extracted with ethyl acetate (20 mL) six times. The
combined organic layers were dried over MgSO4, filtered and concentrated, and the
resulting oil was purified by column chromatography (SiO2, ethyl acetate: hexanes 50:50,
80:20 then ethyl acetate: acetic acid 99:1) to furnish β- hydroxy acid (+)-2.22 (569 mg,
1.16 mmol, 87.7%) as a colorless oil. []20
D = +56.17 (c 1.47, CHCl3); IR (film) 3421,
2934, 1719, 1612, 1514, 1443, 1249, 1177, 1094, 1035, 822 cm-1; 1H NMR (500 MHz,
CDCl3) δ =7.46 (s, 1H), 7.26 (d, J = 8.6 Hz, 2H), 6.87 (d, J = 8.6 Hz, 2H), 6.21 (s, 1H),
5.03 (q, J = 6.5 Hz, 1H), 4.86 (dd, J =9.3 Hz, 2.6 Hz, 1H), 4.58 (d, J = 11.0 Hz, 1H), 4.39
(d, J = 11.0 Hz, 1H), 4.04 (brs, 1H), 3.80 (s, 3H), 3.75 (brs, 1H), 3.21 (s, 3H), 2.50 (m,
2H), 2.13 (d, J = 14.3Hz, 1H), 1.89 (m, 1H), 1.89 (s, 3H), 1.72 (m, 1H), 1.63 (m, 1H) ,
1.38 – 1.58 (m, 4H), 1.29 (d, J = 6.5 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ = 176.1,
160.9, 159.5, 151.5, 144.2, 133.8, 130.2, 129.7, 114.1, 113.2, 79.1, 75.1, 70.5, 68.0, 67.4,
56.6, 55.4, 41.4, 40.7, 36.8, 33.3, 21.0, 19.5, 17.8; high resolution mass spectrum (ES)
m/z 490.2440 [(M-H) calcd for C26H36NO8]

Alcohol ()-2.68: To a solution of diisopropylamine (10.6 mL, 75.4 mmol, 4.2 equiv) in
60 mL THF, a n-BuLi solution (2.33 M in hexanes, 30 mL, 70.04 mmol, 3.9 equiv) was
added dropwise over 10 minutes at 0 °C under a nitrogen atmosphere. The resulting
mixture was stirred for 15 minutes at the same temperature before the addition of
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ammonium-borane solid (2.22 g, 71.84 mmol, 4.0 equiv) in one portion at 0 °C. The
temperature was increased to room temperature, and the reaction mixture was stirred for
30 minutes before it was recooled to 0 °C. A solution of alcohol (-)-2.67 (9.55 g, 17.96
mmol, 1.0 equiv) in 90 mL of THF was then added dropwise, and the temperature was
allowed to increase to room temperature after the addition. The resulting mixture was
stirred at the same temperature for 2 hours before it was slowly quenched with 100 mL of
3 N HCl aqueous solution over 20 minutes at 0 °C. The resulting mixture was stirred at
0°C for a further 30 minutes before the dilution with Et2O (200 mL). The organic layer
was separated, and the aqueous phase was extracted with Et2O (50 mL) twice. The
combined organic layers were washed with saturated aqueous NaHCO3 (50 mL) and
brine (30 mL), dried over MgSO4, filtered and concentrated, and the resulting oil was
purified by column chromatography (SiO2, ethyl acetate: hexanes 50:50, 80:20) to furnish
alcohol ()-2.68 (6.60 g, 17.81 mmol, 99.2%) as a colorless oil. []20
D = -15.66 (c 3.20,
CHCl3); IR (film) 3342, 2929, 2857, 1417, 1427, 1389, 1112, 1036, 824, 740, 701, 613.3
cm-1; 1H NMR (500 MHz, CDCl3) δ =7.72-7.65 (m, 4 H), 7.45-7.35 (m, 6H), 3.52-3.47
(m, 3H), 3.40 (m, 1H), 1.79 (m, 1H), 1.70 (m, 1H), 1.22 (ddd, J = 13.5 Hz, 9.0 Hz, 4.
Hz), 1.14 (ddd, J = 13.5 Hz, 9.0 Hz, 4.5 Hz), 1.08 (s, 9H), 0.90 (d, J = 7.0 Hz, 3H), 0.89
(d, J = 7.5 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ = 135.8, 134.3, 134.2, 129.7, 127.8,
68.8, 69.2, 37.0, 33.31, 33.26, 27.1, 19.5, 16.8, 16.6; high resolution mass spectrum (ES)
m/z 371.2390 [(M+H) calcd for C23H35O2Si]
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Olefin ()-2.69：To a solution of alcohol ()-2.68 (6.50 g, 17.5 mmol, 1.0 equiv) in 70
mL dichloromethane, diisopropylethylamine (9.15 mL, 52.5 mmol, 3.0 equiv) and
DMSO (6.21 mL, 87.5 mmol, 5.0 equiv) were added followed by portionwise addition of
SO3.pyridine (8.36 g, 52.5 mmol, 3.0 equiv) at 0 °C under an air atmosphere. The
resulting mixture was stirred for 1 hour at the same temperature before it was quenched
by 2 M NaHSO4 aqueous solution (30 mL). The organic layer was separated, and the
aqueous phase was extracted with Et2O (50 mL) twice. The combined organic layers
were washed with saturated aqueous NaHCO3 (50 mL) and brine (30 mL), dried over
MgSO4, filtered and concentrated, and the resulting corresponding aldehyde was moved
to the next step as a colorless oil without further purification.
To a solution of (-)-B-methoxydiisopinocampheylborane (9.41 g, 29.8 mmol, 1.7 equiv)
in 50 mL Et2O, allylmagnesium bromide solution (1.0 M in Et2O, 21.87 mL, 21.87 mmol,
1.25 equiv) was added dropwise over 20 minutes at -78 °C under a nitrogen atmosphere.
The resulting mixture was stirred for 1 hour at the same temperature. The temperature
was allowed to increase to room temperature, and the reaction mixture was stirred for 1
hour before it was recooled to -78 °C. A solution of aldehyde (-)-2.68 (17.50 mmol, 1.0
equiv, crude) in 35 mL of Et2O was then added dropwise to the reaction mixture at -78 °C
over 20 minutes. The resulting mixture was stirred at the same temperature for 1 hour
before the temperature was allowed to increase to 0 °C. A pH7 buffer solution (30 mL)
was then added followed by the careful addition of 30% H2O2 (7 mL) over 20 minutes at
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0 °C . The resulting mixture was then stirred at room temperature overnight before it was
diluted by Et2O. The organic layer was separated, and the aqueous phase was extracted
with Et2O (60 mL) twice. The combined organic layers were washed with saturated
aqueous NaS2O3 (30 mL) and brine (30 mL), dried over MgSO4, filtered and
concentrated, and the resulting oil was purified by column chromatography (SiO2, ethyl
acetate: hexanes 10:90, 20:80, 30:70) to furnish olefin ()-2.69 (6.53 g, 15.93 mmol,
91.0% over 2 steps) as a colorless oil. []20D = -13.42 (c 2.86, CHCl3); IR (film) 3325,
3071, 2959, 2930, 2858, 1709, 1640, 1589, 1471, 1428, 1389, 1112, 914, 824, 702 cm-1;
1

H NMR (500 MHz, CDCl3) δ =7.68-7.62 (m, 4 H), 7.41-7.31 (m, 6H), 5.81 (dddd, J =

17.5 Hz, 9.7 Hz. 7.2 Hz, 6.5 Hz, 1H), 5.18-5.08 (m, 2H), 3.53-3.48 (m, 3H), 2.31-2.25
(m, 1H), 2.15 (m, 1H), 1.76 (brs, 1H), 1.62 (brs, 1H), 1.35-1.25 (m, 1H), 1.21-1.11 (m,
1H), 1.07 (s, 9H), 0.91 (d, J = 6.8 Hz, 3H), 0.87 (d, J =6.7 Hz, 3H); 13C NMR (125 MHz,
CDCl3) δ = 135.9, 135.7, 134.29, 134.27, 129.7, 127.8, 118.0, 74.7, 69.8, 39.2, 36.8, 35.3,
33.4, 27.1, 19.5, 16.7, 14.1; high resolution mass spectrum (ES) m/z 411.2717 [(M+H)
calcd for C26H39O2Si]

Olefin ()-2.70: To a solution of olefin ()-2.69 (1.03 g, 2.51 mmol, 1.0 equiv) in 20 mL
of dichloromethane at 0 °C under a nitrogen atmosphere, 2,6-lutidine (0.7 mL, 6.02
mmol, 2.4 equiv) was added, followed by the dropwise addition of TIPSOTf (0.8 g, 3.01
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mmol, 1.2 equiv). The reaction mixture was stirred for 2 hours at 0 °C before it was
quenched by addition of saturated aqueous NaHCO3 (10 mL). The organic layer was
removed, and the aqueous layer was extracted with dichloromethane (10 mL) twice. The
combined organic layers were washed with brine (5 mL), dried over MgSO4, filtered and
concentrated, the resulting oil was purified by column chromatography (SiO2, ethyl
acetate: hexanes 2:98, 5:95, 10:90) to furnish olefin ()-2.70 (1.29 g, 2.28 mmol, 90.7%)
as a colorless oil. []20
D = -9.99 (c 2.22, CHCl3); IR (film) 3072, 2942, 2865, 1463, 1428,
1388, 1112, 882, 824, 784, 701, 678, 613 cm-1; 1H NMR (500 MHz, CDCl3) δ =7.717.68 (m, 4 H), 7.43-7.36 (m, 6H), 5.78 (dddd, J = 17.2 Hz, 9.8 Hz. 7.2 Hz, 6.5 Hz, 1H),
5.04 (dd, J = 17.2 Hz, 1.8 Hz, 1H), 4.99 (dt, J = 9.8 Hz, 1.0 Hz, 1H), 3.79 (m,1H), 3.49
(m, 2H), 2.28 (m, 2H), 1.80-1.68 (m, 2H), 1.41 (td, J = 9.8 Hz, 4.0 Hz, 1H), 1.37 (td, J =
9.8 Hz, 4.0 Hz, 1H), 1.12-1.02 (m, 30 H), 0.89 (d, J = 6.8 Hz, 3H), 0.83 (d, J = 6.7 Hz,
3H);
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C NMR (125 MHz, CDCl3) δ = 136.1 135.87, 135.86, 134.39, 134.37, 129.7,

127.8, 116.6, 76.7, 70.0, 39.3, 36.4, 34.9, 33.5, 27.1, 19.5, 18.6, 18.5, 16.6, 13.9, 13.2;
high resolution mass spectrum (ES) m/z 589.3871 [(M+Na)+ calcd for C35H58O2Si2Na]

Aldehyde ()-2.4: To a solution of olefin ()-2.70 (570 mg, 1.01 mmol, 1.0 equiv) in 35
mL of acetone/tert-butanol/water (3:3:1), NMO (357 mg, 3.0 mmol, 3.0 equiv) was added
as one portion followed by potassium osmate(VI) dehydrate (30 mg, 0.08 mmol, 0.08

126

equiv) at 0 °C. The resulting mixture was stirred overnight at room temperature before it
was quenched with 10 g of solid Na2S2O3. The resulting heterogeneous mixture was
stirred for a further 30 minutes before it was diluted by ethyl acetate (20 mL). The
organic layer was separated, and the aqueous phase was extracted with ethyl acetate (30
mL) three times. The combined organic layers were washed with saturated aqueous
NH4Cl (10 mL) and brine (5 mL), dried over MgSO4, filtered and concentrated. The
resulting corresponding diol was moved to the next step as a black oil without further
purification.
To a solution of the corresponding diol of ()-2.70 (1.01 mmol, crude) in 25 mL of
acetone/water (4:1), NaIO4 (750 mg, 3.50 mmol, 3.50 equiv.) was added as one portion at
room temperature under air atmosphere. The resulting mixture was stirred at the same
temperature for three hours before it was diluted with ethyl acetate (30 mL).

The

organic layer was separated and the aqueous phase was extracted with ethyl acetate (20
mL). The combined organic layers were washed with brine (10 mL), dried over MgSO4,
filtered and concentrated, the resulting oil was purified by column chromatography (SiO2,
ethyl acetate: hexanes 2:98, 5:95, 10:90) to furnish aldehyde ()-2.4 (436 mg, 0.75 mmol,
75.0% over 2 steps) as a colorless oil. []20D = -21.74 (c 1.75, CHCl3); IR (film) 2943,
2865, 1727, 1463, 1427, 1389, 1112, 882, 824, 740, 702, 667 cm-1; 1H NMR (500 MHz,
CDCl3) δ = 9.87 (t, J = 2.2 Hz, 1H), 7.71-7.68 (m, 4 H), 7.46-7.39 (m, 6H), 4.34 (m, 1H),
3.51 (d, J = 6.0 Hz, 2H), 2.54 (m, 2H), 1.82 (m, 1H), 1.73 (m, 1H), 1.39 (td, J = 13.0 Hz,
2.5 Hz, 1H), 1.27 (m, 1H), 1.09 (s, 30 H), 0.91 (d, J = 6.8 Hz, 3H), 0.85 (d, J = 6.7 Hz,
3H); 13C NMR (125 MHz, CDCl3) δ = 202.4, 135.8, 134.17, 134.15, 129.7, 127.3, 72.6,
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70.0, 47.7, 36.8, 34.4, 33.3, 27.0, 19.4, 18.4, 18.3, 16.1, 15.2, 12.9; high resolution mass
(ES) m/z 591.3664 [(M+Na)+ calcd for C34H56O3Si2Na]

Dioxanone ()-2.70: To a solution of β–hydroxy acid (+)-2.22 (58.0 mg, 0.118 mmol, 1.0
equiv.) in 0.9 mL of THF, 0.6 mL of HMDS was added as one portion at room
temperature under a nitrogen atmosphere. The resulting mixture was stirred for 22 hours
at 40 to 45 °C before the HMDS/THF was removed under high vacuum (pressure < 5
Torr). The mixture was then azeotropically purified with toluene to remove the residual
amount of HMDS, applying high vacuum with no access of air followed by stirring
overnight at 40 to 45 °C under the same high vacuum conditions. The resulting trissilylated ester was dissolved in 2 mL of dichloromethane before the addition of aldehyde
(-)-2.4 (80.0 mg, 0.138 mmol, 1.17 equiv) solution in 2 mL of dichloromethane at -78 °C
under nitrogen atmosphere. TMSOTf (50.0 mg, 0.225 mmol, 1.90 equiv of a newly
opened bottle purchased from Sigma-Aldrich®) was then added to the reaction mixture at
78 °C. The resulting mixture was stirred for 1 hour at -78 °C under a nitrogen atmosphere
before allowing access to air via insertion a needle at -78 °C for 10 minutes to introduce
small amount of moisture. The reaction mixture was then stirred at -78 °C under a
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nitrogen atmosphere for 50 minutes before it was slowly diluted by 5 mL of
dichloromethane at the same temperature. The resulting mixture was then quenched with
100 mg of 2,6-lutidine and moved to the high vacuum condition to remove solvent at 5 to
10 °C. The resulting oil was purified by column chromatography (SiO2, ethyl acetate:
hexanes, 10:90, 20:80) to furnish dioxanone ()-2.70 (125 mg, 0.112 mmol, 95.1%) as a
colorless oil. []20D = -3.25 (c 1.15, CHCl3); IR (film) 2930, 2864, 1752, 1513, 1463,
1428, 1388, 1250, 1112, 883, 824, 740, 702 cm-1; 1H NMR (500 MHz, C6D6) δ = 7.817.79 (m, 4 H), 7.30 (d, J = 8.6 Hz, 2H), 7.27-7.24 (m, 7H), 6.85 (d, J = 8.6 Hz, 2H), 6.16
(s, 1H), 5.58 (q, J = 6.5 Hz, 1H), 5.29 (q, J = 6.8 Hz, 1H), 5.08 (t, J = 6.4 Hz, 1H), 4.53
(d, J = 11.3 Hz, 1H), 4.42 (d, J = 11.3 Hz, 1H), 4.13 (m, 1H), 3.67 (m, 1H), 3.63-3.53 (m,
2H), 3.34 (s, 3H), 3.30-3.25 (m, 1H), 3.12 (s, 3H), 2.40-2.33 (m, 1H), 2.20-2.10 (m, 2H),
2.06-1.96 (m, 2H), 1.87-1.81 (m, 1H), 1.74 (d, J = 1.1 Hz, 3H), 1.48-1.25 (m, 6H), 1.39
(d, J = 6.5 Hz, 3H), 1.19 (s, 9H), 1.13-1.17 (m, 21 H), 1.12-1.05 (m, 3H), 1.01 (d, J = 6.7
Hz, 3H), 0.92-0.89 (s, 1H), 0.83 (d, J = 6.7 Hz, 3H), 0.14 (s, 9H);
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C NMR (125 MHz,

C6D6) δ = 166.7, 161.3, 160.4, 152.3, 146.9, 136.7, 135.0, 134.3, 132.3, 130.6, 130.1,
129.2, 114.7, 113.9, 102.0, 76.0, 75.7, 75.1, 73.7, 71.4, 70.9, 66.9, 56.9, 55.4, 43.3, 40.1,
37.1, 36.9, 36.6, 35.22, 35.18, 34.3, 27.8, 21.4, 20.2, 20.0, 19.21, 19.15, 18.2, 16.9, 15.4,
13.0, 0.9; high resolution mass (ES) m/z 1114.6652 [(M+H)+ calcd for C63H100NO10Si3]
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Enol Acetal ()-2.71: To a solution of dioxanone ()-2.70 (200 mg, 0.180 mmol, 1.0
equiv) in 2.3 mL of THF in a glass microwave vial (2-5 mL), 0.08 mL of 2,6-lutidine was
added followed by 2.4 mL of Petasis reagent (0.25 M in THF/toluene, freshly prepared,
0.60 mmol, 3.35 equiv) at room temperature under an air atmosphere. The resulting
mixture was sealed and stirred for 3 hours at 100 °C in microwave at the “high” level of
absorption setting before it was cooled down. The resulting mixture was diluted by 20
mL of hexanes and stirred for 10 minutes before it was filtered and concentrated. The
resulting oil was purified by column chromatography (SiO2, ethyl acetate: hexanes, 5:95,
10:90) to furnish enol acetal ()-2.71 (174 mg, 0.157 mmol, 87.2%) as a colorless oil.
[]20D = -0.90 (c 1.43, CHCl3); IR (film) 2930, 2864, 1512, 1462, 1428, 1388, 1249, 1112,
883, 738, 702, 666 cm-1; 1H NMR (500 MHz, C6D6) δ = 7.81-7.77 (m, 4 H), 7.31 (d, J =
8.6 Hz, 2H), 7.26-7.22 (m, 7H), 6.83 (d, J = 8.6 Hz, 2H), 6.15 (s, 1H), 5.59 (q, J = 6.5
Hz, 1H), 5.08 (q, J = 5.4 Hz, 1H), 4.93 (t, J = 5.9 Hz, 1H), 4.64 (s, 1H), 4.53-4.43 (m,
2H), 4.24 (brs, 1H), 4.10 (s, 1H), 3.72-3.67 (m, 1H), 3.61-3.53 (m, 2H), 3.48-3.44 (m,
1H), 3.31 (s, 3H), 3.12 (s, 3H), 2.40-2.33 (m, 1H), 2.17-2.06 (m, 3H), 1.91-1.85 (m, 2H),
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1.74 (s, 3H), 1.64-1.46 (m, 6H), 1.39 (d, J = 6.5 Hz, 3H) , 1.21-1.12 (m, 33H), 1.01 (d, J
= 6.9 Hz, 3H), 0.98-0.94 (m, 1H), 0.89 (d, J = 6.7 Hz, 3H), 0.14 (s, 9H); 13C NMR (125
MHz, C6D6) δ = 161.2, 160.3, 158.0, 152.1, 146.9, 136.7, 135.0, 134.2, 132.4, 130.5,
130.0, 129.1, 114.6, 113.9, 101.7, 93.6, 77.3, 76.2, 75.7, 74.0, 71.3, 70.8, 66.9, 56.8, 55.3,
43.3, 40.2, 37.1, 36.8, 35.87, 35.83, 35.3, 34.3, 27.8, 21.6, 20.2, 20.0, 19.24, 19.19, 18.2,
17.1, 15.2, 14.0, 0.9; high resolution mass (ES) m/z 1112.6841 [(M+H)+ calcd for
C64H102NO9Si3]

Methylene Tetrahydropyran ()-2.21: To a solution of methyltriphenylphosphonium
bromide (475 mg, 1.33 mmol) in 8 mL of THF, 2 mL of KOtBu solution (1.0 M solution
in THF, 2.0 mmol) was added dropwise at 0 °C under a nitrogen atmosphere. The
resulting mixture was stirred for 30 minutes at the same temperature to give the ylide
solution (0.133 M in THF, 10 mL).
To a solution of enol acetal (-)-2.71 (70 mg, 0.0629 mmol, 1.0 equiv) in 7 mL of THF,
0.31 mL of dimethylaluminum chloride solution (1.0 M in hexanes, newly opened, 0.31
mmol, 4.9 equiv) was added over 3 seconds at -78 °C under a nitrogen atmosphere. The
resulting mixture was stirred for 30 seconds at -78 °C before the addition of freshly
131

prepared ylide solution (0.133 M in THF, 4.2 mL, 0.559 mmol, 8.9 equiv) at the same
temperature. The resulting mixture was stirred for a further 10 minutes at -78 °C before it
was quenched by 10 mL of saturated aqueous NH4Cl solution. The resulting mixture was
diluted by 20 mL of ethyl acetate. The organic layer was separated, and the aqueous
phase was extracted with ethyl acetate (10 mL) twice. The combined organic layers were
washed with brine (5 mL), dried over MgSO4, filtered and concentrated, and the resulting
oil was purified by column chromatography (SiO2, ethyl acetate: hexanes 2:98, 5:95,
10:90) to furnish methylene tetrahydropyran ()-2.21 (59 mg, 0.0531 mmol, 84.4%) as a
colorless oil. []20D = -4.12 (c 0.83, CHCl3); IR (film) 2929.8, 2864.3, 1589.5, 1512.8,
1462.3, 1428.0, 1388.0, 1249.2, 1112.2, 882.8, 739.6, 701.5 cm-1; 1H NMR (500 MHz,
C6D6) δ = 7.83 -7.80 (m, 4 H), 7.35 (d, J = 8.5 Hz, 2H), 7.28-7.23 (m, 7H), 6.86 (d, J =
8.5 Hz, 2H), 6.16 (s, 1H), 5.63 (q, J = 6.5 Hz, 1H), 5.14 (t, J = 6.2 Hz, 1H), 4.76 (d, J =
4.3 Hz, 2H), 4.53 (d, J = 5.9 Hz, 2H), 4.28-4.25 (m, 1H), 3.80-3.73 (m, 1H), 3.66-3.56
(m, 3H), 3.32 (s, 3H), 3.32-3.29 (m, 1H), 3.13 (s, 3H), 2.44-2.37 (m, 1H), 2.25-2.19 (m,
1H), 2.14 (d, J = 13.1Hz, 2H) 2.01 (d, J = 11.7 Hz, 1H), 1.92 (t, J = 11.7 Hz, 2H), 1.82 1.70 (m, 3H), 1.75 (d, J = 1.2 Hz, 3H), 1.72-1.62 (m, 2H), 1.60-1.53 (m, 2H), 1.44 (d, J =
6.3 Hz, 3H) , 1.25-1.12 (m, 33H), 1.03 (d, J = 6.6 Hz, 3H), 0.95-0.91 (m, 1H), 0.91 (d, J
= 7.3 Hz, 3H), 0.17 (s, 9H); 13C NMR (125 MHz, C6D6) δ = 160.6, 159.7, 151.5, 146.5,
145.6, 136.1, 134.6, 133.7, 132.0, 130.0, 129.5, 128.6, 114.0, 113.4, 108.4, 78.6, 75.8,
75.5, 75.2, 74.5, 70.8, 70.6, 66.4, 56.3, 54.8, 42.9, 42.2, 41.3, 40.4, 37.3 36.8, 35.0, 34.1,
33.8, 27.2, 21.8, 19.6, 19.5, 18.8, 18.7, 17.7, 16.3, 15.5, 13.6, 0.4; high resolution mass
(ES) m/z 1110.7103 [(M+H)+ calcd for C65H105NO8Si3]
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Diol (+)-2.75: To a solution of methylene tetrahydropyran (250 mg, 0.225 mmol, 1.0
equiv) in 46 mL of THF/H2O (45:1), 18-crown-6 (1.2 g, 4.54 mmol, 20.0 equiv) was
added followed by KOH (1.5 g, 26.26 mmol, 116.8 equiv) at room temperature. The
resulting mixture was stirred for 3 hours at the same temperature before it was quenched
by the addition of saturated aqueous NH4Cl solution (30 mL). The resulting mixture was
diluted by 50 mL of ethyl acetate. The organic layer was separated, and the aqueous
phase was extracted with ethyl acetate (20 mL) twice. The combined organic layers were
washed with brine (10 mL), dried over MgSO4, filtered and concentrated, and the
resulting oil was purified by column chromatography (SiO2, ethyl acetate: hexanes 30:70,
40:60, 50:50) to furnish diol (-)-2.76 (145 mg, 0.181 mmol, 80.6%) as a colorless oil.
[]20D = 3.13(c = 1.50, CHCl3); IR (film) 2932, 2864, 1727, 1514, 1463, 1249, 1092 cm-1;
1

H NMR (500 MHz, CDCl3) δ = 7.44 (s, 1H), 7.26 (d, J = 8.1 Hz, 2H), 6.87 (d, J = 8.1

Hz, 2H), 6.18 (s, 1H), 5.12 (q, J = 6.5 Hz, 1H), 4.83 (d, J = 8.7 Hz, 1H), 4.68 (s, 2H),
4.60 (d, J = 10.9 Hz, 1H), 4.39 (d, J = 10.9 Hz, 1H), 3.98 (brs, 1H), 3.79 (s, 3H), 3.793.77 (brs, 1H), 3.52-3.47 (m, 1H), 3.42-3.39 (m, 1H), 3.34 (t, J = 10.1 Hz, 1H), 3.20 (s,
3H), 3.20-3.17 (m, 1H), 2.18 (d, J = 12.6 Hz, 1H), 2.15-2.03 (m, 2H), 1.99-1.87 (m, 3H),
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1.87 (s, 3H), 1.80-1.73 (brs, 1H), 1.70-1.59 (m, 4H), 1.59-1.50 (m, 2H), 1.49-1.40 (m,
3H), 1.32-1.25 (m, 1H), 1.29 (d, J = 6.4 Hz, 3H), 1.20 (m, 1H), 1.11-0.99 (m, 21H), 0.87
(d, J = 6.5 Hz, 3H), 0.80 (d, J = 6.8 Hz, 3H);

13

C NMR (125 MHz, CDCl3) δ = 160.6,

159.6, 150.4, 145.2, 144.8, 133.4, 130.2, 129.8, 114.2, 113.8, 108.4, 79.3, 78.3, 75.6,
75.0, 74.1, 70.5, 69.4, 68.3, 56.6, 55.5, 41.9, 41.0, 40.3, 36.9, 36.2, 34.3, 33.7, 33.4, 20.9,
19.5, 18.6, 18.51, 18.48, 17.8, 16.2, 15.0, 13.3; high resolution mass (ES) m/z 800.5486
[(M+H)+ calcd for C46H78NO8Si]

Aldehyde (+)-2.76: To a solution of diol (+)-2.75 (30 mg, 0.0375 mmol, 1.0 equiv) in 2
mL of dichloromethane, a solution of TEMPO (5 mg/mL in dichloromethane, 5 mg,
0.032 mmol, 0.85 equiv) was added followed by iodobenzene diacetate (24 mg, 0.075
mmol, 2.0 equiv) at room temperature in an air atmosphere. The resulting mixture was
stirred for 1.5 hours at the same temperature before it was quenched with saturated
aqueous Na2S2O3 solution (5 mL). The resulting mixture was stirred for 5 minutes before
it was diluted by 10 mL of ethyl acetate. The organic layer was separated, and the
aqueous phase was extracted with ethyl acetate (10 mL) twice. The combined organic
layers were washed with brine (5 mL), dried over MgSO4, filtered and concentrated, and
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the resulting oil was purified by column chromatography (SiO2, ethyl acetate: hexanes
10:90, 20:80, 30:70) to furnish aldehyde (+)-2.76 (23 mg, 0.0288 mmol, 76.9%) as a
colorless oil. []20D = 2.45 (c 0.42, CHCl3); IR (film) 2927, 2864, 1726, 1624, 1514, 1463,
1381, 1248, 1097, 883 cm-1; 1H NMR (500 MHz, CDCl3) δ = 9.61 (s, 1H), 7.44 (s, 1H),
7.28 (d, J = 8.1 Hz, 2H), 6.88 (d, J = 8.1 Hz, 2H), 6.18 (s, 1H), 5.13 (q, J = 6.5 Hz, 1H),
4.84 (d, J = 8.6 Hz, 1H), 4.70 (d, J = 6.0 Hz, 2H), 4.60 (d, J = 11.2 Hz, 1H), 4.40 (dd, J =
11.2 Hz, 5.2 Hz, 1H), 4.20 (brs, 1H), 3.80 (s, 3H), 3.80-3.77 (brs, 1H), 3.35 (t, J = 10.1
Hz, 1H), 3.21 (s, 3H), 3.21-3.17 (m, 1H), 2.45 (q, J = 5.45 Hz, 1H), 2.19 (d, J = 13.6 Hz,
1H), 2.12 (d, J = 12.8 Hz, 1H), 2.06 (d, J = 12.8 Hz, 1H), 1.95-1.88 (m, 2H), 1.88 (s, 3H),
1.80-1.73 (brs, 1H), 1.70-1.60 (m, 6H), 1.60-1.52 (m, 3H), 1.42-1.44 (m, 2H), 1.29 (d, J
= 6.5 Hz, 3H), 1.25 (s, 3H), 1.11-0.99 (m, 18H), 0.95-0.85 (m, 3H), 0.82 (d, J = 6.9 Hz,
3H);

13

C NMR (125 MHz, CDCl3) δ = 205.6, 160.5, 159.5, 150.3, 145.0, 144.8, 133.3,

130.1, 129.7, 114.1, 113.7, 108.5, 79.3, 78.2, 75.3, 74.9, 73.4, 70.5, 68.3, 56.6, 55.4, 44.6,
41.7, 40.9, 40.8, 40.0, 36.8, 36.6, 33.6, 31.5, 29.8, 20.7, 19.4, 18.5, 18.4, 17.7, 14.9, 13.2;
high resolution mass (ES) m/z 820.5123 [(M+Na)+ calcd for C46H75NO8SiNa]
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Carboxylic Acid (+)-2.20 (route 1, from aldehyde (+)-2.76): To a solution of aldehyde
(+)-2.76 (15 mg, 0.019 mmol, 1.0 equiv) in 3.5 mL of tBuOH/H2O (2.5:1), 2-methyl-2butene (0.5 mL), NaH2PO3 (15 mg, 0.13 mmol, 6.7 equiv) and NaClO2 (12 mg, 90%,
0.12 mmol, 6.4 equiv) were added subsequently at room temperature in an air
atmosphere. The resulting mixture was stirred for 20 minutes at the same temperature
before it was diluted by saturated pH7 aqueous buffer solution (5 mL) and then ethyl
acetate (10 mL). The organic layer was separated, and the aqueous phase was extracted
with ethyl acetate (5 mL) twice. The combined organic layers were washed with brine (2
mL), dried over MgSO4, filtered and concentrated, and the resulting oil was purified by
column chromatography (SiO2, ethyl acetate: hexanes 10:90, 20:80, 30:70) to furnish
aldehyde (+)-2.76 (13.1 mg, 0.0161 mmol, 85.4%) as a colorless oil.
Carboxylic Acid (+)-2.20 (route 2, from diol (+)-2.75): To a solution of diol (+)-2.75
(18.0 mg, 0.0226 mmol, 1.0 equiv) in 0.5 mL of t-BuOH and 0.2 mL of pH 7 buffer
solution, TEMPO solution (0.025 M in CH3CN, 0.025 mL, 0.025 mmol, 1.11 equiv.) was
added at room temperature under an air atmosphere. The resulting mixture was stirred for
20 minutes at the same temperature before the subsequent addition of NaClO2 (1 M in
water, 0.075 mL, 0.075 mmol, 3.32 equiv) and NaClO (0.025 M in water, 0.67 mL, 0.038
mmol, 1.66 equiv) solution. The reaction was stirred at room temperature for 3 hours
before it was quenched by saturated aqueous Na2S2O3 solution (3 mL), After dilution
with ethyl acetate (5 mL), the organic layer was separated, and the aqueous phase was
extracted with ethyl acetate (5 mL) twice. The combined organic layers were washed
with brine (2 mL), dried over MgSO4, filtered and concentrated, and the resulting oil was
purified by column chromatography (SiO2, ethyl acetate: hexanes 20:80, 30:70, 50:50,
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80:20) to furnish acid (+)-2.61 (12.4 mg, 0.0152 mmol, 67.3%) as a colorless oil
[]20D = 3.07 (c 0.30, CHCl3); IR (film) 2926, 2865, 1735, 1707, 1514, 1463, 1381, 1248,
883, 821, 666 cm-1; 1H NMR (500 MHz, CDCl3) δ = 7.46 (s, 1H), 7.27 (d, J = 8.1 Hz,
2H), 6.87 (d, J = 8.1 Hz, 2H), 6.22 (s, 1H), 5.03 (q, J = 6.5 Hz, 1H), 4.89 (d, J = 8.8 Hz,
1H), 4.68 (d, J = 6.0 Hz, 2H), 4.61 (d, J = 11.2 Hz, 1H), 4.40 (d, J = 11.2 Hz, 1H), 3.98
(t, J = 6.5 Hz, 1H), 3.80 (s, 3H), 3.80-3.77 (brs, 1H), 3.27-3.20 (m, 1H), 3.21 (s, 3H),
3.20-3.13 (m, 1H), 2.48 (m, 1H), 2.21-2.10 (m, , 3H), 2.01-1.97 (m, 1H), 1.89 (s, 3H),
1.89-1.87 (m, 1H). 1.78-1.65 (m, 5H), 1.61-1.50 (m, 5H), 1.48-1.35 (m, 2H), 1.29 (d, J =
6.5 Hz, 3H), 1.30-1.25 (m, 1H), 1.20-1.14 (m, 4H) 1.11-1.03 (m, 19H), 1.02-0.93 (m,
1H), 0.87 (d, J = 6.5 Hz, 3H);

13

C NMR (125 MHz, CDCl3) δ = 180.4, 160.9, 159.5,

151.1, 145.0, 144.5, 133.7, 130.1, 129.7, 114.1, 113.4, 108.4, 79.7, 78.6, 75.9, 75.0, 73.3,
70.5, 68.0, 56.6, 55.4, 42.0, 41.2, 41.0, 40.8, 37.9, 36.8, 36.6, 36.3, 33.7, 21.6, 19.5, 18.5,
18.4, 18.0, 17.8, 14.6, 13.3; high resolution mass (ES) m/z 814.5298 [(M+H)+ calcd for
C46H76NO9Si]

Macrolide (+)-2.48: To a solution of carboxylic acid (+)-2.20 (24 mg, 0.030 mmol, 1.0
equiv.) in 0.75 mL of THF, Hunig’s base (0.06 mL) was added followed by 2,4,6137

trichlorobenzoyl chloride (54 mg, 0.22 mmol, 7.5 equiv) at room temperature under a
nitrogen atmosphere. The resulting mixture was stirred for 3 hours at the same
temperature before it was diluted by toluene (3 mL). This activated macrolide precursor
solution was stored at room temperature for further transformation.
To a solution of DMAP (120 mg, 0.982 mmol, 33.2 equiv) in 30 mL of toluene, the
activated macrolide precursor solution was slowly added using a syringe pump over 5
hours at reflux temperature under a nitrogen atmosphere. The resulting mixture was
stirred for a further 12 hours at the same temperature before it was cooled to room
temperature. The resulting mixture was filtered and concentrated, the resulting mixture
was purified by column chromatography (SiO2, ethyl acetate: hexanes 5:95, 10:90, 20:80)
to give the crude macrolide, which was then purified by PTLC (SiO2, ethyl acetate:
hexanes 10:90) to furnish macrolide (+)-2.48 (20.8 mg, 0.0261 mmol, 88.5%) as a
colorless oil.
[]20D = 10.31 (c = 0.33, CHCl3); IR (film) 2927, 2856, 1750, 1653, 1613. 1577, 1548,
1513, 1464, 1378, 1248, 1160, 1097, 883, 820, 666 cm-1; 1H NMR (500 MHz, CDCl3) δ =
7.44 (s, 1H), 7.30 (d, J = 8.6 Hz, 2H), 6.89 (d, J = 8.6 Hz, 2H), 6.20 (s, 1H), 5.96 (dd, J =
12.6 Hz, 2.6 Hz, 1H), 5.20 (q, J = 6.5 Hz, 1H), 4.70 (s, 2H), 4.64 (d, J = 10.9 Hz, 1H),
4.43 (d, J = 10.9 Hz, 1H), 4.12 (dd, J = 11.1 Hz, 4.1 Hz, 1H), 3.81 (s, 3H), 3.42 (t, J =
10.0 Hz, 1H), 3.30 (t, J = 11.1 Hz, 1H), 3.21 (s, 3H), 3.10 (t, J = 9.2 Hz, 1H), 2.73 (td, J
= 13.3 Hz, 3.5 Hz, 1H), 2.69-2.63 (m, 1H), 2.13-2.03 (m, 3H), 1.99-1.93 (m, 1H), 1.91
(d, J = 1.3 Hz, 3H), 1.89-1.85 (m, 1H). 1.83-1.70 (m, 4H), 1.66-1.58 (m, 4H), 1.50-1.55
(m, 1H), 1.48-1.35 (m, 2H), 1.31 (d, J = 6.6 Hz, 3H), 1.30-1.25 (m, 2H), 1.14 (d, J = 6.8
Hz, 3H) 1.12-1.05 (m, 19H), 0.95-0.90 (m, 1H), 0.85 (d, J = 6.5 Hz, 3H); 13C NMR (125
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MHz, CDCl3) δ = 175.0, 160.7, 159.5, 151.4, 145.0, 141.3, 134.0, 130.9, 129.7, 114.1,
113.4, 108.7, 76.1, 75.9, 75.0, 74.5, 71.8, 71.3, 65.0, 56.7, 55.5, 42.5, 41.8, 41.5, 39.2,
38.6, 37.6, 35.2, 34.5, 31.6, 20.8, 19.4, 18.6, 18.5, 18.1, 17.9, 14.3, 13.4; high resolution
mass (ES) m/z 796.5194 [(M+H)+ calcd for C46H74NO9Si]

Alcohol (+)-2.78: To a solution of TIPS ether (+)-2.48 (9.0 mg, 0.0113 mmol, 1.0 equiv)
in 3.5 mL of THF in a plastic container, pyridine (3.9 mL) was added followed by
HF/pyridine complex (1.0 mL) at room temperature in an air atmosphere. The resulting
mixture was stirred for 48 hours at 45 °C before it was quenched slowly with saturated
aqueous NaHCO3 (12.0 mL) at room temperature. The resulting mixture was diluted with
ethyl acetate (20 mL). The organic layer was separated, and the aqueous phase was
extracted with ethyl acetate (8 mL) twice. The combined organic layers were washed
with brine (5 mL), dried over MgSO4, filtered and concentrated, the resulting mixture
was purified by column chromatography (SiO2, ethyl acetate: hexanes, 30:70. 40:60,
50:50) to furnish alcohol (+)-2.78 (5.1 mg, 0.0080 mmol, 70.5%) as a colorless oil.
[]20D = 4.93 (c 0.42, CHCl3); IR (film) 2917.8, 2849.3, 1708.1, 1552.4, 1513.4, 1463.2,
1378.4, 1149.9, 1096.8, 807.1, 720.3 cm-1; 1H NMR (500 MHz, CDCl3) δ = 7.49 (s, 1H),
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7.27 (d, J = 8.1 Hz, 2H), 6.87 (d, J = 8.1 Hz, 2H), 6.20 (s, 1H), 5.84 (dd, J = 12.6 Hz, 2.6
Hz, 1H), 5.16 (q, J = 6.5 Hz, 1H), 4.68 (s, 2H), 4.60 (d, J = 10.9 Hz, 1H), 4.41 (d, J =
10.9 Hz, 1H), 3.80 (s, 4H), 3.47 (t, J = 10.4 Hz, 1H), 3.30 (q, J = 10.4 Hz, 2H), 3.23 (s,
3H), 2.75 (td, J = 12.6 Hz, 3.2 Hz, 1H), 2.70-2.64 (m, 1H), 2.13 (d, J = 13.5 Hz, 2H),
2.04-1.95 (m, 2H), 1.90 (s, 3H), 1.86-1.76 (m, 3H), 1.76-1.60 (m, 5H), 1.48-1.33 (m,
4H), 1.30 (d, J = 6.4 Hz, 3H), 1.18 (d, J = 6.5 Hz, 3H), 0.85 (d, J = 6.5 Hz, 3H);

13

C

NMR (125 MHz, CDCl3) δ = 175.9, 160.6, 159.4, 151.2, 145.0, 140.6, 134.7, 130.7,
129.7, 114.0, 113.4, 108.5, 76.1, 75.7, 75.03, 74.95, 71.0, 68.9, 65.8, 56.7, 55.4, 41.9,
41.7, 41.5, 38.0, 37.0, 36.5, 35.4, 33.8, 31.6, 21.1, 19.4, 17.8, 16.7, 13.1; high resolution
mass (ES) m/z 640.3849 [(M+H)+ calcd for C37H54NO8]

δ-Lactone ()-2.79: δ-lactone ()-2.79 was isolated as a by-product of TIPS removal
reaction of macrolide (+)-2.48
[]20D = -3.51 (c 0.7, CHCl3); IR (film) 2923, 2852, 1738, 1553, 1514, 1463, 1379, 1249,
1174, 1099, 1036, 804 cm-1; 1H NMR (500 MHz, CDCl3) δ = 7.45 (s, 1H), 7.27 (d, J =
8.3 Hz, 2H), 6.88 (d, J = 8.3 Hz, 2H), 6.18 (s, 1H), 5.13 (q, J = 6.5 Hz, 1H), 4.83 (d, J =
9.0 Hz, 1H), 4.71 (s, 2H), 4.62 (d, J = 5.5 Hz, 1H), 4.60 (d, J = 10.9 Hz, 1H), 4.41 (d, J =
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10.9 Hz, 1H), 3.98 (s, 1H), 3.80 (s, 4H), 3.57 (t, J = 10.4 Hz, 1H), 3.30-3.24 (m, 1H),
3.21 (s, 3H), 2,63-2.57 (m, 1H), 2.22-2.18 (m, 2H), 2.07 (d, J = 14.3 Hz, 1H), 2.06-1.98
(m, 1H), 1.98-1.82 (m, 3H), 1.90 (s, 3H), 1.75-1.52 (m, 5H), 1.51-1.42 (m, 4H), 1.32 (d, J
= 6.4 Hz, 3H), 1.26 (d, J = 6.5 Hz, 3H), 1.01 (d, J = 6.5 Hz, 3H); 13C NMR (125 MHz,
CDCl3) δ = 174.8, 160.6, 159.6, 150.5, 144.9, 144.3, 133.4, 130.2, 129.8, 114.2, 113.8,
109.1, 80.3, 79.2, 78.2, 75.0, 74.2, 70.5, 68.2, 56.7, 55.5, 41.5, 41.02, 40.98, 40.0, 36.7,
36.0, 33.5, 31.5, 30.6, 20.7, 19.5, 18.1, 17.8, 11.9; high resolution mass (ES) m/z
640.3859 [(M+H)+ calcd for C37H54NO8]

δ-Lactone ()-2.81: To a solution of PMB ether (-)-2.79 (4.0 mg, 0.0063 mmol, 1.0
equiv.) in 1.5 mL of dichloromethane, a mixture of TFA/H2O (0.4 mL, TFA:H2O 1:1) was
added dropwise at room temperature. The resulting mixture was stirred for 1 hour at the
same temperature before it was quenched with saturated aqueous NaHCO3 (5.0 mL) at
room temperature. The resulting mixture was diluted with ethyl acetate (10 mL). The
organic layer was separated, and the aqueous phase was extracted with ethyl acetate (5
mL) twice. The combined organic layers were washed with brine (5 mL), dried over
MgSO4, filtered and concentrated, and the resulting mixture was purified by column
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chromatography (SiO2, ethyl acetate: hexanes, 40:60, 50:50, 70:30) to furnish δ-lactone ()-2.81 (2.2 mg, 0.00419 mmol, 67.0%) as a colorless oil.
[]20D = -12.58 (c 0.20, CHCl3); IR (film) 2920, 1727, 1649, 1551, 1449, 1379, 1323,
1204, 1097 cm-1; 1H NMR (500 MHz, CD3OD) δ = 7.69 (s, 1H), 6.23 (s, 1H), 5.23 (q, J =
6.4 Hz, 1H), 4.82 (m, 1H), 4.73 (d, J = 1.5 Hz, 2H), 4.68 (ddd, J = 9.5, 2.5, 2.5 Hz, 1H),
3.68 (m, 1H), 3.46 (t, J = 10.5 Hz, 1H), 3.24 (m, 1H), 3.21 (s, 1H), 2.64 (m, 1H), 2.24 (s,
1H), 2.22 (s, 1H), 2.10-2.00 (m, 2H), 1.95-1.85 (m, 4H), 1.89 (s, 3H), 1.78-1.72 (m, 2H),
1.65 (m, 1H), 1.60 (m, 1H), 1.52-1.42 (m, 3H), 1.28 (d, J = 6.5 Hz, 3H), 1.24 (d, J = 7.3
Hz, 3H), 1.01 (d, J = 6.9 Hz, 3H) 13C NMR (125 MHz, CD3OD) δ = 177.0, 161.5, 151.7,
145.7, 145.6, 135.3, 114.1, 108.8, 81.8, 79.4, 75.9, 75.5, 70.5, 66.2, 56.5, 44.1, 42.0, 41.6,
40.2, 38.3, 37.0, 36.2, 32.3, 31.4, 22.3, 19.3, 17.9, 17.3, 11.8; high resolution mass (ES)
m/z 520.3254 [(M+H)+ calcd for C29H46NO7]

Phosphoric Ester (-)-2.87: To a solution of alcohol (+)-2.78 (3.5 mg, 0.0055 mmol, 1.0
equiv) in 0.2 mL of acetonitrile, 1H-tetrazole solution (0.45 M in acetonitrile, 0.195 mL,
0.088 mmol, 16.0 equiv) was added followed by i-Pr2NP(OFm)2 solution (57.5 mg in 0.2
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mL dichloromethane, 0.110 mmol, 20.0 equiv) at room temperature in an argon
atmosphere. The resulting mixture was stirred for 50 minutes at the same temperature
before it was cooled to 0 °C. 0.2 mL of H2O2 solution (50% in water) was added to the
reaction mixture at 0 °C, allowing the resulting mixture to be stirred at the same
temperature for 30 minutes. The resulting mixture was quenched by saturated aqueous
NaHCO3 (3.0 mL) at room temperature. The resulting mixture was diluted by ethyl
acetate (5 mL). The organic layer was separated, and the aqueous phase was extracted
with ethyl acetate (3 mL) twice. The combined organic layers were washed with brine (5
mL), dried over MgSO4, filtered and concentrated, and the resulting mixture was purified
by column chromatography (SiO2, ethyl acetate: hexanes, 40:60, 50:50, 60:40) to furnish
phosphorus ester 2.86 together with inseparable phosphate impurity as a colorless oil.
To a solution of the resulting mixture, including phosphoric ester 2.86 in DCM/pH7
aqueous buffer solution (4.4 mL, 10:1), DDQ (8.0 mg) was added in one portion at room
temperature. The resulting mixture was stirred for 30 minutes at the same temperature
before it was diluted by diethyl ether (10 mL). The organic layer was separated, and the
aqueous phase was extracted with diethyl ether (2 mL) twice. The combined organic
layers were washed with brine (1 mL), dried over MgSO4, filtered and concentrated, and
the resulting mixture was purified by column chromatography (SiO2, ethyl acetate:
hexanes, 50:50, 60:40, 80:20) to furnish phosphoric ester ()-2.87 (3.2 mg, 0.00334
mmol, 61.0% over two steps) as a colorless oil.
[]20D = -4.00 (c 0.6, CHCl3); IR (film) 2925, 2853, 1729, 1555, 1451, 1381, 1252, 1076,
1012, 741 cm-1; 1H NMR (500 MHz, CDCl3) δ = 7.76-7.68 (m, 4H), 7.56-7.49 (m, 3H),
7.46 (d, J = 7.5 Hz, 1H), 7.41-7.31 (m, 4H), 7.39 (s, 1H), 7.30-7.20 (m, 4H), 6.16 (s, 1H),
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5.98 (dd, J = 11.8 , 3.1 Hz, 1H), 5.18 (q, J = 6.5 Hz, 1H) , 4.72 (d, J = 3.1 Hz, 2H), 4.60
(m, 1H), 4.30-4.23 (m, 2H), 4.23-4.15 (m, 2H), 4.15-4.10 (m, 2H), 3.63 (brt, J = 9.2 Hz,
1H), 3.30 (t, J = 10.7 Hz, 1H), 3.22 (s, 1H), 3.07 (t, J = 9.1 Hz, 1H), 2.71 (m, 1H), 2.49
(m, 1H), 2.10 (d, J = 13.5 Hz, 1H), 2.03 (d, J = 13.5 Hz, 1H), 1.94-1.82 (m, 2H), 1.89 (s,
3H), 1.75 (dd, J = 13.5, 4.4 Hz, 2H), 1.72-1.60 (m, 4H), 1.86-1,76 (m, 3H), 1.47-1.39 (m,
2H), 1.39-1.30 (m, 2H), 1.28 (d, J = 6.4 Hz, 3H), 1.09 (m, 1H), 0.99 (d, J = 6.6 Hz, 3H),
0.89 (d, J = 6.4 Hz, 3H);
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C NMR (125 MHz, CDCl3) δ = 174.4, 160.7, 151.6, 144.6,

143.38, 143.35, 143.32, 143.29, 141.5, 141.2, 133.9, 128.13, 128.11, 128.09, 127.38,
127.36, 127.31, 125.4, 125.3, 125.24, 125.22, 120.32, 120.27, 120.25, 113.2, 108.9,
78.81, 78.75, 75.1, 75.0, 74.6, 69.55, 69.48, 69.43, 69.21, 69.17, 64.9, 56.7, 48.23, 48.21,
48.18, 48.14, 42.0, 41.5, 41.4, 39.0, 38.4, 38.2, 35.2, 33.8, 33.7, 33.1, 20.9, 19.4, 17.9,
17.8, 14.3;

31

P NMR (200 MHz, CDCl3) δ = -1.53 ; high resolution mass (ES) m/z

956.4521 [(M+H)+ calcd for C57H67NO10P]

Enigmazole A (Phosphoric Acid Format) 2.90: To a solution of phosphorus ester (-)2.87 (2.0 mg, 0.0021 mmol, 1.0 equiv) in 0.4 ml of MeOH/H2O (2:1), 6 mg of Na2CO3
was added at room temperature. The resulting mixture was stirred for 24 hours at the
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same temperature before the addition of CD3COOD (15 mg). The resulting mixture then
stirred at the same temperature for 10 minutes before it was extracted with pentane (0.5
mL) there times. The solvent and CD3COOD was removed under high vaccum from the
mixture to furnish enigmazole A ()-2.1 together with CD3COONa. The further
purification was achieved by RP HPLC (VydacTM 5 μm C18, 250*10 mm, 5%
MeCN/95% H2O with 0.1% TFA to 40% MeCN/60% H2O with 0.1% TFA linear gradient
over 15 min, then 40% MeCN/60% H2O with 0.1% TFA for 15 min, 10 mL/min, λ = 254
nm) to give enigmazole A free acid format (1.4 mg, 0.0020 mmol, 95.0%) as a colorless
oil. 1H NMR (500 MHz, CD3OD) δ = 7.70 (s, 1H), 6.21 (s, 1H), 5.97 (dd, J = 12.8, 2.2
Hz, 1H), 5.24 (q, J = 6.5 Hz, 1H), 4.72 (s, 2H), 4.58 (m, 1H), 3.58 (td, J = 10.1 Hz, 3.0
Hz, 1H), 3.20 (s, 3H), 3.14 (m, 1H), 2.87 (m, 1H), 2.51 (td, J = 13.7 Hz, 3.8 Hz, 1H),
2.20-2.13 (m, 2H), 2.01-1.94 (m, 3H), 1.89 (d, J = 1.2 Hz, 3H), 1.86-1.83 (m, 1H), 1.781.70 (m, 4H), 1.69-1.60 (m, 2H), 1.48 (q, J = 12.4 Hz, 1H), 1.44-1.37 (m,1H), 1.37-1.30
(m, 1H), 1.26 (d, J = 6.6 Hz, 3H), 1.11 (d, J = 6.7 Hz, 3H), 1.05-1.01 (m, 1H), 0.98 (d, J
= 5.9 Hz, 1H) 13C NMR (125MHz, CD3OD) δ = 176.2, 161.9, 152.8, 146.2, 142.2, 136.0,
114.0, 109.0, 77.8 (d, J = 5.8 Hz), 76.9, 76.2, 75.9, 69.8, 65.9, 56.8, 43.0, 42.6, 42.4,
40.1, 39.6, 39.2, 36,1, 34.6 (d, J = 5.2 Hz), 33.6, 21.9, 19.5, 18.1, 17.7, 15.6.
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Enigmazole A (Monophosphate Format) ()-2.1: To the neat phosphoric acid 2.90 (1.4
mg) in a 3mm glass NMR tube, 0.2 mL of saturated NaHCO3 CD3OD solution was added
to furnish monophosphate ()-2.1 in CD3OD solution
[]20D = -1.05 (c = 0.12, CHCl3), 1H NMR (500 MHz, CD3OD) δ = 7.68 (s, 1H), 6.21 (s,
1H), 5.95 (dd, J = 12.8, 2.5 Hz, 1H), 5.24 (q, J = 6.5 Hz, 1H), 4.70 (d, J = 1.5 Hz, 1H),
4.69 (d, J = 1.5 Hz, 1H), 4.42 (m, 1H), 3.62 (td, J = 10.1 Hz, 2.9 Hz, 1H), 3.20 (s, 3H),
3.12 (dd, J = 10.2 Hz, 8.9 Hz, 1H), 2.98 (m, 1H), 2.50 (td, J = 13.4 Hz, 3.9 Hz, 1H), 2.21
(d, J =12.8 Hz, 1H), 2.13 (d, J = 12.8 Hz, 1H). 2.10 (m, 1H), 1.97 (t, J = 12.2, 1H), 1.89
(s, 3H), 1.88-1.83 (m, 3H), 1.80-1.72 (m, 3H), 1.66-1.60 (m, 2H), 1.54 (q, J =12.4 Hz,
1H), 1.39 (t, J = 11.3 Hz, 1H), 1.37 (t, J = 11.1 Hz, 1H), 1.26 (d, J = 6.4 Hz, 3H), 1.10 (d,
J = 6.6 Hz, 3H), 1.02 (td, J = 12.0 Hz, 2.6 Hz, 1H), 0.97 (d, J = 6.6 Hz, 1H) 13C NMR
(125MHz, CD3OD) δ = 176.5, 161.9, 152.7, 146.6, 142.4, 136.0, 113.9, 108.6, 77.6, 76.2,
75.7, 75.2 (d, J = 6.4 Hz), 69.8, 65.7, 56.8, 43.0, 42.6, 42.5, 40.1, 39.6, 39.3, 36,2, 34.7
(d, J = 6.6 Hz), 33.6, 21.8, 19.4, 18.3, 17.7, 15.0; 31P (200 MHz, CD3OD) δ = 1.45; high
resolution mass (ES) m/z 598.2759 [(M-H)- calcd for C29H45NO10P]
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Enigmazole A (Diphosphate Format) 2.91: To a solution of enigmazole A
(Monophosphate Format) ()-2.1 (1.4 mg) in 0.2 mL of saturated NaHCO3 CD3OD
solution in 3mm glass NMR tube , 0.02 mL of 1 M NaOH CD3OD solution was added to
furnish enigmazole A (diphosphate format) 2.91 in CD3OD solution. 1H NMR (500 MHz,
CD3OD) δ = 7.68 (s, 1H), 6.21 (s, 1H), 5.93 (dd, J = 13.1, 2.9 Hz, 1H), 5.23 (q, J = 6.5
Hz, 1H), 4.67 (s, 2H), 4.31 (m, 1H), 3.64 (td, J = 10.8 Hz, 2.8 Hz, 1H), 3.20 (s, 3H), 3.14
(m, 1H), 3.09 (m, 1H), 2.50 (td, J = 12.3 Hz, 3.1 Hz, 1H), 2.29-2.20 (m, 2H), 2.14-2.09
(m, 1H), 2.06-1.95 (m, 2H), 1.88 (d, J = 1.2 Hz, 3H), 1.87-1.78 (m, 2H), 1.78-1.70 (m,
2H), 1.78-1.67 (m, 2H), 1.63-1.51 (m, 3H), 1.48 (q, J = 12.4 Hz, 1H), 1.40-1.47 (m, 3H),
1.26 (d, J = 6.6 Hz, 3H), 1.12 (d, J = 6.5 Hz, 3H), 1.06-0.99 (m, 1H), 0.97 (d, J = 6.7 Hz,
1H)

13

C NMR (125MHz, CD3OD) δ = 177.4, 161.9, 152.6, 147.0, 142.5, 135.9, 114.0,

108.3, 78.0, 76.3, 75.7, 73.6, 69.8, 65.7, 56.8, 43.2, 42.7, 42.6, 40.3, 39.8, 39.5, 36,3, 34.9
(d, J = 6.8 Hz), 33.7, 21.8, 19.5, 18.6, 17.7, 15.4 (Na2CO3 peak was shown in 161.5)
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Appendix. Spectral Data for Compunds in Chapter 2
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Firgure A1.1 the 500 MHz 1H-NMR Spectrum of Iodide (+)-2.29 in CDCl3
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Firgure A1.2 the 125 MHz 13C-NMR Spectrum of Iodide (+)-2.29 in CDCl3
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Firgure A1.3 The Infrared Spectrum of Iodide (+)-2.29
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Firgure A1.4 the 500 MHz 1H-NMR Spectrum of chloride 2.33 in CDCl3

153

Firgure A1.5 the 125 MHz 13C-NMR Spectrum of chloride 2.33 in CDCl3
in CDCl3

.

.

154

Firgure A1.6 the Infrared Spectrum of chloride 2.33
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Firgure A1.8 the 125 MHz 13C-NMR Spectrum of ester (+)-2.34 in CDCl3

157

Firgure A1.9 the Infrared Spectrum of ester (+)-2.34 in CDCl3
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Firgure A1.10 the 500 MHz 1H-NMR Spectrum of Aldehyde (+)-2.35 in CDCl3
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Firgure A1.11 the 125 MHz 13C-NMR Spectrum of Aldehyde (+)-2.35 in CDCl3
in CDCl3
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Firgure A1.12 The Infrared Spectrum of Aldehyde (+)-2.35
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Firgure A1.13 the 500 MHz 1H-NMR Spectrum of Dithiane (+)-2.23 in CDCl3
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Firgure A1.14 the 125 MHz 13C-NMR Spectrum of Dithiane (+)-2.23 in CDCl3
in CDCl3
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Firgure A1.15 The Infrared Spectrum of Dithiane (+)-2.23
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Firgure A1.16 the 500 MHz 1H-NMR Spectrum of Dithiane (-)-2.42 in CDCl3
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Firgure A1.17 the 150 MHz 13C-NMR Spectrum of Dithiane (-)-2.42 in CDCl3
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Firgure A1.18 the Infrared Spectrum of Dithiane (-)-2.42
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Firgure A1.19 the 500 MHz 1H-NMR Spectrum of Alcohol (-)-2.43 in CDCl3
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Firgure A1.20 the 125 MHz 13C-NMR Spectrum of Alcohol (-)-2.43 in CDCl3
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Firgure A1.21 the Infrared Spectrum of Alcohol (-)-2.43
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Firgure A1.22 the 500 MHz 1H-NMR Spectrum of Diol (-)-2.44 in CDCl3
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Firgure A1.23 the 125 MHz 13C-NMR Spectrum of Diol (-)-2.44 in CDCl3
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Firgure A1.21 the Infrared Spectrum of Diol (-)-2.44
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Firgure A1.25 the 500 MHz 1H-NMR Spectrum of Epoxide (-)-2.24 in CDCl3
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Firgure A1.26 the 125 MHz 13C-NMR Spectrum of Epoxide (-)-2.24 in CDCl3
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Firgure A1.27 the Infrared Spectrum of Epoxide (-)-2.24
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Firgure A1.28 the 500 MHz 1H-NMR Spectrum of Alcohol (+)-2.45 in CDCl3
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Firgure A1.29 the 125 MHz 13C-NMR Spectrum of Alcohol (+)-2.45 in CDCl3
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Firgure A1.30 the Infrared Spectrum of Alcohol (+)-2.45
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Firgure A1.31 the 500 MHz 1H-NMR Spectrum of Olefin (-)-2.46 in CDCl3
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Firgure A1.32 the 125 MHz 13C-NMR Spectrum of Olefin (-)-2.46 in CDCl3
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Firgure A1.33 the Infrared Spectrum of Olefin (-)-2.46

182

Firgure A1.34 the 500 MHz 1H-NMR Spectrum of Dithiane (+)-2.52 in CDCl3
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Firgure A1.35 the 125 MHz 13C-NMR Spectrum of Dithiane (+)-2.52 in CDCl3
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Firgure A1.36 the Infrared Spectrum of Dithiane (+)-2.52
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Firgure A1.37 the 500 MHz 1H-NMR Spectrum of Ketone (+)-2.53 in CDCl3
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Firgure A1.38 the 125 MHz 1H-NMR Spectrum of Ketone (+)-2.53 in CDCl3
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Firgure A1.39 the Infrared Spectrum of Ketone (+)-2.53
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Firgure A1.40 the 500 MHz 1H-NMR Spectrum of Diol (+)-2.54 in CDCl3
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Firgure A1.41 the 125 MHz 13C-NMR Spectrum of Diol (+)-2.54 in CDCl3
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Firgure A1.42 the Infrared Spectrum of Diol (+)-2.54
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Firgure A1.43 the 500 MHz 1H-NMR Spectrum of Acetal (-)-2.55 in CDCl3
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Firgure A1.44 the 125 MHz 1H-NMR Spectrum of Acetal (-)-2.55 in CDCl3
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Firgure A1.45 the Infrared Spectrum of Acetal (-)-2.55
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Firgure A1.46 the 500 MHz 1H-NMR Spectrum of Alcohol (+)-2.56 in CDCl3
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Firgure A1.47 the 125 MHz 13C-NMR Spectrum of Alcohol (+)-2.56 in CDCl3
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Firgure A1.48 the 500 MHz 1H-NMR Spectrum of Diol (+)-2.57 in CDCl3
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Firgure A1.49 the 125 MHz 13C-NMR Spectrum of Diol (+)-2.57 in CDCl3
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Firgure A1.50 the Infrared Spectrum of Diol (+)-2.57
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Firgure A1.51 the 500 MHz 1H-NMR Spectrum of Alcohol (-)-2.64 in CDCl3
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Firgure A1.52 the 125 MHz 13C-NMR Spectrum of Alcohol (-)-2.64 in CDCl3
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Firgure A1.53 the Infrared Spectrum of Alcohol (-)-2.64
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Firgure A1.54 the 500 MHz 1H-NMR Spectrum of Acid (+)-2.65 in CDCl3
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Firgure A1.55 the 125 MHz 13C-NMR Spectrum of Acid (+)-2.65 in CDCl3
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Firgure A1.56 the Infrared Spectrum of Acid (+)-2.65
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Firgure A1.57 the 500 MHz 1H-NMR Spectrum of Acid (+)-2.61 in CDCl3
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Firgure A1.58 the 125 MHz 13C-NMR Spectrum of Acid (+)-2.61 in CDCl3

207

Firgure A1.59 the Infrared Spectrum of Acid (+)-2.61 in CDCl3
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Firgure A1.60 the 500 MHz 1H-NMR Spectrum of Eastern Hemisphere (+)-2.22 in CDCl3
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Firgure A1.61 the 125 MHz 13C-NMR Spectrum of Eastern Hemisphere (+)-2.22 in CDCl3
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Firgure A1.62 the Infrared Spectrum of Eastern Hemisphere (+)-2.22
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Firgure A1.63 the 500 MHz 1H-NMR Spectrum of Alcohol (-)-2.68 in CDCl3
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Firgure A1.64 the 125 MHz 13C-NMR Spectrum of Alcohol (-)-2.68 in CDCl3
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Firgure A1.65 the Infrared Spectrum of Alcohol (-)-2.68

214

Firgure A1.66 the 500 MHz 1H-NMR Spectrum of Olefin (-)-2.69 in CDCl3
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Firgure A1.67 the 125 MHz 13C-NMR Spectrum of Olefin (-)-2.69 in CDCl3
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Firgure A1.68 the Infrared Spectrum of Olefin (-)-2.69 in CDCl3
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Firgure A1.69 the 500 MHz 1H-NMR Spectrum of Olefin (-)-2.70 in CDCl3
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Firgure A1.70 the 125 MHz 13C-NMR Spectrum of Olefin (-)-2.70 in CDCl3
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Firgure A1.71 the Infrared Spectrum of Olefin (-)-2.70 in CDCl3
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Firgure A1.72 the 500 MHz 1H-NMR Spectrum of Western Hemisphere (-)-2.4 in CDCl3
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Firgure A1.73 the 125 MHz 13C-NMR Spectrum of Western Hemisphere (-)-2.4 in CDCl3
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Firgure A1.74 the Infrared of Western Hemisphere (-)-2.4
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Firgure A1.75 the 500 MHz 1H-NMR Spectrum of Dioxanone(-)-2.70 in C6D6
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Firgure A1.76 the 125 MHz 13C-NMR Spectrum of Dioxanone(-)-2.70 in C6D6
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Firgure A1.77 the Infrared Spectrum of Dioxanone(-)-2.70 in C6D6
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Firgure A1.78 the 500 MHz 1H-NMR Spectrum of Enol Acetal (-)-2.71 in C6D6
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Firgure A1.79 the 125 MHz 13C-NMR Spectrum of Enol Acetal (-)-2.71 in C6D6
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Firgure A1.80 the Infrared Spectrum of Enol Acetal (-)-2.71
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Firgure A1.81 the 500 MHz 1H-NMR Spectrum of Olefin (-)-2.21 in C6D6
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Firgure A1.82 the 125 MHz 13C-NMR Spectrum of Olefin (-)-2.21 in C6D6
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Firgure A1.83 the Infrared Spectrum of Olefin (-)-2.21
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Firgure A1.84 the 500 MHz 1H-NMR Spectrum of Diol (+)-2.75 in CDCl3
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Firgure A1.85 the 125 MHz 13C-NMR Spectrum of Diol (+)-2.75 in CDCl3
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Firgure A1.86 the Infrared Spectrum of Diol (+)-2.75
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Firgure A1.87 the 500 MHz 1H-NMR Spectrum of Aldehyde (+)-2.76 in CDCl3
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Firgure A1.88 the 125 MHz 13C-NMR Spectrum of Aldehyde (+)-2.76 in CDCl3
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Firgure A1.89 the Infrared Spectrum of Aldehyde (+)-2.76
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Firgure A1.90 the 500 MHz 1H-NMR Spectrum of Acid (+)-2.20 in CDCl3
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Firgure A1.91 the 125 MHz 13C-NMR Spectrum of Acid (+)-2.20 in CDCl3
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Firgure A1.92 the Infrared Spectrum of Acid (+)-2.20
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Firgure A1.93 the 500 MHz 1H-NMR Spectrum of Macrolide (+)-2.48 in CDCl3
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Firgure A1.94 the 125 MHz 13C-NMR Spectrum of Macrolide (+)-2.48 in CDCl3
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Firgure A1.95 the Infrared Spectrum of Macrolide (+)-2.48
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Firgure A1.96 the 500 MHz 1H-NMR Spectrum of Alcohol (+)-2.78 in CDCl3

245

Firgure A1.97 the 125 MHz 13C-NMR Spectrum of Alcohol (+)-2.78 in CDCl3
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Firgure A1.98 the Infrared Spectrum of Alcohol (+)-2.78
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Firgure A1.99 the 500 MHz 1H-NMR Spectrum of δ-lactone (-)-2.79 in CDCl3

248

Firgure A1.100 the 125 MHz 13C-NMR Spectrum of δ-lactone (-)-2.79 in CDCl3
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Firgure A1.101 the Infrared Spectrum of δ-lactone (-)-2.79
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Firgure A1.102 the 500 MHz 1H-NMR Spectrum of δ-lactone (-)-2.81 in MeOD
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Firgure A1.103 the 125 MHz 13C-NMR Spectrum of δ-lactone (-)-2.81 in MeOD

252

Firgure A1.104 the Infrared Spectrum of δ-lactone (-)-2.81

253

Firgure A1.105 the 500 MHz 1H-NMR Spectrum of Ester (-)-2.87 in CDCl3
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Firgure A1.106 the 125 MHz 13C-NMR Spectrum of Ester (-)-2.87 in CDCl3

255

Firgure A1.107 the 200 MHz 31P-NMR Spectrum of Ester (-)-2.87 in CDCl3
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Firgure A1.108 the Infrared Spectrum of Ester (-)-2.87
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Firgure A1.109 the 500 MHz 1H-NMR Spectrum of Enigmazole A Phosphoric Acid 2.90 in CD3OD
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Firgure A1.110 the 125 MHz 13C-NMR Spectrum of Enigmazole A Phosphoric Acid 2.90 in CD3OD
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Firgure A1.111 the 500 MHz 1H-NMR Spectrum of Enigmazole A Monophosphate ()-2.1 in CD3OD

260

Firgure A1.112 the 125 MHz 13C-NMR Spectrum of Enigmazole A Monophosphate ()-2.1 in CD3OD

261

Firgure A1.113 the 200 MHz 31P-NMR Spectrum of Enigmazole A Monophosphate ()-2.1 in CD3OD

262

Firgure A1.114 the 500 MHz 1H-NMR Spectrum of Enigmazole A Diphosphate 2.91 in CD3OD

263

Firgure A1.115 the 125 MHz 13C-NMR Spectrum of Enigmazole A Diphosphate 2.91 in CD3OD
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